Document:

EX-10.39

 Exhibit 10.39 
 MANNKIND CORPORATION 
 Common Stock 

(par value $0.01 per share) 
 At-The-Market Issuance Sales Agreement 
 March 18, 2013 

Brinson Patrick Securities Corporation 
 1515
Broadway 
 11th Floor 
 New
York, NY 10036 
 Ladies and Gentlemen: 
 MannKind Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Brinson Patrick Securities Corporation
(“BPSC”), as follows: 
 1. Issuance and Sale of Shares. The Company agrees that, from time to time
during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through BPSC, shares (the “Placement Shares”) of the Company’s common stock, par value $0.01 per share (the
“Common Stock”), up to an aggregate offering price of $50,000,000 less the aggregate offering price of any Common Stock sold pursuant to the Concurrent Facility Agreement (as defined below), provided however , that in no
event shall the Company issue or sell through BPSC such number of Placement Shares that (a) would cause the Company to not satisfy the eligibility requirements for use of Form S-3 (including Instruction I.B.6. thereof), (b) exceeds the
number of shares of Common Stock registered on the effective Registration Statement (as defined below) pursuant to which the offering is being made or (c) exceeds the number of authorized but unissued shares of the Company’s Common Stock
(the lesser of (a), (b) and (c), the “Maximum Amount”). Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in this Section 1 on the
amount of Placement Shares issued and sold under this Agreement shall be the sole responsibility of the Company and that BPSC shall have no obligation in connection with such compliance. The issuance and sale of Placement Shares through BPSC
will be effected pursuant to the Registration Statement filed by the Company and declared effective by the Securities and Exchange Commission (the “Commission”), although nothing in this Agreement shall be construed as requiring the
Company to use the Registration Statement to issue any Placement Shares. 
 The Company has filed, in accordance with the
provisions of the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations thereunder (the “Securities Act Regulations”), with the Commission a registration statement on Form S-3
(File No. 333-183679), including a base prospectus, relating to certain securities, including the Placement 

 
Shares to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations thereunder. The Company has prepared a prospectus supplement specifically relating to the Placement Shares (the “Prospectus
Supplement”) to the base prospectus included as part of such registration statement. The Company will furnish to BPSC, for use by BPSC, copies of the prospectus included as part of such registration statement, as supplemented by the
Prospectus Supplement, relating to the Placement Shares. Except where the context otherwise requires, such registration statement, including all documents filed as part thereof or incorporated by reference therein, and including any information
contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act Regulations or deemed to be a part of such registration statement pursuant to Rule 430B of the Securities
Act Regulations, is herein called the “Registration Statement.” The base prospectus, including all documents incorporated therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus
Supplement, in the form in which such prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act Regulations, is herein called the
“Prospectus.” Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference
herein to the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with
the Commission deemed to be incorporated by reference therein (the “Incorporated Documents”). 
 For purposes
of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis
and Retrieval System, or if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, “EDGAR”). 
 2. Placements. Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a “Placement”), it will notify BPSC by email notice (or other method
mutually agreed to in writing by the parties) of the proposed terms of such Placement, which shall include at a minimum the number of Placement Shares to be issued, the time period during which sales are requested to be made, any limitation on the
number of Placement Shares that may be sold in any one day and any minimum price below which sales may not be made (a “Placement Notice”), the form of which is attached hereto as Schedule 1. The Placement Notice shall originate
from any of the individuals from the Company set forth on Schedule 3 (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from BPSC set forth on Schedule 3, as
such Schedule 3 may be amended from time to time. The Placement Notice shall be effective unless and until (i) BPSC declines to accept the terms contained therein for any reason, in its sole discretion by email notice to the Company within
one Business Day (as defined below) from the time the Placement Notice is received, (ii) the entire amount of the Placement Shares thereunder have been sold, (iii) the Company suspends or terminates the Placement Notice or (iv) this
Agreement has been terminated under the provisions of Section 13. The amount of any discount, 

  
 2 

 
commission or other compensation to be paid by the Company to BPSC in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in Schedule
2. It is expressly acknowledged and agreed that neither the Company nor BPSC will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to BPSC and BPSC does
not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of
the Placement Notice will control. 
 3. Sale of Placement Shares by BPSC. 

(a) Subject to the terms and conditions of this Agreement, for the period specified in the Placement Notice, BPSC will use its
commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the NASDAQ Global Market (the “Exchange”), to sell the Placement
Shares up to the amount specified, and otherwise in accordance with the terms of such Placement Notice. BPSC will provide written confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following
the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the compensation payable by the Company to BPSC pursuant to Section 2 with respect to such sales, and the
Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by BPSC (as set forth in Section 5(b)) from the gross proceeds that it receives from such sales. Subject to the terms of the Placement
Notice, BPSC shall sell Placement Shares only by methods deemed to be an “at the market” offering as defined in Rule 415 of the Securities Act Regulations, including without limitation sales made directly on the Exchange, on any other
existing trading market for the Common Stock or to or through a market maker. Subject to the terms of the Placement Notice and only with the Company’s prior written consent, BPSC may also sell Placement Shares by any other method permitted
by law, including but not limited to in negotiated transactions. “Trading Day” means any day on which shares of Common Stock are purchased and sold on the Exchange. 

(b) During the term of this Agreement, neither BPSC nor any of its affiliates or subsidiaries shall engage in (i) any short sale of
any security of the Company, (ii) any sale of any security of the Company that BPSC does not own or any sale which is consummated by the delivery of a security of the Company borrowed by, or for the account of, BPSC or (iii) any market
making bidding, stabilization or other trading activity with respect to the Common Stock or related derivative securities if such activity would be prohibited under Regulation M or other anti-manipulation rules under the Securities Act. Neither
BPSC nor any of its affiliates or subsidiaries shall engage in any proprietary trading or trading for BPSC’s (or its affiliates’ or subsidiaries’) own account. 
 4. Suspension of Sales. The Company or BPSC may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on
Schedule 3, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email
correspondence to each of the 

  
 3 

 
individuals of the other party set forth on Schedule 3), suspend any sale of Placement Shares; provided, however, that such suspension shall not affect or impair any party’s obligations with
respect to any Placement Shares sold hereunder prior to the receipt of such notice. Each of the parties agrees that no such notice under this Section 4 shall be effective against any other party unless it is made to one of the individuals
named on Schedule 3 hereto, as such Schedule may be amended from time to time. 
 5. Sale and Delivery to BPSC;
Settlement. 
 (a) Sale of Placement Shares. On the basis of the representations and warranties herein
contained and subject to the terms and conditions herein set forth, unless BPSC declines to accept the terms of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated
in accordance with the terms of this Agreement, BPSC, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares up to the
amount specified in, and otherwise in accordance with, the terms of such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that BPSC will be successful in selling Placement Shares, (ii) BPSC will
incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by BPSC to use its commercially reasonable efforts consistent with its normal trading and sales
practices and applicable law and regulations to sell such Placement Shares as required under this Agreement and (iii) BPSC shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as
otherwise agreed by BPSC and the Company. 
 (b) Settlement of Placement Shares. Unless otherwise specified in the
applicable Placement Notice, settlement for sales of Placement Shares will occur on the third (3rd) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a
“Settlement Date”). The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the “Net Proceeds”) will be equal to the aggregate sales price
received by BPSC, after deduction for (i) BPSC’s commission, discount or other compensation for such sales payable by the Company pursuant to Section 2 hereof, and (ii) any transaction fees imposed by any governmental or
self-regulatory organization in respect of such sales. 
 (c) Delivery of Placement Shares. On or before each
Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting BPSC’s or its designee’s account (provided BPSC shall have given the Company written notice of
such designee a reasonable period of time prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto
which in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, BPSC will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior
to, the Settlement Date. If the Company, or its transfer agent (if applicable), defaults in its obligation to deliver Placement Shares on a Settlement Date through no fault of BPSC, the Company agrees that in addition to and in no way

  
 4 

 
limiting the rights and obligations set forth in Section 11(a) hereto, it will (i) hold BPSC harmless against any loss, claim, damage, or expense (including reasonable legal fees and
expenses), as incurred, arising out of or in connection with such default by the Company or its transfer agent (if applicable) and (ii) pay to BPSC (without duplication) any commission, discount, or other compensation to which it would
otherwise have been entitled absent such default. 
 (d) Limitations on Offering Size. Under no circumstances
shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares, the aggregate gross sales proceeds of Placement Shares sold pursuant to this Agreement would exceed the lesser
of (A) together with all sales of Placement Shares under this Agreement, the Maximum Amount and (B) the amount authorized from time to time to be issued and sold under this Agreement by the Company’s board of directors, a duly
authorized committee thereof or a duly authorized executive committee, and notified to BPSC in writing. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price
lower than any minimum price authorized from time to time by the Company’s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to BPSC in writing. 

6. Representations and Warranties of the Company. Except as disclosed in the Registration Statement or the Prospectus
(including Incorporated Documents), the Company represents and warrants to, and agrees with BPSC that as of the date of this Agreement and as of each Applicable Time (as defined below), unless such representation, warranty or agreement specifies a
different time: 
 (a) Registration Statement and Prospectus. The Company and, assuming no act or omission on the
part of BPSC that would make such statement untrue, the transactions contemplated by this Agreement meet the requirements for and comply with the conditions for the use of Form S-3 under the Securities Act. The Registration Statement has been
filed with the Commission and has been declared effective under the Securities Act. The Prospectus Supplement will name BPSC as an agent in the section entitled “Plan of Distribution.” The Company has not received, and has no
notice of, any order of the Commission preventing or suspending the use of the Registration Statement, or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement Shares as
contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule. Any statutes, regulations, contracts or other documents that are required to be described in the
Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement have been so described or filed. Copies of the Registration Statement, the Prospectus, and any such amendments or supplements and all documents
incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to BPSC and its counsel. The Company has not distributed and, prior to the
later to occur of each Settlement Date and completion of the distribution of the Placement Shares, will not distribute any offering material in connection with the offering or sale of the Placement Shares other than the Registration Statement and
the Prospectus and any Issuer Free Writing Prospectus (as defined below) to which BPSC has consented, such consent not to be unreasonably withheld, conditioned 

  
 5 

 
or delayed. The Common Stock is currently quoted on the Exchange under the trading symbol “MNKD”. The Company has not, in the 12 months preceding the date hereof, received
notice from the Exchange to the effect that the Company is not in compliance with the listing or maintenance requirements and the Company has no reason to believe that it will not in the foreseeable future continue to be in compliance with all such
listing and maintenance requirements. 
 (b) No Misstatement or Omission. The Registration Statement, when it became
effective, and the Prospectus, and any amendment or supplement thereto, on the date of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements of the Securities Act. At each
Settlement Date, the Registration Statement and the Prospectus, as of such date, will conform in all material respects with the requirements of the Securities Act. The Registration Statement, when it became effective, did not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendment and supplement thereto, on the date thereof and at each
Applicable Time (defined below), did not or will not include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading. The documents incorporated by reference in the Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue
statement of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they were made, not misleading. The foregoing
shall not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by BPSC specifically for use in the preparation thereof. 

(c) Conformity with Securities Act and Exchange Act. The Registration Statement, the Prospectus, or any amendment or
supplement thereto, and the documents incorporated by reference in the Registration Statement, the Prospectus or any amendment or supplement thereto, when such documents were or are filed with the Commission under the Securities Act or the Exchange
Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable. 

(d) Financial Information. The consolidated financial statements of the Company included or incorporated by reference in the
Registration Statement and the Prospectus, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and the Subsidiaries (as defined below) as of the dates indicated
and the consolidated results of operations, cash flows and changes in stockholders’ equity of the Company for the periods specified (subject, in the case of unaudited statements, to normal year-end audit adjustments) and have been prepared in
compliance with the requirements of the Securities Act and Exchange Act, as applicable, and in conformity with GAAP (as defined below) applied on a consistent basis (except for such adjustments to accounting standards and practices as are noted
therein and except in the case of unaudited financial statements to the extent they may exclude footnotes or may be condensed or summary 

  
 6 

 
statements) during the periods involved; the other financial and statistical data with respect to the Company and the Subsidiaries contained or incorporated by reference in the Registration
Statement and the Prospectus are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company; there are no financial statements (historical or pro forma) that are required to
be included or incorporated by reference in the Registration Statement or the Prospectus that are not included or incorporated by reference as required; the Company and the Subsidiaries do not have any material liabilities or obligations, direct or
contingent (including any off-balance sheet obligations), not described in the Registration Statement (including the exhibits thereto and Incorporated Documents) and the Prospectus which are required to be described in the Registration Statement or
the Prospectus (including exhibits thereto and Incorporated Documents); and all disclosures contained or incorporated by reference in the Registration Statement and the Prospectus regarding “non-GAAP financial measures” (as such term is
defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable; 

(e) Conformity with EDGAR Filing. The Prospectus delivered to BPSC for use in connection with the sale of the Placement
Shares pursuant to this Agreement will be identical to the versions of the Prospectus created to be transmitted to the Commission for filing via EDGAR, except to the extent permitted by Regulation S-T. 

(f) Organization. The Company and each of its Subsidiaries are, and will be, duly organized, validly existing as a
corporation and in good standing under the laws of their respective jurisdictions of organization. The Company and each of its Subsidiaries are, and will be, duly licensed or qualified as a foreign corporation for transaction of business and in
good standing under the laws of each other jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such license or qualification, and have all corporate power and authority
necessary to own or hold their respective properties and to conduct their respective businesses as described in the Registration Statement and the Prospectus, except where the failure to be so qualified or in good standing or have such power or
authority would not, individually or in the aggregate, have a material adverse effect or would reasonably be expected to have a material adverse effect on the assets, business, operations, earnings, properties, condition (financial or otherwise),
prospects, stockholders’ equity (as set forth on the Company’s most recent balance sheet included in the Incorporated Documents) or results of operations of the Company and the Subsidiaries (as defined below) taken as a whole (a
“Material Adverse Effect”). 
 (g) Subsidiaries. Schedule 4 hereto sets forth each of the
Company’s significant subsidiaries (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission), if any (each such significant subsidiary, a “Subsidiary” and collectively, the
“Subsidiaries”). Except as set forth in the Registration Statement and in the Prospectus, the Company owns, directly or indirectly, all of the equity interests of the Subsidiaries free and clear of any lien, charge, security
interest, encumbrance, right of first refusal or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of preemptive and similar rights. 

  
 7 

 (h) No Violation or Default. Neither the Company nor any of its Subsidiaries is
(i) in violation of its charter or by-laws or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of
any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is
bound or to which any of the property or assets of the Company or any of its Subsidiaries are subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or
regulatory authority, except, in the case of each of clauses (ii) and (iii) above, for any such violation or default that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. To the
Company’s knowledge, no other party under any material contract or other agreement to which it or any of its Subsidiaries is a party is in default in any respect thereunder where such default would have a Material Adverse Effect. 

(i) No Material Adverse Change. Subsequent to December 31, 2012, and other than the Company’s execution of this
Agreement and the sale of any Placement Shares hereunder and the Company’s execution of an At-The-Market Issuance Sales Agreement substantially similar to this Agreement with MLV & Co. LLC (the “Concurrent Facility
Agreement”) and the sale of any shares of the Company’s common stock thereunder, there has not been (i) any Material Adverse Effect, (ii) any transaction which is material to the Company and the Subsidiaries taken as a whole,
(iii) any obligation or liability, direct or contingent (including any off-balance sheet obligations), incurred by the Company or any Subsidiary, which is material to the Company and the Subsidiaries taken as a whole, (iv) any material
change in the capital stock or outstanding long-term indebtedness of the Company or any of its Subsidiaries or (v) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than
in each case above (A) in the ordinary course of business, (B) as otherwise disclosed in the Registration Statement or Prospectus (including any document deemed incorporated by reference therein) or (C) where such matter, item, change
or development would not make the statements in the Registration Statement or the Prospectus contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading. 
 (j) Capitalization. The issued and outstanding shares of capital stock of the Company have been
validly issued, are fully paid and non-assessable and, other than as disclosed in or contemplated by the Registration Statement or the Prospectus, and are not subject to any preemptive rights, rights of first refusal or similar rights. The
Company has an authorized, issued and outstanding capitalization as set forth in the Registration Statement and the Prospectus as of the dates referred to therein (other than the grant of additional options or other equity awards under the
Company’s existing stock option plans, or changes in the number of outstanding shares of Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, shares of
Common Stock outstanding on the date hereof or described in the Registration Statement and the Prospectus (including any document deemed incorporated by reference therein) or as a result of the issuance of Placement Shares or shares of the
Company’s common stock under the Concurrent Facility Agreement) and such authorized capital stock conforms in all material respects to the description 

  
 8 

 
thereof set forth in the Registration Statement and the Prospectus. The description of the Common Stock in the Registration Statement and the Prospectus (including any document deemed
incorporated by reference therein) is complete and accurate in all material respects. Other than as set forth or described in the Registration Statement and the Prospectus, as of the dates referred to therein, the Company did not have
outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock or other
securities. 
 (k) Authorization; Enforceability. The Company has full legal right, power and authority to enter
into this Agreement and perform the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable against the
Company in accordance with its terms, except to the extent that (i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general equitable
principles and (ii) the indemnification and contribution provisions of Section 11 hereof may be limited by federal or state securities laws and public policy considerations in respect thereof. 

(l) Authorization of Placement Shares. The Placement Shares, when issued and delivered pursuant to the terms approved by the
board of directors of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, will be duly and validly authorized and issued and fully paid and nonassessable, free
and clear of any pledge, lien, encumbrance, security interest or other claim (other than any pledge, lien, encumbrance, security interest or other claim arising from an act or omission of BPSC or a purchaser), including any statutory or contractual
preemptive rights, resale rights, rights of first refusal or other similar rights, and will be registered pursuant to Section 12 of the Exchange Act. The Placement Shares, when issued, will conform in all material respects to the
description thereof set forth in or incorporated into the Prospectus. 
 (m) No Consents Required. No consent,
approval, authorization, order, registration or qualification of or with any court or arbitrator or any governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement, and the issuance
and sale by the Company of the Placement Shares as contemplated hereby, except for the registration of the Placement Shares under the Securities Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be
required under applicable state securities laws or by the by-laws and rules of the Financial Industry Regulatory Authority (“FINRA”) or the Exchange in connection with the sale of the Placement Shares by BPSC. 

(n) No Preferential Rights. Except as set forth in the Registration Statement and the Prospectus, (i) no person, as such
term is defined in Rule 1-02 of Regulation S-X promulgated under the Securities Act (each, a “Person”), has the right, contractual or otherwise, to cause the Company to issue or sell to such Person any shares of Common Stock or
shares of any other capital stock or other securities of the Company (other than upon the exercise of options or warrants to purchase Common Stock or upon the exercise of options or stock awards

  
 9 

 
that may be granted from time to time under the Company’s stock option plans), (ii) no Person has any preemptive rights, rights of first refusal, or any other rights (whether pursuant
to a “poison pill” provision or otherwise) to purchase any shares of Common Stock or shares of any other capital stock or other securities of the Company from the Company which have not been duly waived with respect to the offering
contemplated hereby, (iii) except as may be disclosed to BPSC in writing, no Person has the right to act as an underwriter or as a financial advisor to the Company in connection with the offer and sale of the Common Stock, and (iv) no
Person has the right, contractual or otherwise, to require the Company to register under the Securities Act any shares of Common Stock or shares of any other capital stock or other securities of the Company, or to include any such shares or other
securities in the Registration Statement or the offering contemplated thereby, whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Placement Shares as contemplated thereby or otherwise. 

(o) Independent Public Accountants. Deloitte & Touche LLP, whose report on the consolidated financial statements of
the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 10-K filed with the Commission and incorporated into the Registration Statement, is and, during the periods covered by its reports, was an
independent public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, Deloitte & Touche LLP is not in violation of the auditor
independence requirements of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) with respect to the Company. 
 (p) Enforceability of Agreements. To the Company’s knowledge, all agreements between the Company and third parties expressly referenced in the Prospectus, other than such agreements that
have expired by their terms or whose termination is disclosed in documents filed by the Company on EDGAR, are legal, valid and binding obligations of the Company enforceable in accordance with their respective terms, except to the extent that
(i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general equitable principles and (ii) the indemnification provisions of certain
agreements may be limited by federal or state securities laws or public policy considerations in respect thereof, except for any unenforceability that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse
Effect. 
 (q) No Litigation. There are no legal, governmental or regulatory actions, suits or proceedings pending,
nor, to the Company’s knowledge, any legal, governmental or regulatory investigations, to which the Company or a Subsidiary is a party or to which any property of the Company or any of its Subsidiaries is the subject that, individually or in
the aggregate, if determined adversely to the Company or any of its Subsidiaries, would reasonably be expected to have a Material Adverse Effect or materially and adversely affect the ability of the Company to perform its obligations under this
Agreement; to the Company’s knowledge, no such actions, suits or proceedings are threatened or contemplated by any governmental or regulatory authority or threatened by others that, individually or in the aggregate, if determined adversely to
the Company or any of its Subsidiaries, would reasonably be expected to have a Material Adverse Effect; and (i) there are no current or pending legal, governmental or regulatory actions, suits or proceedings or, to the Company’s knowledge,
investigations that are 

  
 10 

 
required under the Securities Act to be described in the Prospectus that are not described in the Prospectus including any Incorporated Document; and (ii) there are no contracts or other
documents that are required under the Securities Act to be filed as exhibits to the Registration Statement that are not so filed. 
 (r) Licenses and Permits. The Company and each of its Subsidiaries possess or have obtained, all licenses, certificates, consents, orders, approvals, permits and other authorizations issued
by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their
respective businesses as described in the Registration Statement and the Prospectus (the “Permits”), except where the failure to possess, obtain or make the same would not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries have received written notice of any proceeding relating to revocation or modification of any such Permit or has any reason to believe that such Permit will not be
renewed in the ordinary course, except where the failure to obtain any such renewal would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

(s) Market Capitalization. As of the close of trading on the Exchange on the Trading Day immediately prior to
the date of this Agreement, the aggregate market value of the outstanding voting and non-voting common equity (as defined in Securities Act Rule 405) of the Company held by persons other than affiliates (as defined in Securities Act Rule
405) was $75 million or more (calculated in accordance with Instruction 1.B.1 of Form S-3). The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months
previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity
that is not a shell company. To enable BPSC to rely on Rule 5110(b)(7)(C)(i) of FINRA, the Company represents that, as of the date of this Agreement, the Company (i) has a non-affiliate, public common equity float of at least $150 million or a
non-affiliate, public common equity float of at least $100 million and annual trading volume of at least three million shares and (ii) has been subject to the Exchange Act reporting requirements for a period of at least 36 months. 

(t) No Material Defaults. Neither the Company nor any of the Subsidiaries has defaulted on any installment on indebtedness
for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. The Company has not filed a report pursuant to
Section 13(a) or 15(d) of the Exchange Act since the filing of its last Annual Report on Form 10-K, indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has defaulted on any
installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. 

(u) Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor, to the Company’s knowledge, any of
their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted 

  
 11 

 
or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or
resale of the Placement Shares. 
 (v) Broker/Dealer Relationships. Neither the Company nor any of the Subsidiaries
or any related entities (i) is required to register as a “broker” or “dealer” in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is a
“person associated with a member” or “associated person of a member” (within the meaning set forth in the FINRA Manual). 
 (w) No Reliance. The Company has not relied upon BPSC or legal counsel for BPSC for any legal, tax or accounting advice in connection with the offering and sale of the Placement Shares.

 (x) Taxes. The Company and each of its Subsidiaries have filed all federal, state, local and foreign tax returns
which have been required to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to do so would not reasonably be
expected to have a Material Adverse Effect. Except as otherwise disclosed in or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined adversely to the Company or any of its Subsidiaries which has
had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been asserted or
threatened against it which would have a Material Adverse Effect. 
 (y) Title to Real and Personal Property. The
Company and its Subsidiaries have good and marketable title in fee simple to all items of real property and good and valid title to all personal property (excluding Intellectual Property) described in the Registration Statement or Prospectus as
being owned by them that are material to the businesses of the Company or such Subsidiary, in each case free and clear of all liens, encumbrances and claims, except those that (i) do not materially interfere with the use made of such property
by the Company and any of its Subsidiaries or (ii) would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Any real property described in the Registration Statement or Prospectus as being
leased by the Company and any of its Subsidiaries is held by them under valid, existing and enforceable leases, except those that (A) do not materially interfere with the use made or proposed to be made of such property by the Company or any of
its Subsidiaries or (B) would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect. 
 (z) Intellectual Property. To its knowledge, the Company and its Subsidiaries own or possess adequate rights to use all patents, patent applications, trademarks (both registered and
unregistered), service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses and know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or
procedures) (collectively, the “Intellectual Property”), necessary for the conduct of their respective businesses as conducted as of the date hereof, except to the extent that the failure to own or possess adequate rights to use

  
 12 

 
such Intellectual Property would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; except as disclosed in writing to BPSC, the Company and any of
its Subsidiaries have not received any written notice of any claim of infringement or conflict which asserted Intellectual Property rights of others, which infringement or conflict, if the subject of an unfavorable decision, would result in a
Material Adverse Effect; there are no pending, or to the Company’s knowledge, threatened judicial proceedings or interference proceedings against the Company or its Subsidiaries challenging the Company’s or its Subsidiaries’ rights in
or to or the validity of the scope of any of the Company’s or its Subsidiaries’ owned material patents, patent applications or proprietary information; no other entity or individual has any right or claim in any of the Company’s or
its Subsidiaries’ owned material patents, patent applications or any patent to be issued therefrom by virtue of any contract, license or other agreement entered into between such entity or individual and the Company or a Subsidiary or by any
non-contractual obligation of the Company or a Subsidiary, other than by written licenses granted by the Company or a Subsidiary and other than such rights or claims that would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect; the Company and its Subsidiaries have not received any written notice of any claim challenging the rights of the Company or a Subsidiary in or to any Intellectual Property owned, licensed or optioned by the Company or such
Subsidiary which claim, if the subject of an unfavorable decision, would result in a Material Adverse Effect. 
 (aa)
Environmental Laws. The Company and its Subsidiaries (i) are in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health and
safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (ii) have received and are in compliance with all permits, licenses or other approvals
required of them under applicable Environmental Laws to conduct their respective businesses as described in the Registration Statement and the Prospectus; and (iii) have not received notice of any actual or potential liability for the
investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or (iii) above, for any such failure to comply or failure to
receive required permits, licenses, other approvals or liability as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 
 (bb) Disclosure Controls. The Company and each of its Subsidiaries maintain systems of internal accounting controls designed to provide reasonable assurance that (i) transactions are
executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to
maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware of any material weaknesses in its internal control over financial reporting (other than as set forth in the Prospectus). Since
the date of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to
materially affect, the Company’s internal control over financial reporting (other than as 

  
 13 

 
set forth in the Prospectus). The Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 and 15d-15) for the Company and designed such disclosure
controls and procedures to ensure that material information relating to the Company and each of its Subsidiaries is made known to the certifying officers by others within those entities, particularly during the period in which the Company’s
Annual Report on Form 10-K or Quarterly Report on Form 10-Q, as the case may be, is being prepared. The Company’s certifying officers have evaluated the effectiveness of the Company’s controls and procedures as of a date within 90
days prior to the filing date of the Form 10-K for the fiscal year most recently ended (such date, the “Evaluation Date”). The Company presented in its Form 10-K for the fiscal year most recently ended the conclusions of the
certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no significant changes in the Company’s internal
controls (as such term is defined in Item 307(b) of Regulation S-K under the Securities Act) or, to the Company’s knowledge, in other factors that could significantly adversely affect the Company’s internal controls. To the
knowledge of the Company, the Company’s “internal controls over financial reporting” and “disclosure controls and procedures” are effective. 
 (cc) Sarbanes-Oxley. There is and has been no failure on the part of the Company or, to the knowledge of the Company, any of the Company’s directors or officers, in their capacities as
such, to comply with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former principal
executive officer of the Company and each former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms,
statements and other documents required to be filed by it or furnished by it to the Commission. For purposes of the preceding sentence, “principal executive officer” and “principal financial officer” shall have the meanings
given to such terms in the Sarbanes-Oxley Act. 
 (dd) Finder’s Fees. Neither the Company nor any of the
Subsidiaries has incurred any liability for any finder’s fees, brokerage commissions or similar payments in connection with the transactions herein contemplated, except as may otherwise exist with respect to BPSC pursuant to this Agreement.

 (ee) Labor Disputes. No labor disturbance by or dispute with employees of the Company or any of its Subsidiaries
exists or, to the knowledge of the Company, is threatened which would reasonably be expected to result in a Material Adverse Effect 
 (ff) Investment Company Act. Neither the Company nor any of the Subsidiaries is or, after giving effect to the offering and sale of the Placement Shares, will be an “investment
company” or an entity “controlled” by an “investment company,” as such terms are defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”). 

(gg) Operations. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as 

  
 14 

 
amended, the money laundering statutes of all jurisdictions to which the Company or its Subsidiaries are subject, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency having jurisdiction over the Company or its Subsidiaries (collectively, the “Money Laundering Laws”), except as would not reasonably be expected
to result in a Material Adverse Effect; and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws
is pending or, to the knowledge of the Company, threatened. 
 (hh) Off-Balance Sheet Arrangements. There are no
transactions, arrangements and other relationships between and/or among the Company, and/or, to the knowledge of the Company, any of its affiliates and any unconsolidated entity, including, but not limited to, any structured finance, special purpose
or limited purpose entity (each, an “Off Balance Sheet Transaction”) that would reasonably be expected to affect materially the Company’s liquidity or the availability of or requirements for its capital resources, including
those Off Balance Sheet Transactions described in the Commission’s Statement about Management’s Discussion and Analysis of Financial Conditions and Results of Operations (Release Nos. 33-8056; 34-45321; FR-61), in each case that are
required to be described in the Prospectus which have not been described as required. 
 (ii) Underwriter
Agreements. The Company anticipates being a party to the Concurrent Facility Agreement simultaneous with this Agreement, but will not have an open sales order in force with more than one agent or underwriter under such agreements at any
given time, provided, however, that nothing in this Agreement shall prohibit the Company from entering into the Concurrent Facility Agreement, a committed equity financing facility or similar transaction. 

(jj) ERISA. To the knowledge of the Company, (i) each material employee benefit plan, within the meaning of
Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that is maintained, administered or contributed to by the Company or any of its affiliates for employees or former employees of the
Company and any of its Subsidiaries has been maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986,
as amended (the “Code”); (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any such plan excluding transactions effected pursuant to a
statutory or administrative exemption; and (iii) for each such plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no “accumulated funding deficiency” as defined in Section 412
of the Code has been incurred, whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) equals or exceeds the present value of all benefits accrued under such
plan determined using reasonable actuarial assumptions, other than, in the case of (i), (ii) and (iii) above, as would not reasonably be expected to have a Material Adverse Effect. 

(kk) Forward Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act
and Section 21E of the Exchange Act) (a “Forward  

  
 15 

 
Looking Statement”) contained in the Registration Statement and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good
faith. The Forward Looking Statements incorporated by reference in the Registration Statement and the Prospectus from the Company’s Annual Report on Form 10-K for the fiscal year most recently ended (i) except for any Forward Looking
Statement included in any financial statements and notes thereto, are within the coverage of the safe harbor for forward looking statements set forth in Section 27A of the Securities Act, Rule 175(b) under the Securities Act or Rule 3b-6 under
the Exchange Act, as applicable, (ii) were made by the Company with a reasonable basis and in good faith and reflect the Company’s good faith commercially reasonable best estimate of the matters described therein, and (iii) have been
prepared in accordance with Item 10 of Regulation S-K under the Securities Act. 
 (ll) Margin Rules. Neither
the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the
Federal Reserve System or any other regulation of such Board of Governors. 
 (mm) Insurance. The Company and each
of its Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the Company and each of its Subsidiaries reasonably believe are adequate for the use of their properties and as is customary for companies of similar
size engaged in similar businesses in similar industries. 
 (nn) No Improper Practices. (i) Neither the
Company nor, to the Company’s knowledge, the Subsidiaries, nor to the Company’s knowledge, any of their respective executive officers has, in the past five years, made any unlawful contributions to any candidate for any political office
(or failed fully to disclose any contribution in violation of law) or made any contribution or other payment to any official of, or candidate for, any federal, state, municipal, or foreign office or other person charged with similar public or
quasi-public duty in violation of any law or of the character required to be disclosed in the Prospectus; (ii) no relationship, direct or indirect, exists between or among the Company or, to the Company’s knowledge, any Subsidiary or any
affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or, to the Company’s knowledge, any Subsidiary, on the other hand, that is required by the Securities Act to be described in the Registration
Statement and the Prospectus that is not so described; (iii) no relationship, direct or indirect, exists between or among the Company or any Subsidiary or any affiliate of them, on the one hand, and the directors, officers, stockholders or
directors of the Company or, to the Company’s knowledge, any Subsidiary, on the other hand, that is required by the rules of FINRA to be described in the Registration Statement and the Prospectus that is not so described; (iv) except as
described in the Prospectus, there are no material outstanding loans or advances or material guarantees of indebtedness by the Company or, to the Company’s knowledge, any Subsidiary to or for the benefit of any of their respective officers or
directors or any of the members of the families of any of them; (v) the Company has not offered, or caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (A) a customer or supplier of the
Company or any Subsidiary to alter the customer’s or supplier’s level or type of business with the Company or any Subsidiary or (B) a trade journalist or publication to write or publish favorable information about the Company or any
Subsidiary or any of their respective products or services; and (vi)

  
 16 

 
neither the Company nor any Subsidiary nor, to the Company’s knowledge, any employee or agent of the Company or any Subsidiary has made any payment of funds of the Company or any Subsidiary
or received or retained any funds in violation of any law, rule or regulation (including, without limitation, the Foreign Corrupt Practices Act of 1977), which payment, receipt or retention of funds is of a character required to be disclosed in the
Registration Statement or the Prospectus. 
 (oo) Status Under the Securities Act. The Company was not and is not an
ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares. 

(pp) No Misstatement or Omission in an Issuer Free Writing Prospectus. Each Issuer Free Writing Prospectus, as of its issue date
and as of each Applicable Time (as defined in Section 24 below), did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus,
including any incorporated document deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity
with written information furnished to the Company by BPSC specifically for use therein. 
 (qq) No
Conflicts. Neither the execution of this Agreement by the Company, nor the issuance, offering or sale of the Placement Shares, nor the consummation by the Company of any of the transactions contemplated herein and therein, nor the
compliance by the Company with the terms and provisions hereof and thereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or will constitute a default under, or has resulted in or will
result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any contract or other agreement to which the Company may be bound or to which any of the property or assets
of the Company is subject, except (i) such conflicts, breaches or defaults as may have been waived and (ii) such conflicts, breaches, defaults, liens, charges or encumbrances that would not reasonably be expected to have a Material Adverse
Effect; nor will such action result (x) in any violation of the provisions of the certificate of incorporation or bylaws of the Company, or (y) in any material violation of the provisions of any statute or any order, rule or regulation
applicable to the Company or of any court or of any federal, state or other regulatory authority or other government body having jurisdiction over the Company, except where such violation would not reasonably be expected to have a Material Adverse
Effect. 
 (rr) Clinical Studies. The clinical, pre-clinical and other studies and tests conducted by or, to the
knowledge of the Company, on behalf of the Company were, and, if still pending, are being, conducted in accordance in all material respects with all applicable statutes, laws, rules and regulations (including, without limitation, those administered
by the United States Food and Drug Administration (the “FDA”) or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA), except where the failure do
so would not have a Material Adverse Effect. The Company has not received any written notices or other written correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions
similar to those performed by the FDA requiring the Company to terminate or suspend any ongoing clinical or pre-clinical studies or tests. 

  
 17 

 (ss) Compliance Program. The Company has established and administers a
compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any
other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

(tt) OFAC. (i) Neither the Company nor any of its Subsidiaries (collectively, the “Entity”) or, to the
Company’s knowledge, any director, officer, employee, agent, affiliate or representative of the Entity, is a government, individual, or entity (in this paragraph (tt), “Person”) that is, or is owned or controlled by a Person
that is: 
 (A) the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s
Office of Foreign Assets Control (“OFAC”), the United Nations Security Council (“UNSC”), the European Union (“EU”), Her Majesty’s Treasury (“HMT”), or other relevant sanctions
authority (collectively, “Sanctions”), nor 
 (B) located, organized or resident in a country or
territory that is the subject of Sanctions (including, without limitation, Burma/Myanmar, Cuba, Iran, North Korea, Sudan and Syria). 
 (ii) The Company represents and covenants that the Entity will not, directly or indirectly, knowingly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any
subsidiary, joint venture partner or other Person: 
 (A) to fund or facilitate any activities or business
of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or 
 (B) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise).

 (iii) The Company represents and covenants that, except as detailed in the Prospectus, for the past five
years, the Entity has not knowingly engaged in, is not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was
the subject of Sanctions. 
 (uu) Stock Transfer Taxes. On each Settlement Date, all stock transfer or other taxes
(other than income taxes) which are required to be paid in connection with the sale and 

  
 18 

 
transfer of the Placement Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes will be or will have been fully
complied with in all material respects. 
 Any certificate signed by an officer of the Company and delivered to BPSC or to counsel for BPSC
pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to BPSC as to the matters set forth therein. 

7. Covenants of the Company. The Company covenants and agrees with BPSC that: 

(a) Registration Statement Amendments. After the date of this Agreement and during any period in which a Prospectus relating to any
Placement Shares is required to be delivered by BPSC under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act) (the “Prospectus Delivery Period”),
(i) the Company will notify BPSC promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has become effective or any subsequent
supplement to the Prospectus (other than documents incorporated by reference therein) has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus or for additional information,
(ii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus (except for documents incorporated by reference therein) unless a copy thereof has been submitted to BPSC at least two Business Days before
the filing and BPSC has not reasonably and in good faith objected thereto within two Business Days of receiving such copy (provided, however, that (A) the failure of BPSC to make such objection shall not relieve the Company of any obligation or
liability hereunder, or affect BPSC’s right to rely on the representations and warranties made by the Company in this Agreement, (B) the Company has no obligation to provide BPSC any advance copy of such filing or to provide BPSC an
opportunity to object to such filing if such filing does not name BPSC or does not relate to the transactions contemplated by this Agreement, and (C) the only remedy BPSC shall have with respect to the failure by the Company to provide BPSC
with such copy or the filing of such amendment or supplement despite BPSC’s objection shall be to cease making sales under this Agreement) and the Company will furnish to BPSC at the time of filing thereof a copy of any document that upon
filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; and (iii) the Company will cause each amendment or supplement to the Prospectus to be filed with the
Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act or, in the case of any document to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange Act,
within the time period prescribed (the determination to file or not file any amendment or supplement with the Commission under this Section 7(a), based on the Company’s reasonable opinion or reasonable objections, shall be made exclusively
by the Company). 
 (b) Notice of Commission Stop Orders. The Company will advise BPSC, promptly after it receives
notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering
or sale in 

  
 19 

 
any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop
order or to obtain its withdrawal if such a stop order should be issued. The Company will advise BPSC promptly after it receives any request by the Commission for any amendments to the Registration Statement or any amendment or supplements to
the Prospectus or any Issuer Free Writing Prospectus or for additional information related to the offering of the Placement Shares or for additional information related to the Registration Statement, the Prospectus or any Issuer Free Writing
Prospectus. 
 (c) Delivery of Prospectus; Subsequent Changes. During the Prospectus Delivery Period, the Company
will use commercially reasonable efforts to comply in all material respects with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports and any
definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If the Company has omitted any information from
the Registration Statement pursuant to Rule 430A under the Securities Act, it will use its best efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430A and to notify BPSC promptly of all
such filings. If during the Prospectus Delivery Period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make
the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will
promptly notify BPSC to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or
omission or effect such compliance; provided, however, that the Company may delay any such amendment or supplement if, in the judgment of the Company, it is in the best interests of the Company to do so. 

(d) Listing of Placement Shares. During the Prospectus Delivery Period, the Company will use its commercially reasonable
efforts to cause the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions as BPSC reasonably designates and to continue such qualifications in effect so long as
required for the distribution of the Placement Shares; provided, however, that the Company shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities or file a general consent to service of process in
any jurisdiction. 
 (e) Delivery of Registration Statement and Prospectus. The Company will furnish to BPSC and its
counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed
with the Commission during the Prospectus Delivery Period (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such
quantities as BPSC may from time to time reasonably request and, at BPSC’s request, will also furnish copies of the Prospectus to each 

  
 20 

 
exchange or market on which sales of the Placement Shares may be made; provided, however, that the Company shall not be required to furnish any document (other than the Prospectus) to BPSC to the
extent such document is available on EDGAR. 
 (f) Earnings Statement. The Company will make generally available to
its security holders as soon as practicable, but in any event not later than 15 months after the end of the Company’s current fiscal quarter, an earnings statement covering a 12-month period that satisfies the provisions of Section 11(a)
and Rule 158 of the Securities Act. 
 (g) Use of Proceeds. The Company will use the Net Proceeds as described in
the Prospectus in the section entitled “Use of Proceeds.” 
 (h) Notice of Other Sales. Without the
prior written consent of BPSC, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this
Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock during the period beginning on the second (2nd) Trading Day immediately prior to the date on which any
Placement Notice is delivered to BPSC hereunder and ending on the second (2nd) Trading Day immediately following the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has
been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date of such suspension or termination); and, at any time during which a Placement Notice is pending and for two (2) Trading Days after
the last sale of Placement Shares under such Placement Notice, will not directly or indirectly in any other “at the market” or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise
dispose of any shares of Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock prior to the
termination of this Agreement with respect to Placement Shares sold pursuant to such Placement Notice; provided, however, that such restrictions will not be required in connection with the Company’s issuance or sale of (i) Common Stock,
options to purchase Common Stock or stock awards or Common Stock issuable upon the exercise of options or vesting of stock awards, pursuant to any employee or director stock option or benefits plan, stock ownership plan or dividend reinvestment plan
(but not Common Stock subject to a waiver to exceed plan limits in its dividend reinvestment plan) of the Company whether now in effect or hereafter implemented; (ii) Common Stock issuable upon conversion of securities or the exercise of
warrants, options or other rights in effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to BPSC and (iii) Common Stock, or securities convertible into or exercisable for Common Stock,
offered and sold in a privately negotiated transaction to vendors, customers, investors, strategic partners or potential strategic partners and conducted in a manner so as not to be integrated with the offering of Common Stock hereby. 

(i) Change of Circumstances. The Company will, at any time during the pendency of a Placement Notice advise BPSC promptly
after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document required to be provided to BPSC pursuant to this
Agreement. 

  
 21 

 (j) Due Diligence Cooperation. The Company will cooperate with any reasonable
due diligence review conducted by BPSC or its representatives in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during regular
business hours and at the Company’s principal offices or such other location mutually agreeable by the parties, as BPSC may reasonably request. 
 (k) Required Filings Relating to Placement of Placement Shares. The Company agrees that on such dates as the Securities Act shall require, the Company will (i) file a prospectus
supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (the date of each and every such filing under Rule 424(b), a “Filing Date”), which prospectus supplement will set forth, within
the relevant period, the amount of Placement Shares sold through BPSC, the Net Proceeds to the Company and the compensation payable by the Company to BPSC with respect to such Placement Shares, and (ii) deliver such number of copies of each
such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market. 
 (l) Representation Dates; Certificate. On the date of this Agreement and each time during the term of this Agreement the Company: 

(i) files the Prospectus relating to the Placement Shares or amends or supplements (other than a prospectus supplement
relating solely to an offering of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective amendment, sticker, or supplement but not by means of
incorporation of documents by reference into the Registration Statement or the Prospectus relating to the Placement Shares; 
 (ii) files an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A containing restated financial statements or a material amendment to the previously filed Form 10-K); 

(iii) files its quarterly reports on Form 10-Q under the Exchange Act; or 

(iv) files a current report on Form 8-K containing amended audited financial information (other than information
“furnished” pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain properties as discontinued operations in accordance with Statement of
Financial Accounting Standards No. 144) under the Exchange Act; 
 (Each date of filing of one or more of the documents
referred to in clauses (i) through (iv) shall be a “Representation Date”) 
 the Company shall furnish BPSC (but in
the case of clause (iv) above only if BPSC reasonably 

  
 22 

 
determines that the information contained in such Form 8-K is material) with a certificate, in the form attached hereto as Exhibit 7(l). The requirement to provide a certificate under this
Section 7(l) shall be automatically waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the date the Company delivers a Placement Notice hereunder (which for such
calendar quarter shall be considered a Representation Date); provided, however, that such waiver shall not apply for any Representation Date on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, if the
Company subsequently decides to sell Placement Shares following a Representation Date when the Company relied on such waiver and did not provide BPSC with a certificate under this Section 7(l), then before the Company delivers the Placement
Notice or BPSC sells any Placement Shares, the Company shall provide BPSC with a certificate, in the form attached hereto as Exhibit 7(l), dated the date of the Placement Notice. 

(m) Legal Opinion. On or prior to the date of the first Placement Notice given hereunder, the Company shall cause to be
furnished to BPSC a written opinion and letter of Cooley LLP (“Company Counsel”), or such other counsel reasonably satisfactory to BPSC, covering opinions and statements substantially in the forms attached hereto as Exhibits 7(m)(1)
and 7(m)(2). Thereafter within five (5) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as Exhibit 7(l) for which no waiver is applicable, the Company
shall cause to be furnished to BPSC a letter of Company Counsel, or other counsel reasonably satisfactory to BPSC, covering statements substantially in the form attached hereto as Exhibits 7(m)(2), modified, as necessary, to relate to the
Registration Statement and the Prospectus as then amended or supplemented; provided, however, the Company shall be required to furnish to BPSC no more than one letter hereunder per calendar quarter and the Company shall not be required to furnish
letter if the Company does not intend to deliver a Placement Notice in such calendar quarter until such time as the Company delivers its next Placement Notice; provided, further, that in lieu of such letters for subsequent periodic filings under the
Exchange Act, counsel may furnish BPSC with a letter (a “Reliance Letter”) to the effect that BPSC may rely on a prior letter delivered under this Section 7(m) to the same extent as if it were dated the date of such letter
(except that statements in such prior letter shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of the date of the Reliance Letter). 

(n) Comfort Letter. On or prior to the date the first Placement Notice is given hereunder and thereafter within five
(5) Trading Days after each Representation Date referred to in Section 7(l)(ii), the Company shall cause its independent accountants to furnish BPSC letters (the “Comfort Letters”), dated the date the Comfort Letter is
delivered, which shall meet the requirements set forth in this Section 7(n); provided, that if requested by BPSC, the Company shall cause a Comfort Letter to be furnished to BPSC prior to the tenth (10th) Trading Day after the date of
occurrence of any material transaction or event (including the restatement of the Company’s financial statements) requiring the filing of a current report on Form 8-K containing material financial information and the date the first Placement
Notice is given hereunder following such a material transaction or event, whichever is later. The Comfort Letter from the Company’s independent accountants shall be in a form and substance reasonably satisfactory to BPSC,
(i) confirming that they are an independent public accounting firm within the meaning of the Securities Act and the PCAOB, (ii) stating, as of such date, the conclusions and findings of

  
 23 

 
such firm with respect to the financial information and other matters ordinarily covered by accountants’ “comfort letters” to underwriters in connection with registered public
offerings (the first such letter, the “Initial Comfort Letter”) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and
modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter. 
 (o) Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute,
the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for
soliciting purchases of the Placement Shares other than BPSC. 
 (p) Investment Company Act. The Company will
conduct its affairs in such a manner so as to reasonably ensure that neither it nor any of its Subsidiaries will be or become, at any time prior to the termination of this Agreement, an “investment company,” as such term is defined in the
Investment Company Act. 
 (q) Sarbanes-Oxley Act. The Company and the Subsidiaries will maintain and keep accurate
books and records reflecting their assets and maintain internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles and including those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and
dispositions of the assets of the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit the preparation of the Company’s consolidated financial statements in accordance with generally accepted
accounting principles, (iii) that receipts and expenditures of the Company are being made only in accordance with management’s and the Company’s directors’ authorization, and (iv) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on its financial statements. The Company and the Subsidiaries will maintain such controls and other
procedures, including, without limitation, those required by Sections 302 and 906 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that are designed to ensure that information required to be disclosed by the Company in the
reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, including, without limitation, controls and procedures designed to
ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer and principal
financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure and to ensure that material information relating to the Company or the Subsidiaries is made known to them by others
within those entities, particularly during the period in which such periodic reports are being prepared. 

  
 24 

 8. Representations and Covenants of BPSC. BPSC represents and warrants that it
is duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which BPSC is exempt from registration or
such registration is not otherwise required. BPSC shall continue, for the term of this Agreement, to be duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the
Placement Shares will be offered and sold, except such states in which BPSC is exempt from registration or such registration is not otherwise required, during the term of this Agreement. BPSC will comply with all applicable laws and regulations
(including, without limitation, Regulation M) in connection with performing its obligations under this Agreement. 
 9.
Payment of Expenses. 
 (a) The Company will pay all expenses incident to the performance of its obligations under this
Agreement, including (i) the preparation, filing, including any fees required by the Commission, and printing of the Registration Statement (including financial statements and exhibits) as originally filed and of each amendment and supplement
thereto and each Issuer Free Writing Prospectus, in such number as BPSC shall reasonably deem necessary, (ii) the printing and delivery to BPSC of this Agreement and such other documents as may be required in connection with the offering,
purchase, sale, issuance or delivery of the Placement Shares, (iii) the preparation, issuance and delivery of the certificates, if any, for the Placement Shares to BPSC, including any stock or other transfer taxes and any capital duties, stamp
duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement Shares to BPSC, (iv) the fees and disbursements of the counsel, accountants and other advisors to the Company, (v) the reasonable fees and
disbursements of counsel to BPSC, up to a maximum amount of $25,000, (vi) the fees and expenses of the transfer agent and registrar for the Common Stock, (vii) the filing fees incident to any review by FINRA of the terms of the sale of the
Placement Shares, and (viii) the fees and expenses incurred in connection with the listing of the Placement Shares on the Exchange. 
 (b) If this Agreement is terminated by BPSC in accordance with the provisions of Section 13(a) hereof as a result of a material breach by the Company of its obligations hereunder, the Company shall
reimburse BPSC for all of its reasonable out-of-pocket expenses, including reasonable fees and disbursements of counsel for BPSC (less any amounts paid under clause (a)(v) above) up to a maximum of $25,000. 

10. Conditions to BPSC’s Obligations. The obligations of BPSC hereunder with respect to a Placement will be subject to
the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its obligations hereunder, to the completion by BPSC of a due diligence review satisfactory to it in
its reasonable judgment, and to the continuing satisfaction (or waiver by BPSC in its sole discretion) of the following additional conditions: 
 (a) Registration Statement Effective. The Registration Statement shall have become effective and shall be available for the sale of all Placement Shares contemplated to be issued by any
Placement Notice. 

  
 25 

 (b) No Material Notices. None of the following events shall have occurred and
be continuing: (i) receipt by the Company of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which
would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness
of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement
Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) any event that makes any material statement made in the Registration Statement or the Prospectus or any material document
incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or documents so that, in the case of the Registration Statement,
it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus, it will not
contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 (c) No Misstatement or Material Omission. BPSC shall not have advised the Company that the Registration Statement
or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in BPSC’s reasonable opinion is material, or omits to state a fact that in BPSC’s opinion is material and is required to be stated therein or
is necessary to make the statements therein not misleading. 
 (d) Material Changes. Except as contemplated in the
Prospectus, or disclosed in the Company’s reports filed with the Commission, there shall not have been any material adverse change, on a consolidated basis, in the authorized capital stock of the Company or any Material Adverse Effect, or any
development in the business or affairs of the Company that could reasonably be expected to cause a Material Adverse Effect. 

(e) Legal Opinion. BPSC shall have received the opinions of Company Counsel required to be delivered pursuant
Section 7(m) on or before the date on which such delivery of such opinions are required pursuant to Section 7(m). 

(f) Comfort Letter. BPSC shall have received the Comfort Letter required to be delivered pursuant Section 7(n) on or
before the date on which such delivery of such letter is required pursuant to Section 7(n). 
 (g) Representation
Certificate. BPSC shall have received the certificate required to be delivered pursuant to Section 7(l) on or before the date on which delivery of such certificate is required pursuant to Section 7(l). 

  
 26 

 (h) No Suspension. Trading in the Common Stock shall not have been suspended on
the Exchange and the Common Stock shall not have been delisted from the Exchange. 
 (i) Other Materials. On each
date on which the Company is required to deliver a certificate pursuant to Section 7(l), the Company shall have furnished to BPSC such appropriate further information, certificates and documents as BPSC may have reasonably requested in writing
prior to such date and which are usually and customarily furnished by an issuer of securities in connection with the underwritten public offering thereof. All such opinions, certificates, letters and other documents will be in compliance with
the provisions hereof. The Company will furnish BPSC with such conformed copies of such opinions, certificates, letters and other documents as BPSC shall reasonably request. 

(j) Securities Act Filings Made. All filings with the Commission required by Rule 424 under the Securities Act to have been
filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424. 
 (k) Approval for Listing. The Placement Shares shall either have been approved for listing on the Exchange, subject only to notice of issuance, or the Company shall have filed an application
for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement Notice. 
 (l) No
Termination Event. There shall not have occurred any event that would permit BPSC to terminate this Agreement pursuant to Section 13(a). 
 11. Indemnification and Contribution. 
 (a) Company
Indemnification. The Company agrees to indemnify and hold harmless BPSC, its partners, members, directors, officers, employees and agents and each person, if any, who controls BPSC within the meaning of Section 15 of the Securities Act
or Section 20 of the Exchange Act as follows: 
 (i) against any and all loss, liability, claim, damage and
expense whatsoever, as incurred, joint or several, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged
omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in the any related Issuer
Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; 
  

  
 27 

 (ii) against any and all loss, liability, claim, damage and expense
whatsoever, as incurred, joint or several, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based
upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section 11(d) below) any such settlement is effected with the written consent of the Company, which consent shall not
unreasonably be delayed or withheld; and 
 (iii) against any and all expense whatsoever, as incurred (including
the reasonable fees and disbursements of counsel), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim
whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above, provided, however , that this indemnity agreement shall
not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with written information furnished to the
Company by BPSC expressly for use in the Registration Statement (or any amendment thereto) or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto). 

(b) BPSC Indemnification. BPSC agrees to indemnify and hold harmless the Company and its directors and each officer of the
Company who signed the Registration Statement, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under
common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section 11(a), as incurred, but only with respect to untrue statements or omissions, or alleged untrue
statements or omissions, made in the Registration Statement (or any amendments thereto) or any Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information furnished to
the Company in writing by BPSC expressly for use therein. 
 (c) Procedure. Any party that proposes to assert the
right to be indemnified under this Section 11 will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section 11,
notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might
have to any indemnified party otherwise than under this Section 11 and (ii) any liability that it may have to any indemnified party under the foregoing provision of this Section 11 unless, and only to the extent that, such omission
results in the forfeiture or material impairment of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the
indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with
any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after 

  
 28 

 
notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other
expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any
such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party,
(2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party,
(3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of
such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of
which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or
related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or
parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the indemnifying party receives a written invoice relating to fees, disbursements and other charges in reasonable detail. An
indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise
or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this Section 11 (whether or not any indemnified party is a party thereto), unless such settlement,
compromise or consent (1) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (2) does not include a statement as to or an admission of
fault, culpability or a failure to act by or on behalf of any indemnified party. 
 (d) Contribution. In order to
provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this Section 11 is applicable in accordance with its terms but for any reason is held to be unavailable from
the Company or BPSC, the Company and BPSC will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement
of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than BPSC, such as persons who control the Company within the meaning of the Securities Act, officers of the
Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and BPSC may be subject in such proportion as shall be appropriate to reflect the relative benefits received by
the Company on the one hand and BPSC on the other hand. The relative benefits received by the Company on the one hand and BPSC on the other hand shall be deemed to be in the same proportion as the total net proceeds from the sale of the Placement
Shares (before deducting 

  
 29 

 
expenses) received by the Company bear to the total compensation received by BPSC (before deducting expenses) from the sale of Placement Shares on behalf of the Company. If, but only if, the
allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but
also the relative fault of the Company, on the one hand, and BPSC, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other
relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state
a material fact relates to information supplied by the Company or BPSC, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and BPSC agree that
it would not be just and equitable if contributions pursuant to this Section 11(d) were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to
herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this Section 11(d) shall be deemed to include, for the purpose of this
Section 11(d), any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with Section 11(c) hereof. Notwithstanding the
foregoing provisions of this Section 11(d), BPSC shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 11(d), any person who controls a party to this Agreement within the
meaning of the Securities Act, and any officers, directors, partners, employees or agents of BPSC, will have the same rights to contribution as that party, and each officer and director of the Company who signed the Registration Statement will have
the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for
contribution may be made under this Section 11(d), will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any
other obligation it or they may have under this Section 11(d) except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for
a settlement entered into pursuant to the last sentence of Section 11(c) hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to
Section 11(c) hereof. 
 12. Representations and Agreements to Survive Delivery. The indemnity and contribution
agreements contained in Section 11 of this Agreement and all representations and warranties of the Company and BPSC herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any
investigation made by or on behalf of BPSC, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or
(iii) any termination of this Agreement. 

  
 30 

 13. Termination. 

(a) BPSC may terminate this Agreement, by notice to the Company, as hereinafter specified at any time (1) if there has been, since
the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse Effect, or any development that has occurred that is reasonably likely to have a Material Adverse Effect has occurred
or in the sole judgment of BPSC makes it impractical or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (2) if there has occurred any material adverse change in the financial markets in
the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or
economic conditions, in each case the effect of which is such as to make it, in the sole judgment of BPSC, impracticable or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (3) if trading
in the Common Stock has been suspended or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices for trading have been fixed on the Exchange, (4) if any suspension of
trading of any securities of the Company on any exchange or in the over-the-counter market shall have occurred and be continuing for at least ten (10) Trading Days, (5) if a major disruption of securities settlements or clearance services
in the United States shall have occurred and be continuing, or (6) if a banking moratorium has been declared by either U.S. Federal or New York authorities. Any such termination shall be without liability of any party to any other party
except that the provisions of Section 9 (Payment of Expenses), Section 11 (Indemnification and Contribution), Section 12 (Representations and Agreements to Survive Delivery), Section 18 (Governing Law and Time; Waiver of Jury
Trial) and Section 19 (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. If BPSC elects to terminate this Agreement as provided in this Section 13(a), BPSC shall provide the
required notice as specified in Section 14 (Notices). 
 (b) The Company shall have the right, by giving ten (10) days
notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of
Section 9, Section 11, Section 12, Section 18 and Section 19 hereof shall remain in full force and effect notwithstanding such termination. 
 (c) BPSC shall have the right, by giving ten (10) days notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such
termination shall be without liability of any party to any other party except that the provisions of Section 9, Section 11, Section 12, Section 18 and Section 19 hereof shall remain in full force and effect notwithstanding
such termination. 
 (d) Unless earlier terminated pursuant to this Section 13, this Agreement shall automatically
terminate upon the earlier to occur of (i) the third (3 rd ) year anniversary of the date hereof and (ii) the issuance and sale of all of the Placement Shares through BPSC on the terms and subject to the conditions set forth herein except
that the provisions of Section 9, Section 11, Section 11, Section 12, Section 18 and Section 19 hereof shall remain in full force and effect notwithstanding such termination. 

  
 31 

 (e) This Agreement shall remain in full force and effect unless terminated pursuant to
Sections 13(a), (b), (c), or (d) above or otherwise by mutual agreement of the parties; provided, however, that any such termination by mutual agreement shall in all cases be deemed to provide that Section 9, Section 11,
Section 12, Section 18 and Section 19 shall remain in full force and effect. Upon termination of this Agreement, the Company shall not have any liability to BPSC for any discount, commission or other compensation with respect to
any Placement Shares not otherwise sold by BPSC under this Agreement. 
 (f) Any termination of this Agreement shall be
effective on the date specified in such notice of termination; provided, however, that such termination shall not be effective until the close of business on the date of receipt of such notice by BPSC or the Company, as the case may be. If such
termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement. 
 14. Notices. All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise
specified, and if sent to BPSC, shall be delivered to: 
  

					
		 	 Brinson Patrick Securities Corporation
 1515 Broadway, 11th Floor
 New York, NY 10036

		 	 Attention:

Telephone:
 Facsimile:
	  	 Corporate Finance
 (212)
453-5000
 (212) 453-5555

 with a copy to: 
  

					
		 	 LeClairRyan, A Professional Corporation
 One Riverfront Plaza
 1037 Raymond Boulevard, 16th Floor

Newark, NJ 07102

		 	 Attention:

Telephone:
 Facsimile:
	  	 James T. Seery
 (973)
491-3315
 (973) 491-3415

 and if to the Company, shall be delivered to: 

 

					
		 	 MannKind Corporation

28903 North Avenue Paine
 Valencia, CA 91355

		 	 Attention:

Telephone
 Facsimile:
	  	 General Counsel
 (661)
775-5350
 (661) 775-2086

  
 32 

					
	with a copy to:
		
		 	Cooley LLP
		 	4401 Eastgate Mall
		 	San Diego, CA 92121
		 	Attention:	  	L. Kay Chandler
		 		  	Sean M. Clayton
		 	Telephone:	  	(858) 550-6000
		 	Facsimile:	  	(858) 550-6420

 Each party to this Agreement may change such address for notices by sending to the parties to this
Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before
4:30 p.m., New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on
the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, “Business Day” shall mean any day on which the Exchange
and commercial banks in the City of New York are open for business. 
 An electronic communication (“Electronic
Notice”) shall be deemed written notice for purposes of this Section 14 if sent to the electronic mail address specified by the receiving party under separate cover. Electronic Notice shall be deemed received at the time the party
sending Electronic Notice receives confirmation of receipt by the receiving party. Any party receiving Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (“Nonelectronic
Notice”) which shall be sent to the requesting party within ten (10) days of receipt of the written request for Nonelectronic Notice. 
 15. Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the Company and BPSC and their respective successors and the affiliates, controlling persons, officers
and directors referred to in Section 11 hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this
Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party. 
 16. Adjustments for Stock Splits. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share consolidation, stock
split, stock dividend, corporate domestication or similar event effected with respect to the Placement Shares. 
 17. Entire
Agreement; Amendment; Severability. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes 

  
 33 

 
the entire agreement of the parties with respect to the subject matter hereof and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the
parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and BPSC. In the event that any one or more of the
provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible
extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving
effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement. 
 18. GOVERNING LAW AND TIME; WAIVER OF JURY TRIAL. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF
CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. THE COMPANY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO
THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 
 19. CONSENT TO JURISDICTION. EACH PARTY HEREBY
IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND
HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR
THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR
REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED
HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. 
 20. Use of
Information. BPSC may not use any information gained in connection with this Agreement and the transactions contemplated by this Agreement, including due diligence, to advise any party with respect to transactions not expressly approved by
the Company. 

  
 34 

 21. Counterparts. This Agreement may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile transmission. 

22. Effect of Headings. The section and Exhibit headings herein are for convenience only and shall not affect the
construction hereof. 
 23. Permitted Free Writing Prospectuses. The Company represents, warrants and agrees that,
unless it obtains the prior consent of BPSC (such consent not to be unreasonably withheld, conditioned or delayed), and BPSC represents, warrants and agrees that, unless it obtains the prior consent of the Company (such consent not to be
unreasonably withheld, conditioned or delayed), it has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a “free writing
prospectus,” as defined in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by BPSC or by the Company, as the case may be, is hereinafter referred to as a “Permitted Free
Writing Prospectus.” The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has
complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the
parties hereto agree that all free writing prospectuses, if any, listed in Exhibit 23 hereto are Permitted Free Writing Prospectuses. 
 24. Absence of Fiduciary Relationship. The Company acknowledges and agrees that: 
 (a) BPSC is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction contemplated by this Agreement and the process leading to such
transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on the one hand, and BPSC, on the other hand, has
been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not BPSC has advised or is advising the Company on other matters, and BPSC has no obligation to the Company with respect to the
transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement; 
 (b) it is capable
of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated by this Agreement; 
 (c) BPSC has not provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax
advisors to the extent it has deemed appropriate; 

  
 35 

 (d) it is aware that BPSC and its affiliates are engaged in a broad range of transactions
which may involve interests that differ from those of the Company and BPSC has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise; and 

(e) it waives, to the fullest extent permitted by law, any claims it may have against BPSC for breach of fiduciary duty or alleged breach
of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that BPSC shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or
to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company, other than in respect of BPSC’s obligations under this Agreement and to keep information provided by the Company
to BPSC and BPSC’s counsel confidential to the extent not otherwise publicly-available. 
 25. Definitions. As
used in this Agreement, the following terms have the respective meanings set forth below: 
 “Applicable Time”
means (i) each Representation Date and (ii) the time of each sale of any Placement Shares pursuant to this Agreement. 

“Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433,
relating to the Placement Shares that (1) is required to be filed with the Commission by the Company, (2) is a “road show” that is a “written communication” within the meaning of Rule 433(d)(8)(i) whether or not
required to be filed with the Commission, or (3) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Placement Shares or of the offering that does not reflect the final terms, in each case in the
form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g) under the Securities Act Regulations. 

“Rule 164,” “Rule 172,” “Rule 405,” “Rule 415,” “Rule
424,” “Rule 424(b),” “Rule 430B,” and “Rule 433” refer to such rules under the Securities Act Regulations. 

All references in this Agreement to financial statements and schedules and other information that is “contained,”
“included” or “stated” in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is
incorporated by reference in the Registration Statement or the Prospectus, as the case may be. 
 All references in this
Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free
Writing Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all
references in this Agreement to “supplements” to the Prospectus shall include, without limitation, any supplements, “wrappers” or similar materials prepared in connection with any offering, sale or private placement of any
Placement Shares by BPSC outside of the United States. 

  
 36 

 If the foregoing correctly sets forth the understanding between the Company and BPSC, please
so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and BPSC. 
  

					
	Very truly yours,
	
	MANNKIND CORPORATION
		
	By:	 	 /s/ Matthew J. Pfeffer

		 	Name:	 	Matthew J. Pfeffer
		 	Title:	 	Chief Financial Officer
	
	 ACCEPTED as of the date first-above written:

	
	 BRINSON PATRICK SECURITIES CORPORATION

		
	By:	 	 /s/ Todd Wyche

		 	Name:	 	Todd Wyche
		 	Title:	 	Chief Executive Officer

 [Signature Page to At-The-Market Issuance Sales Agreement] 

 SCHEDULE 1 

 
  

FORM OF PLACEMENT NOTICE 
  

 
  

					
	From:	 	MannKind Corporation
		
	To:	 	Brinson Patrick Securities Corporation
			
		 	Attention:	 	Todd Wyche
	Subject:	 	At-The-Market Issuance—Placement Notice
		
	Gentlemen:	 	

 Pursuant to the terms and subject to the conditions contained in the At-The-Market Issuance Sales
Agreement between MannKind Corporation, a Delaware corporation (the “Company”), and Brinson Patrick Securities Corporation (“BPSC”), dated March 18, 2013, the Company hereby requests that BPSC sell up to
                     of the Company’s Common Stock, par value $0.01 per share, at a minimum market price of
$             per share, during the time period beginning [month, day, time] and ending [month, day, time]. [The Company may include such other sales parameters as it deems appropriate.]

 SCHEDULE 2 

 
  

Compensation 
  

 
 The Company
shall pay to BPSC in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount up to 3.0% of the gross proceeds from each sale of Placement Shares. 

 SCHEDULE 3 

 
  

Notice Parties 
  

 
 The Company

 Matthew Pfeffer 
 David Thomson 
 Hakan Edstrom 

BPSC 
 Nino
Jimenz 
 Tim Studley 
 Todd Wyche 
 The above-mentioned individuals from BPSC can be reached at
trading@brinsonpatrick.com and at 212-453-3000 

 SCHEDULE 4 

 
  

Subsidiaries 
  

 
 None.

 EXHIBIT 7(l) 
 Form of Representation Date Certificate 
 This Officers Certificate (this
“Certificate”) is executed and delivered in connection with Section 7(l) of the At-The-Market Issuance Sales Agreement (the “Agreement”), dated March 18, 2013, and entered into between MannKind Corporation
(the “Company”) and Brinson Patrick Securities Corporation. All capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement. 

The undersigned, a duly appointed and authorized officer of the Company, having made reasonable inquiries to establish the accuracy of
the statements below and having been authorized by the Company to execute this certificate on behalf of the Company, hereby certifies, on behalf of the Company and not in the undersigned’s individual capacity, as follows: 

1. As of the date of this Certificate, (i) the Registration Statement does not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading and (ii) neither the Registration Statement nor the Prospectus contains any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (iii) no event has occurred as a result of which it
is necessary to amend or supplement the Prospectus in order to make the statements therein not untrue or misleading for (i) and (ii) to be true. 
 2. Each of the representations and warranties of the Company contained in the Agreement was true and correct in all material respects, when originally made, and, except for those representations and
warranties that speak solely as of a specific date, is true and correct as of the date of this Certificate. 
 3. Except as
waived by BPSC in writing, each of the covenants required to be performed by the Company in the Agreement on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the
Agreement, has been duly, timely and fully performed in all material respects and each condition required to be complied with by the Company on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the
date hereof as set forth in the Agreement has been duly, timely and fully complied with in all material respects. 
 4. No stop
order suspending the effectiveness of the Registration Statement or of any part thereof has been issued, and, to the Company’s knowledge, no proceedings for that purpose have been instituted or are pending or threatened by any securities or
other governmental authority (including, without limitation, the Commission). 
 5. No order suspending the effectiveness of the
Registration Statement or the qualification or registration of the Placement Shares under the securities or Blue Sky laws of any jurisdiction are in effect and no proceeding for such purpose is pending before, or threatened, to the Company’s
knowledge or in writing by, any securities or other governmental authority (including, without limitation, the Commission). 

 The undersigned has executed this Officer’s Certificate on behalf of the Company as of the date first
written above. 
  

			
	MANNKIND CORPORATION
		
	By:	 	  

	Name:	 	  

	Title:	 	  

 Exhibit 23 
 Permitted Free Writing Prospectus 
 None.EX-4.1

 Exhibit 4.1 

 
  
 SALESFORCE.COM, INC. 

AS ISSUER 
 0.25% CONVERTIBLE SENIOR NOTES DUE 2018 
  

 
 INDENTURE

 DATED AS OF MARCH 18, 2013 

 
  

U.S. BANK NATIONAL ASSOCIATION 
 AS TRUSTEE 
  

 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	ARTICLE 1. DEFINITIONS AND INCORPORATION BY REFERENCE	  	 	1	  
			
	        Section 1.01	  	Definitions	  	 	1	  
	        Section 1.02	  	Other Definitions	  	 	9	  
	        Section 1.03	  	Incorporation by Reference of Trust Indenture Act	  	 	10	  
	        Section 1.04	  	Rules of Construction	  	 	11	  
	        Section 1.05	  	Acts of Holders	  	 	11	  
		
	ARTICLE 2. THE NOTES	  	 	12	  
			
	        Section 2.01	  	Form and Dating	  	 	12	  
	        Section 2.02	  	Execution and Authentication	  	 	13	  
	        Section 2.03	  	Registrar, Paying Agent and Conversion Agent	  	 	14	  
	        Section 2.04	  	Paying Agent to Hold Money and Notes in Trust	  	 	15	  
	        Section 2.05	  	Holder Lists	  	 	15	  
	        Section 2.06	  	Transfer and Exchange	  	 	15	  
	        Section 2.07	  	Replacement Notes	  	 	18	  
	        Section 2.08	  	Outstanding Notes	  	 	19	  
	        Section 2.09	  	Temporary Notes	  	 	19	  
	        Section 2.10	  	Cancellation	  	 	20	  
	        Section 2.11	  	Persons Deemed Owners	  	 	20	  
	        Section 2.12	  	Transfer of Notes	  	 	20	  
	        Section 2.13	  	CUSIP and ISIN Numbers	  	 	25	  
	        Section 2.14	  	Additional Notes; Repurchases	  	 	25	  
		
	ARTICLE 3. REDEMPTION AND REPURCHASES	  	 	25	  
			
	        Section 3.01	  	No Company Right to Redeem	  	 	25	  
	        Section 3.02	  	Fundamental Change Permits Holders to Require Company to Purchase Notes	  	 	26	  
	        Section 3.03	  	Fundamental Change Conversion Right Notice	  	 	26	  
	        Section 3.04	  	Fundamental Change Purchase Notice	  	 	27	  
	        Section 3.05	  	Effect of Fundamental Change Purchase Notice	  	 	28	  
	        Section 3.06	  	Deposit of Fundamental Change Purchase Price	  	 	29	  
	        Section 3.07	  	Notes Purchased in Part	  	 	29	  
	        Section 3.08	  	Covenant to Comply with Securities Laws Upon Purchase of Notes	  	 	29	  
	        Section 3.09	  	Repayment to the Company	  	 	29	  
	        Section 3.10	  	Covenant Not to Purchase Notes Upon Certain Events of Default	  	 	30	  
		
	ARTICLE 4. COVENANTS	  	 	30	  
			
	        Section 4.01	  	Payment of Notes	  	 	30	  
	        Section 4.02	  	SEC and Other Reports	  	 	31	  
	        Section 4.03	  	Compliance Certificate	  	 	32	  

  
 i 

							
	        Section 4.04	  	Further Instruments and Acts	  	 	32	  
	        Section 4.05	  	Maintenance of Office or Agency	  	 	32	  
	        Section 4.06	  	Delivery of Certain Information	  	 	33	  
	        Section 4.07	  	Par Value Limitation	  	 	33	  
		
	ARTICLE 5. CONSOLIDATION, MERGER AND SALE OF ASSETS	  	 	33	  
			
	        Section 5.01	  	Company May Consolidate, Merge or Sell Its Assets on Certain Terms	  	 	33	  
	        Section 5.02	  	Successor Corporation to Be Substituted	  	 	34	  
		
	ARTICLE 6. DEFAULTS AND REMEDIES	  	 	34	  
			
	        Section 6.01	  	Events of Default	  	 	34	  
	        Section 6.02	  	Acceleration	  	 	37	  
	        Section 6.03	  	Other Remedies	  	 	38	  
	        Section 6.04	  	Waiver of Past Defaults	  	 	38	  
	        Section 6.05	  	Control by Majority	  	 	38	  
	        Section 6.06	  	Limitation on Suits	  	 	38	  
	        Section 6.07	  	Rights of Holders to Receive Payment	  	 	39	  
	        Section 6.08	  	Collection Suit by Trustee	  	 	39	  
	        Section 6.09	  	Trustee May File Proofs of Claim	  	 	39	  
	        Section 6.10	  	Priorities	  	 	39	  
	        Section 6.11	  	Undertaking for Costs	  	 	40	  
	        Section 6.12	  	Waiver of Stay, Extension or Usury Laws	  	 	40	  
		
	ARTICLE 7. TRUSTEE	  	 	40	  
			
	        Section 7.01	  	Duties of Trustee	  	 	40	  
	        Section 7.02	  	Rights of Trustee	  	 	41	  
	        Section 7.03	  	Individual Rights of Trustee	  	 	42	  
	        Section 7.04	  	Trustee’s Disclaimer	  	 	43	  
	        Section 7.05	  	Notice of Defaults	  	 	43	  
	        Section 7.06	  	Reports by Trustee to Holders	  	 	43	  
	        Section 7.07	  	Compensation and Indemnity	  	 	43	  
	        Section 7.08	  	Replacement of Trustee	  	 	44	  
	        Section 7.09	  	Successor Trustee by Merger	  	 	45	  
	        Section 7.10	  	Eligibility; Disqualification	  	 	45	  
	        Section 7.11	  	Preferential Collection of Claims Against Company	  	 	45	  
	        Section 7.12	  	Trustee’s Application for Instructions from the Company	  	 	45	  
		
	ARTICLE 8. DISCHARGE OF INDENTURE	  	 	46	  
			
	        Section 8.01	  	Discharge of Liability on Notes	  	 	46	  
	        Section 8.02	  	Repayment to the Company	  	 	46	  

  
 ii 

							
	 ARTICLE 9. AMENDMENTS
	  	 	46	  
			
	        Section 9.01	  	Without Consent of Holders	  	 	46	  
	        Section 9.02	  	With Consent of Holders	  	 	47	  
	        Section 9.03	  	Execution of Supplemental Indentures	  	 	48	  
	        Section 9.04	  	Notices of Supplemental Indentures	  	 	48	  
	        Section 9.05	  	Effect of Supplemental Indentures	  	 	48	  
	        Section 9.06	  	Conformity with Trust Indenture Act	  	 	48	  
	        Section 9.07	  	Notation on or Exchange of Notes	  	 	48	  
	        Section 9.08	  	Revocation and Effect of Consents, Waivers and Actions	  	 	48	  
		
	ARTICLE 10. CONVERSIONS	  	 	49	  
			
	        Section 10.01	  	Conversion Privilege and Consideration	  	 	49	  
	        Section 10.02	  	Conversion Procedure	  	 	52	  
	        Section 10.03	  	Settlement Upon Conversion	  	 	53	  
	        Section 10.04	  	Company to Provide Stock	  	 	55	  
	        Section 10.05	  	Adjustments to the Conversion Rate	  	 	55	  
	        Section 10.06	  	Effect of Reclassification, Consolidation, Merger or Sale	  	 	65	  
	        Section 10.07	  	Adjustment to Conversion Rate Upon Certain Transactions	  	 	67	  
	        Section 10.08	  	Miscellaneous	  	 	69	  
		
	ARTICLE 11. PAYMENT OF INTEREST	  	 	69	  
			
	        Section 11.01	  	Payment of Interest	  	 	69	  
	        Section 11.02	  	Defaulted Interest	  	 	69	  
	        Section 11.03	  	Interest Rights Preserved	  	 	70	  
		
	ARTICLE 12. MISCELLANEOUS	  	 	70	  
			
	        Section 12.01	  	Trust Indenture Act Controls	  	 	70	  
	        Section 12.02	  	Notices	  	 	70	  
	        Section 12.03	  	Communication by Holders with Other Holders	  	 	71	  
	        Section 12.04	  	Certificate and Opinion as to Conditions Precedent	  	 	71	  
	        Section 12.05	  	Statements Required in Certificate or Opinion	  	 	72	  
	        Section 12.06	  	Separability Clause	  	 	72	  
	        Section 12.07	  	Rules by Trustee	  	 	72	  
	        Section 12.08	  	Governing Law	  	 	72	  
	        Section 12.09	  	No Recourse Against Others	  	 	72	  
	        Section 12.10	  	Calculations	  	 	73	  
	        Section 12.11	  	Successors	  	 	73	  
	        Section 12.12	  	Multiple Originals	  	 	73	  
	        Section 12.13	  	Table of Contents; Headings	  	 	73	  
	        Section 12.14	  	Force Majeure	  	 	73	  
	        Section 12.15	  	Submission to Jurisdiction	  	 	73	  
	        Section 12.16	  	Legal Holidays	  	 	73	  
	        Section 12.17	  	No Security Interest Created	  	 	74	  
	        Section 12.18	  	Benefits of Indenture	  	 	74	  

  
 iii

					
	 Form of Note
	  	 	A-1	  
		
	 Form of Transfer Certificate
	  	 	B-1	  
		
	 Restricted Stock Legend
	  	 	C-1	  

  
 iv 

 INDENTURE dated as of March 18, 2013 between salesforce.com, inc., a Delaware
corporation (“Company”), and U.S. Bank National Association, as trustee (“Trustee”). 
 Each
party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders of the Company’s 0.25% Convertible Senior Notes due 2018: 
 ARTICLE 1. 
 DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01 Definitions. 
 “Affiliate” of any specified Person means any other Person, directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For
the purposes of this definition, “control” when used with respect to any specified Person means the power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the
ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

“Applicable Procedures” means, with respect to any transfer or transaction involving a Global Note or any beneficial
interest therein, the rules and procedures of the Depositary for such Note, in each case to the extent applicable to such transfer or transaction and as in effect from time to time. 

“Bankruptcy Law” means Title 11, United States Code, or any similar U.S. federal, state or non-U.S. law for the
relief of debtors. 
 “Bid Solicitation Agent” means the Trustee or such other Person as may be appointed from
time to time by the Company, without prior notice to the Holders, to solicit market bid quotations for the Notes in accordance with Section 10.01(a)(ii). 
 “Board of Directors” means the board of directors of the Company or a committee of such board duly authorized to act for it. 

“Board Resolution” means a copy of one or more resolutions certified by the Secretary or an Assistant Secretary of the
Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, and delivered to the Trustee. 
 “Business Day” means any day other than a Saturday, a Sunday or any other day on which the Federal Reserve Bank of New York is authorized or obligated by law or executive order to close
or be closed. 
 “Capital Stock” means, for any Person, any and all shares, interests, rights to purchase,
warrants, options, participations or other equivalents of or interests in (however designated) the equity of such Person, but excluding any debt securities convertible into such equity. 

“Certificated Notes” means Notes that are in registered definitive form. 

 “Close of Business” means 5:00 p.m., New York City time. 

“Common Stock” means the shares of the common stock of the Company, par value $0.001 per share, existing on the Issue
Date or any other shares of Capital Stock of the Company into which such shares of common stock shall be reclassified or changed. 
 “Company” means the party named as such in the first paragraph of this Indenture until a successor or assign replaces it pursuant to the applicable provisions hereof and, thereafter,
means the successor or assign. 
 “Company Order” means a written request or order signed in the name of the
Company by any Officer. 
 “Conversion Price” means as of any date, $1,000 divided by the Conversion Rate as of
such date. 
 “Corporate Trust Office” means the corporate trust office of the Trustee at
which at any time the trust created by this Indenture shall be administered, which office at the date hereof is located at 633 West 5th Street, 24th Floor, Los Angeles, California 90071, Attention: Corporate Trust Services (salesforce.com 0.25% Convertible Senior
Notes due 2018), or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the corporate trust office of any successor Trustee at which such trust shall be administered (or such other address
as a successor Trustee may designate from time to time by notice to the Holders and the Company). 

“Custodian” means any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy Law.

 “Daily Conversion Value” means, for each of the 30 consecutive VWAP Trading Days during an Observation
Period, one-thirtieth (1/30th) of the product of (i) the Conversion Rate in effect on such VWAP Trading Day and (ii) the Daily VWAP for such VWAP Trading Day. 
 “Daily Settlement Amount” means, for each of the 30 VWAP Trading Days during an Observation Period: 
 (a) an amount of cash equal to the lesser of (i) one-thirtieth (1/30th) of $1,000 and (ii) the Daily Conversion Value (such minimum, the “Daily Principal Portion”); and

 (b) to the extent the Daily Conversion Value for such VWAP Trading Day exceeds the Daily Principal Portion for such VWAP
Trading Day, a number of shares of the Common Stock (the “Daily Share Amount”), subject to the Company’s right to pay cash in lieu of all or a portion of such number of shares of the Common Stock pursuant to
Section 10.03(b), equal to the fraction, the numerator of which equals the excess of (i) the Daily Conversion Value for such VWAP Trading Day over (ii) the Daily Principal Portion for such Trading Day, and the denominator of which
equals the Daily VWAP for such VWAP Trading Day. 

  
 2 

 “Daily VWAP” means, for any of the 30 VWAP Trading Days in an Observation
Period, the per share volume-weighted average price of the Common Stock as displayed under the heading “Bloomberg VWAP” on Bloomberg page “CRM.N <equity> AQR” (or any successor thereto if such page it not available) in
respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such VWAP Trading Day (or if such volume-weighted average price is unavailable, the market value of one share of the
Common Stock on such VWAP Trading Day) determined using a volume-weighted average method, by the Board of Directors. The Daily VWAP will be determined without regard to afterhours trading or any other trading outside of the regular trading session
trading hours. On and after the occurrence of a Merger Event, the Daily VWAP for a Unit of Reference Property means, for any of the 30 VWAP Trading Days during an Observation Period, the fair market value of a Unit of Reference Property as
determined, in a commercially reasonable manner, using a volume-weighted average method, if possible, by the Board of Directors. 
 “Default” means any event which is, or after notice or passage of time or both would be, an Event of Default. 
 “DTC” mean The Depository Trust Company. 
 “Ex-Dividend
Date” means, with respect to any issuance, dividend or distribution, the first date on which the shares of the Common Stock trade in the applicable exchange or in the applicable market, regular way, without the right to receive the
issuance, dividend or distribution in question. 
 “Exchange Act” means the Securities Exchange Act of 1934, as
amended. 
 “Free Trade Date” means the date that is one year after the last date of original issuance of the
Notes. 
 “Freely Tradable” means, with respect to the Notes and the shares of Common Stock issuable upon
conversion of the Notes, if any, that such Notes or such shares of Common Stock, if any, (i) are eligible to be sold by a Person who has not been an Affiliate of the Company during the preceding three months without any volume or manner of sale
restrictions under the Securities Act, (ii) do not bear a Restricted Security Legend or Restricted Stock Legend and (iii) with respect to Global Notes only, are identified by an unrestricted CUSIP number in the facilities of the applicable
depositary. 
 “Fundamental Change” means an event that shall be deemed to have occurred any time after the
Issue Date when any of the following events occurs: 
 (1) any “person” or “group,” other than
the Company, its Subsidiaries and the employee benefits plans of the Company and of its Subsidiaries, has become the direct or indirect “beneficial owner,” of the shares of the Company’s Capital Stock representing more than 50%
of the total voting power of the Company’s common equity; 
 (2) consummation of any consolidation or merger of the Company
pursuant to which the Common Stock is or will be converted into cash, securities or other property or any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the

  
 3 

 
consolidated assets of the Company and its Subsidiaries, taken as a whole, to any person other than one or more of the Company’s Subsidiaries; provided, however, that if in any
such transaction the holders of more than 50% of the shares of the Company’s common equity, representing more than 50% of the voting power of the common equity, immediately prior to such transaction, own, directly or indirectly, more than 50%
of all classes of common equity, representing more than 50% of the total voting power of the continuing or surviving Person or transferee or the parent thereof immediately after such transaction, such transaction shall not constitute a Fundamental
Change under this clause (2); 
 (3) the holders of the Common Stock approve any plan or proposal for the Company’s
liquidation or dissolution; or 
 (4) the Common Stock (or any other common stock into which the Notes are convertible at such
time) is neither listed nor quoted on a National Securities Exchange. 
 Notwithstanding the foregoing, a transaction or a
series of transactions as set forth in clause (2) above shall not constitute Fundamental Change if, at least 90% of the consideration received or to be received by holders of the Common Stock (excluding cash payments for fractional shares and
cash payments made pursuant to dissenters’ appraisal rights) in connection with such transaction or transactions otherwise constituting a Fundamental Change under clause (2) above consists of shares of common stock or depositary receipts
evidencing interests in ordinary shares or common equity traded on a National Securities Exchange, and as a result of such transaction or transactions, the Notes become convertible into cash and, if applicable, such shares of common stock or
depositary receipts. 
 For purposes of this definition: 

(i) whether a person is a “beneficial owner” will be determined in accordance with Rule 13d-3 under the Exchange Act;

 (ii) “person” includes any syndicate or group that would be deemed to be a “person” under
Section 13(d)(3) of the Exchange Act; and 
 (iii) any transaction or event that constitutes a Fundamental Change under
both clause (1) and clause (2) above will be deemed to be a Fundamental Change solely under clause (2) above. 

“GAAP” means generally accepted accounting principles in the United States of America as in effect and, to the extent
optional, adopted by the Company, on the Issue Date, consistently applied. 
 “Global Note” means a permanent
Global Note that is in the form of the Note attached hereto as Exhibit A and that is deposited with and registered in the name of the Depositary or the nominee of the Depositary. 

“Global Securities Legend” means a legend set forth in Exhibit A. 

  
 4 

 “Holder” or “Holders” means a Person or Persons in whose
name a Note is registered in the Register. 
 “Indenture” means this Indenture, as amended or supplemented from
time to time in accordance with the terms hereof, including the provisions of the TIA that are deemed to be a part hereof. 

“Issue Date” means March 18, 2013. 
 “Last Reported Sale Price” of the Common Stock means, for any day, the closing sale price per share (or if no closing sale price is reported, the average of the last bid price and the
last ask price or, if more than one in either case, the average of the average last bid prices and the average last ask prices) on such day as reported in composite transactions for the principal U.S. securities exchange on which the Common Stock is
listed for trading, without regard to afterhours or extended market trading. If the Common Stock is not listed for trading on a U.S. national or regional securities exchange on the relevant date, the “Last Reported Sale Price” of the
Common Stock will equal the last quoted bid price for the Common Stock in the over-the-counter market on such date as reported by OTC Markets Group Inc. or a similar organization. If the Common Stock is not so quoted on such date, the “Last
Reported Sale Price” will be the average of the mid-point of the last bid prices and the last ask prices for the Common Stock on such date from each of at least three nationally recognized independent investment banking firms selected by the
Company for this purpose. On and after the occurrence of a Merger Event, the Last Reported Sale Price for a Unit of Reference Property means, for any day, the value of a Unit of Reference Property on such day as determined by the Board of Directors
in a commercially reasonable manner. 
 “Make-Whole Fundamental Change” means, subject to the sentence
immediately following clause (4) of the definition of Fundamental Change, any event that either constitutes a Fundamental Change or would constitute a Fundamental Change but for the proviso in clause (2) of the definition of Fundamental
Change. 
 “Market Disruption Event” means, for any Scheduled Trading Day, the occurrence or existence on such
Scheduled Trading Day of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the stock exchange or otherwise) in the Common Stock or in any options contracts or futures contracts relating to
the Common Stock, and such suspension or limitation occurs or exists at any time within the 30 minutes prior to the closing time of the relevant exchange on such Scheduled Trading Day. 

“Maturity Date” means April 1, 2018. 
 “National Securities Exchange” means a securities exchange registered as a national securities exchange under Section 6(a) of the Exchange Act (or any successor thereto). 

  
 5 

 “Notes” means any of the Company’s 0.25% Convertible Senior Notes due
2018 issued under this Indenture. 
 “Observation Period” means, with respect to any Note, (i) if the
Conversion Date for such Note occurs on or after the 35th Scheduled Trading Day immediately preceding the Maturity Date, the 30 consecutive VWAP Trading Day period beginning on and including the 32nd Scheduled Trading Day (or, if such Scheduled
Trading Day is not a VWAP Trading Day, the immediately following VWAP Trading Day) immediately preceding the Maturity Date, and (ii) in all other cases, the 30 consecutive VWAP Trading Day period beginning on, and including, the second
Scheduled Trading Day (or, if such Scheduled Trading Day is not a VWAP Trading Day, the immediately following VWAP Trading Day) immediately following the Conversion Date for such Note. 

“Offering Memorandum” means the final offering memorandum for the offering and sale of the Notes dated March 12,
2013. 
 “Officer” means the Chairman of the Board, the Vice Chairman, the Chief Executive Officer, the
President, the Chief Financial Officer, Chief Legal Officer, any Executive Vice President, any Senior Vice President, any Vice President, the Treasurer or the Secretary or any Assistant Treasurer or Assistant Secretary of the Company. 

“Officer’s Certificate” means a written certificate (i) containing the information specified in Sections 12.04
and 12.05, signed in the name of the Company by any Officer, and delivered to the Trustee; and (ii) if given pursuant to Section 4.03, signed by the principal financial or accounting Officer of the Company, which certificate need not
contain the information specified in Sections 12.04 and 12.05. 
 “Open of Business” means 9:00 a.m., New York
City time. 
 “Opinion of Counsel” means a written opinion containing the information specified in Sections
12.04 and 12.05, from legal counsel. The counsel may be an employee of, or counsel to, the Company who is reasonably satisfactory to the Trustee. 
 “Person” means any individual, corporation, limited liability company, partnership, joint venture, association, joint-stock company, trust, unincorporated organization, or government or
any agency or political subdivision thereof. 
 “Restricted Securities Legend” means a legend in the form set
forth in Exhibit A, or any other substantially similar legend indicating the restricted status of the Notes under Rule 144. 

  
 6 

 “Restricted Stock Legend” means a legend in the form set forth in Exhibit
C, or any other substantially similar legend indicating the restricted status of the shares of Common Stock under Rule 144. 

“Rule 144” means Rule 144 under the Securities Act (or any successor provision), as it may be amended from time to time.

 “Rule 144A” means Rule 144A under the Securities Act (or any successor provision), as it may be amended from
time to time. 
 “Rule 144A Information” shall be such information as is specified pursuant to Rule 144A(d)(4)
under the Securities Act. 
 “Scheduled Trading Day” means a day that is scheduled to be a Trading Day on the
principal U.S. national or regional securities exchange or market on which the Common Stock is listed or admitted for trading. If the Common Stock is not so listed or admitted for trading, “Scheduled Trading Day” means Business Day.

 “SEC” means the Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Significant Subsidiary” means any Subsidiary that is a “significant subsidiary” of the Company within the
meaning of Rule 1-02(w) of Regulation S-X promulgated under the Exchange Act; provided, however, that, in the case of a Subsidiary that meets the criteria of clause (3) of such definition of “significant subsidiary” but
not clause (1) or (2) of such definition, such Subsidiary shall not be deemed to be a Significant Subsidiary unless such Subsidiary’s income from continuing operations before income taxes, extraordinary items and cumulative effect of
a change in accounting principle exclusive of amounts attributable to any non-controlling interests for the last completed fiscal year prior to the date of such determination exceeds $100,000,000. 

“Stock Price” means, with respect to the Common Stock, in connection with a Fundamental Change, (i) in the case of
a Fundamental Change described in clause (2) of the definition of Fundamental Change in which the holders of the Common Stock receive only cash, the amount of cash paid per share of the Common Stock in such Fundamental Change, and
(ii) otherwise, the average of the Last Reported Sales Price of the Common Stock over the five Trading Day period ending on, and including, the Trading Day immediately preceding the applicable Make-Whole Fundamental Change Effective Date.

 “Stock Split” means the forward stock split through a stock dividend, whereby each share of the Common Stock
effectively would be split into four shares of the Common Stock that was approved by the Board of Directors on December 13, 2012. 
 “Subsidiary” means a Person more than 50% of the outstanding Voting Stock of which is owned, directly or indirectly, by the Company or by one or more other Subsidiaries of the Company, or
by the Company and one or more other Subsidiaries of the Company. 

  
 7 

 “TIA” means the Trust Indenture Act of 1939 as in effect on the Issue Date,
provided, however, that if the TIA is amended after such date, TIA means, to the extent required by any such amendment, the TIA as so amended. 
 “Trading Day” means a day on which (i) trading in the Common Stock generally occurs on the New York Stock Exchange or, if the Common Stock is not then listed on the New York Stock
Exchange, on the principal other U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on
which the Common Stock is then traded, and (ii) there is no Market Disruption Event. If the Common Stock (or other security for which a Last Reported Sale Price must be determined) is not so listed or traded, “Trading Day”
means Business Day. 
 “Trading Price” per $1,000 principal amount of the Notes, for any date of determination,
means the average (per $1,000 principal amount of Notes) of the secondary market bid quotations obtained by the Bid Solicitation Agent for $5,000,000 principal amount of Notes at approximately 3:30 p.m., New York City time, on such determination
date from three independent nationally recognized securities dealers selected by the Company; provided that, if three such bids cannot reasonably be obtained by the Bid Solicitation Agent but two such bids are obtained, then the average of
the two bids shall be used, and if only one such bid can reasonably be obtained by the Bid Solicitation Agent, that one bid shall be used. If the Bid Solicitation Agent cannot reasonably obtain at least one bid for $5,000,000 principal amount of the
Notes from an independent nationally recognized securities dealer, then the Trading Price per $1,000 principal amount of Notes will be deemed to be less than 98% of the Trading Price Product for such Trading Day. If, on any date of determination,
the Company does not so instruct the Bid Solicitation Agent to obtain bids when required, the Trading Price per $1,000 principal amount of the Notes will be deemed to be less than 98% of the Trading Price Product on such date of determination.

 “Trust Officer” means any officer within the corporate trust department of the Trustee (or any successor
group of the Trustee) with direct responsibility for the administration of this Indenture and also means, with respect to a particular corporate trust matter hereunder, any other officer of the Trustee to whom such matter is referred because of his
or her knowledge of and familiarity with the particular subject. 
 “Trustee” means the party named as the
“Trustee” in the first paragraph of this Indenture until a successor replaces it pursuant to the applicable provisions of this Indenture and, thereafter, means such successor. The foregoing sentence shall likewise apply to any such
subsequent successor or successors. 
 “Uniform Commercial Code” means the New York Uniform Commercial Code as
in effect from time to time. 
 “Voting Stock” of a Person means Capital Stock of such Person of the class or
classes pursuant to which the holders thereof have the general voting power under ordinary circumstances to elect at least a majority of the board of directors, managers or trustees of such 

  
 8 

 
Person (irrespective of whether or not at the time Capital Stock of any other class or classes shall have or might have voting power by reason of the happening of any contingency). 

“VWAP Market Disruption Event” means (i) a failure by the principal U.S. national or regional securities exchange
or market on which the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (ii) on any Scheduled Trading Day for the Common Stock, the occurrence or existence prior to 1:00 p.m., New York
City time, for more than one half-hour period in the aggregate during regular trading hours, of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant stock exchange or otherwise)
in the Common Stock or in any options, contracts or future contracts relating to the Common Stock. 
 “VWAP Trading
Day” means a day on which (i) there is no VWAP Market Disruption Event and (ii) trading in the Common Stock generally occurs on the New York Stock Exchange or, if the Common Stock is not then listed on the New York Stock Exchange,
on the principal other U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the
Common Stock is then traded. If the Common Stock (or any other security for which a Daily VWAP must be determined) is not so listed or traded, “VWAP Trading Day” means a “Business Day.” 

“Wholly Owned Subsidiary” means, at any time, a Subsidiary all the Voting Stock of which (except directors’
qualifying shares which shall be deemed to include investments by foreign nationals mandated by applicable law) is at such time owned, directly or indirectly, by the Company and its other Wholly Owned Subsidiaries. 

Section 1.02 Other Definitions. 
  

			
	 Term Section:
	  	 Defined in:

	 “Act”
	  	1.05
	 “Additional Interest”
	  	4.02(b)
	 “Additional Shares”
	  	10.07(a)
	 “Agent Members”
	  	2.12(e)
	 “Cash Election”
	  	10.03(b)
	 “Cash Percentage”
	  	10.03(b)(i)
	 “Cash Percentage Notice”
	  	10.03(b)(i)
	 “Company’s Filing Obligations”
	  	6.01(c)
	 “Conversion Agent”
	  	2.03
	 “Conversion Date”
	  	10.02(a)(i)
	 “Conversion Rate”
	  	10.01(a)
	 “Daily Principal Portion”
	  	1.01
	 “Daily Share Amount”
	  	1.01
	 “Defaulted Interest”
	  	11.02
	 “Depositary”
	  	2.01(a)
	 “Event of Default”
	  	6.01(a)
	 “Expiration Date”
	  	10.05(e)

  
 9 

			
	 Term Section:
	  	 Defined in:

	 “Expiration Time”
	  	10.05(e)
	 “Fundamental Change Notice”
	  	3.03(a)
	 “Fundamental Change Notice Date”
	  	3.03(a)
	 “Fundamental Change Purchase Date”
	  	3.02(a)
	 “Fundamental Change Purchase Notice”
	  	3.04(a)
	 “Fundamental Change Purchase Price”
	  	3.02(a)
	 “Interest Payment Date”
	  	11.01
	 “Measurement Period”
	  	10.01(a)(ii)
	 “Merger Event”
	  	10.06(a)
	 “Notice of Conversion”
	  	10.02(a)
	 “Paying Agent”
	  	2.03
	 “QIB”
	  	2.01(a)
	 “Record Date”
	  	11.01
	 “Reference Property”
	  	10.06(a)
	 “Register”
	  	2.03
	 “Registrar”
	  	2.03
	 “Restricted Notes”
	  	2.06(f)(i)
	 “Special Interest”
	  	6.01(c)
	 “Special Record Date”
	  	11.02(a)
	 “Specified Corporate Transaction”
	  	10.01(a)(iv)
	 “Specified Corporate Transaction Notice”
	  	10.01(a)(iv)
	 “Spin-off”
	  	10.05(c)(ii)
	 “Successor Company”
	  	5.01(a)(i)
	 “Temporary Notes”
	  	2.09
	 “Trading Price Product”
	  	10.01(a)(ii)
	 “transfer”
	  	2.06(f)(i)
	 “Unit of Reference Property”
	  	10.06(a)
	 “Valuation Period”
	  	10.05(c)(ii)
	 “Weighted Average Consideration”
	  	10.06(a)(v)(C)

 Section 1.03 Incorporation by Reference of Trust Indenture Act. Whenever this Indenture refers to
a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings: 

“indenture securities” means the Notes. 
 “indenture to be qualified” means this Indenture. 

“indenture trustee” or “institutional trustee” means the Trustee. 

“obligor” on the indenture securities means the Company and any other obligor on the indenture securities. 

  
 10 

 All other TIA terms used in this Indenture that are defined by the TIA, defined by TIA
reference to another statute or defined by SEC rule have the meanings assigned to them by such definitions. 
 Section 1.04
Rules of Construction. 
 (1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it and shall be construed in accordance with GAAP; 

(3) “or” is not exclusive; 
 (4) “including” means including, without limitation; 
 (5) words
in the singular include the plural, and words in the plural include the singular; 
 (6) all references to $, dollars, cash
payments or money refer to United States currency; and 
 (7) unless the context requires otherwise, all references to payments
of interest on the Notes shall include Additional Interest and Special Interest, if any, payable in accordance with the terms of Sections 4.02 or 6.01, as applicable, hereof. 
 Section 1.05 Acts of Holders. Any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be given
or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by agent duly appointed in writing; and, except as herein otherwise expressly provided,
such action shall become effective when such instrument or instruments are delivered to the Trustee and to the Company. Such instrument or instruments (and the action embodied therein and evidenced thereby) are herein sometimes referred to as the
“Act” of Holders signing such instrument or instruments. Proof of execution of any such instrument or of a writing appointing any such agent shall be sufficient for any purpose of this Indenture and conclusive in favor of the
Trustee and the Company, if made in the manner provided in this Section 1.05. 
 (a) The fact and date of the
execution by any Person of any such instrument or writing may be proved by the affidavit of a witness of such execution or by a certificate of a notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the
individual signing such instrument or writing acknowledged to such officer the execution thereof. Where such execution is by a signer acting in a capacity other than such signer’s individual capacity, such certificate or affidavit shall also
constitute sufficient proof of such signer’s authority. The fact and date of the execution of any such instrument or writing, or the authority of the Person executing the same, may also be proved in any other manner that the Trustee deems
sufficient. 

  
 11 

 (b) Any request, demand, authorization, direction, notice, consent, waiver or other Act of
the Holder of any Note shall bind every future Holder of the same Note and the Holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof in respect of anything done, omitted or suffered to be
done by the Trustee, the Company or the Conversion Agent in reliance thereon, whether or not notation of such action is made upon such Note. 
 (c) If the Company shall solicit from the Holders any request, demand, authorization, direction, notice, consent, waiver or other Act, the Company may, at its option, by or pursuant to a Board Resolution,
fix in advance a record date for the determination of Holders entitled to give such request, demand, authorization, direction, notice, consent, waiver or other Act, but the Company shall have no obligation to do so. If such a record date is fixed,
such request, demand, authorization, direction, notice, consent, waiver or other Act may be given before or after such record date, but only the Holders of record at the Close of Business on such record date shall be deemed to be Holders for the
purposes of determining whether Holders of the requisite proportion of outstanding Notes have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other Act, and for that purpose the
outstanding Notes shall be computed as of such record date; provided that no such authorization, agreement or consent by the Holders on such record date shall be deemed effective unless it shall become effective pursuant to the provisions of
this Indenture not later than six months after the record date. 
 ARTICLE 2. 

THE NOTES 

Section 2.01 Form and Dating. The Notes and the Trustee’s certificate of authentication shall be substantially in the form of
Exhibit A, which is a part of this Indenture. The Notes may have notations, legends or endorsements required by law, stock exchange rule or usage. The Company shall provide any such notations, legends or endorsements to
the Trustee in writing. Each Note shall be dated the date of its authentication. Except as otherwise expressly permitted in this Indenture, all Notes shall be identical in all respects. Notwithstanding any differences among them, all
Notes issued under this Indenture shall vote and consent together on all matters as one class. 
 (a) Initial Notes. The
Notes initially shall be offered and sold only to qualified institutional buyers as defined in Rule 144A (“QIBs”) in reliance on Rule 144A and shall be issued in the form of Global Notes that shall be deposited with the Trustee at
its Corporate Trust Office, as custodian for the Depositary and registered in the name of DTC or the nominee thereof (DTC, or any successor thereto, and any such nominee being hereinafter referred to as the “Depositary”), duly
executed by the Company and authenticated by the Trustee as hereinafter provided. 
 (b) Global Notes in General. Each
Global Note shall represent the outstanding Notes as shall be specified therein and each Global Note shall provide that it shall represent the aggregate principal amount of outstanding Notes from time to time endorsed thereon and that the aggregate
principal amount of outstanding Notes represented thereby may from time to time be 

  
 12 

 
reduced or increased, as appropriate, to reflect exchanges, purchases by the Company and conversions. 
 Any adjustment of the aggregate principal amount of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding Notes represented thereby shall be made by the Trustee in
accordance with instructions given by the Holder thereof as required by Section 2.12 hereof and shall be made on the records of the Trustee and the Depositary. 
 Payment of the principal, accrued and unpaid interest (including Additional Interest and Special Interest), if any, or payment of the Fundamental Change Purchase Price on the Global Note shall be made to
the Holder of such Note on the date of payment, unless a record date or other means of determining Holders eligible to receive payment is provided for herein. 
 (c) Book-Entry Provisions. This Section 2.01(d) shall apply only to Global Notes deposited with or on behalf of the Depositary. The Company shall execute and the Trustee shall, in accordance
with Section 2.02, authenticate and deliver Global Notes that (a) shall be registered in the name of the Depository or the nominee of the Depositary and (b) shall be delivered by the Trustee to the Depositary or pursuant to the
Depositary’s instructions. 
 (d) Legends. 
 (i) Each Global Note shall bear the Global Securities Legend unless otherwise directed by the Company. 
 (ii) Each Restricted Note shall bear the Restricted Securities Legend. Each Note that bears or is required to bear the Restricted Securities Legend shall be subject to the restrictions on transfer set
forth therein, and each Holder of such Note, by such Holder’s acceptance thereof, agrees to be bound by all such restrictions on transfer. 
 (iii) Every stock certificate representing the shares of Common Stock issued in the circumstances described in Section 2.06(g) hereof shall bear the Restricted Stock Legend unless removed in
accordance with the provisions of Section 2.06(j) or otherwise at the direction of the Company. 
 Section 2.02
Execution and Authentication. The Notes shall be executed on behalf of the Company by any Officer. The signature of the Officer on the Notes may be manual or facsimile. 
 If an Officer whose signature is on a Note no longer holds that office at the time the Trustee authenticates the Note, the Note shall be valid nevertheless. 

At any time after the Issue Date, the Company may deliver Notes executed by the Company to the Trustee for authentication, together with
a written order of the Company in the form of an Officer’s Certificate for the authentication and delivery of such Notes, and the Trustee, in accordance with such written order of the Company, shall authenticate and deliver such Notes.

  
 13 

 A Note shall not be valid until an authorized signatory of the Trustee manually signs the
certificate of authentication on the Note. The signature shall be conclusive evidence that the Note has been authenticated under this Indenture. 
 The Notes shall originally be issued only in registered form without coupons and only in denominations of $1,000 of principal amount and any integral multiple thereof. 

The aggregate principal amount of Notes that may be authenticated by the Trustee under this Indenture is initially limited to
$1,150,000,000, subject to Section 2.14 and except for Notes authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of other Notes pursuant to Sections 2.06, 2.07, 2.09, 2.12, 3.07, 9.07 and 10.02 hereof.

 The Trustee may appoint authenticating agents. The Trustee may at any time after the Issue Date appoint an authenticating
agent acceptable to the Company to authenticate Notes. An authenticating agent may authenticate Notes whenever the Trustee may do so, except any Notes issued pursuant to Section 2.07 hereof. Each reference in this Indenture to authentication by
the Trustee includes authentication by such agent. An authenticating agent shall have the same right to deal with the Company as the Trustee with respect to such matters for which it has been appointed. 

Section 2.03 Registrar, Paying Agent and Conversion Agent. The Company shall maintain an office or agency where Notes may be
presented for registration of transfer or for exchange (“Registrar”), an office or agency where Notes may be presented for payment (“Paying Agent”), an office or agency where Notes may be presented for
conversion (“Conversion Agent”) and an office or agency where notices to or upon the Company in respect of the Notes and this Indenture may be served. The Registrar shall keep a register for the recordation of, and shall record, the
names and addresses of Holders of the Notes, the Notes held by each Holder and the transfer, exchange and conversion of Notes (the “Register”). The entries in the Register shall be conclusive, and the parties may treat each Person
whose name is recorded in the Register pursuant to the terms hereof as a Holder hereunder for all purposes of this Indenture. The Company may have one or more co-registrars, one or more additional paying agents and one or more additional conversion
agents. The term Paying Agent includes any additional paying agent, including any named pursuant to Section 4.05. The term Conversion Agent includes any additional conversion agent, including any named pursuant to Section 4.05. 

The Company shall enter into an appropriate agency agreement with any Registrar, Paying Agent, Conversion Agent or co-registrar not a
party to this Indenture, which shall incorporate the terms of the TIA. Any such agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the Trustee of the name and address of any such agent. If
the Company fails to maintain a Registrar, Paying Agent or Conversion Agent, the Trustee may agree to act as such and shall be entitled to appropriate compensation therefor pursuant to Section 7.07. The Company or any of its domestically
incorporated Wholly Owned Subsidiaries may act as Paying Agent, Registrar, Conversion Agent or co-registrar. 

  
 14 

 The Company initially appoints the Trustee as the Paying Agent, the Conversion Agent, and
the Registrar, in connection with the Notes, and the Corporate Trust Office to be such office or agency of the Company for the aforesaid purposes. The Company may at any time rescind the designation of the Paying Agent, Conversion Agent or the
Registrar or approve a change in the location through which any of them acts. 
 Section 2.04 Paying Agent to Hold Money and
Notes in Trust. Except as otherwise provided herein, on or prior to each due date of payment in respect of any Note, the Company shall deposit with the Paying Agent a sum of money (in immediately available funds if deposited on the
due date) and shares of Common Stock, if applicable, sufficient to make such payments when so becoming due. The Paying Agent shall (or, if the Paying Agent is not a party hereto, the Company shall require each Paying
Agent to agree in writing that such Paying Agent shall) hold in trust for the benefit of Holders or the Trustee (if the Trustee is not the Paying Agent) all money and shares of Common Stock, if any, held by the Paying Agent for the
making of payments in respect of the Notes and shall notify the Trustee (if the Trustee is not the Paying Agent) of any default by the Company in making any such payment. At any time during the continuance of any such default, the Paying
Agent (if not the Trustee) shall, upon the written request of the Trustee, forthwith pay to the Trustee all money and shares of Common Stock, if any, so held in trust. If the Company or a Wholly Owned Subsidiary acts as
Paying Agent, it shall segregate the money and shares of Common Stock, if any, held by it as Paying Agent and hold it as a separate trust fund. The Company at any time may require a Paying Agent to pay all money and shares of
Common Stock, if any, held by it to the Trustee and to account for any funds and shares of Common Stock, if any, disbursed by the Paying Agent. Upon complying with this Section 2.04, the Paying Agent shall
have no further liability for the money delivered to the Trustee. 
 Section 2.05 Holder Lists. The Trustee shall
preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Holders. If the Trustee is not the Registrar, the Company shall furnish to the Trustee, promptly after each
Record Date, and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of Holders. 

Section 2.06 Transfer and Exchange. 
 (a) Subject to Section 2.12 hereof, upon surrender for registration of transfer of any Note, together with a written instrument of transfer satisfactory to the Registrar duly executed by the Holder
or such Holder’s attorney-in-fact duly authorized in writing, at the office or agency of the Company-designated Registrar or co-Registrar pursuant to Section 2.03, (i) the Company shall execute, and the Trustee (or any authenticating
agent) shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Notes of any authorized denomination or denominations, of a like aggregate principal amount and bearing such restrictive legends as may
be required by this Indenture and (ii) the Registrar shall record the information required pursuant to Section 2.03 regarding the designated transferee or transferees in the Register. The Company shall not charge a service charge for any
registration of transfer or exchange, but the Company may require payment of a sum sufficient to pay all taxes, assessments or other governmental charges that may be imposed in connection with the

  
 15 

 
registration of, transfer or exchange of the Notes from the Holder requesting such transfer or exchange. 
 At the option of the Holder, Notes may be exchanged for other Notes of any authorized denomination or denominations, of a like aggregate principal amount, upon surrender of the Notes to be exchanged, at
such office or agency, together with a written instrument of transfer satisfactory to the Registrar duly executed by the Holder or such Holder’s attorney-in-fact duly authorized in writing, and documents of identity and title satisfactory to
Registrar. Whenever any Notes are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Notes that the Holder making the exchange is entitled to receive, bearing registration numbers not
contemporaneously outstanding. 
 The Company shall not be required to make, and the Registrar need not register, transfers or
exchanges of Notes in respect of which a Fundamental Change Purchase Notice has been given and not validly withdrawn by the Holder thereof in accordance with the terms of this Indenture (except, in the case of Notes to be repurchased in part, the
portion of such Notes not to be repurchased). 
 (b) Notwithstanding any provision to the contrary herein, so long as a Global
Note remains outstanding and is held by or on behalf of the Depositary, transfers of a Global Note, in whole or in part, shall be made only in accordance with Section 2.12 and this Section 2.06(b). Transfers of a Global Note shall be
limited to transfers of such Global Note to the Depositary, to nominees of the Depositary or to a successor of the Depositary or such successor’s nominee. 
 (c) Successive registrations and registrations of transfers and exchanges as aforesaid may be made from time to time as desired, and each such registration shall be noted on the Register. 

(d) Any Registrar appointed pursuant to Section 2.03 shall provide to the Trustee such information as the Trustee may reasonably
require in connection with the delivery by such Registrar of Notes upon transfer or exchange of Notes. 
 (e) No Registrar shall
be required to make registrations of transfer or exchange of Notes during any periods designated in Paragraph 7 of the form of Note attached as Exhibit A hereto or in this Indenture as periods during which such registration of transfers and
exchanges need not be made. 
 (f) Transfer Restrictions. 

(i) Every Note that bears or is required under this Section 2.06(f) to bear the Restricted Securities Legend required by Section 2.01(d)
(the “Restricted Notes”) shall be subject to the restrictions on transfer set forth in this Section 2.06(f) unless such restrictions on transfer shall be eliminated or otherwise waived by written consent of the Company, and the
Holder of each such Restricted Note, by such Holder’s acceptance thereof, agrees to be bound by all such restrictions on transfer. As used in this Section 2.06(f), and Sections 2.06(g), 2.12(b) and 2.12(c), the term “transfer”
encompasses any sale, pledge, transfer, loan, hypothecation or other disposition whatsoever of any Restricted Note. Except as otherwise provided in this Indenture with respect to any Restricted Notes (including, without limitation, Section 2.06(i)

  
 16 

 
below) or as permitted under the terms of such Restricted Securities Legend, if a request is made to remove the legend on any Restricted Note, the legend shall not be removed unless there is
delivered to the Company and the Registrar such satisfactory evidence that neither the Restricted Securities Legend nor the restrictions on transfer set forth therein are required to ensure that transfers thereof comply with the provisions of Rule
144A or Rule 144, that such Notes are not “restricted” within the meaning of Rule 144 or that transfers thereof comply with all other applicable securities laws and regulations. In such a case, upon (i) provision of such satisfactory
evidence, or (ii) notification by the Company to the Trustee and Registrar of the sale of such Note pursuant to a registration statement that is effective at the time of such sale, the Trustee, pursuant to a Company Order, shall authenticate
and deliver a Note that does not bear the Restricted Securities Legend. 
 (ii) Except as provided elsewhere in this Indenture
(including, without limitation, Section 2.06(i) below), until the later of (x) the date that is one year after the last date of original issuance of the Notes and (y) the date that is three months after the Holder ceases to be an
Affiliate of the Company, any certificate evidencing such Notes (and all securities issued in exchange therefor or substitution thereof, other than Common Stock, if any, issued upon conversion thereof, which shall bear the Restricted Stock Legend,
if applicable) shall bear the Restricted Securities Legend unless such Notes have been transferred (a) to the Company, (b) under a registration statement that has been declared effective under the Securities Act, or (c) under any
other available exemption from the registration requirements of the Securities Act pursuant to which the Notes are not required to bear the Restricted Securities Legend. 
 (iii) No transfer of any Note prior to the Free Trade Date will be registered by the Registrar unless the applicable box on the Form of Assignment and Transfer has been checked. 

(g) Legends on the Common Stock. 
 (i) Except as provided elsewhere in this Indenture (including, without limitation, Section 2.06(j) below), until the later of (x) the date that is one year after the last date of original
issuance of the Notes and (y) the date that is three months after the holder of such shares of Common Stock ceases to be an Affiliate of the Company, any stock certificate representing shares of the Common Stock issued upon conversion of such
Notes shall bear the Restricted Stock Legend unless the Notes or such Common Stock, as applicable, has been transferred (a) to the Company; (b) under a registration statement that has been declared effective under the Securities Act; or
(c) under any other available exemption from the registration requirements of the Securities Act pursuant to which the shares of Common Stock are not required to bear the Restricted Stock Legend. 

(ii) Any such shares of Common Stock as to which such restrictions on transfer shall have expired in accordance with their terms may,
subject to applicable securities laws and regulations and upon surrender of the certificates representing such shares of Common 

  
 17 

 
Stock for exchange in accordance with the procedures of the transfer agent for the Common Stock, be exchanged for a new certificate or certificates for a like aggregate number of shares of Common
Stock which shall not bear the Restricted Stock Legend. 
 (h) The Company shall not permit any Note that is purchased or owned
by the Company or any Affiliate thereof to be resold by the Company or such Affiliate unless registered under the Securities Act or resold pursuant to an exemption from the registration requirements of the Securities Act in a transaction that
results in such Notes, as the case may be, no longer being “restricted securities” (as defined under Rule 144). If the legend is removed from the face of a Note and the Note is subsequently held by the Company or an Affiliate of the
Company, the legend shall be reinstated. 
 (i) So long as and to the extent that any Notes are represented by one or more
Global Notes held by or on behalf of the Depositary only, the Company may cause the removal of the Restricted Securities Legend from such Notes at any time on or after the Free Trade Date by: 

(i) providing to the Trustee written notice stating that the Free Trade Date has occurred and instructing the Trustee to remove the
Restricted Securities Legend from such Notes; 
 (ii) providing to the Holders of such Notes written notice that the Restricted
Securities Legend has been removed or deemed removed; 
 (iii) providing to the Trustee and the Depositary written notice to
change the CUSIP number for the Notes to the applicable unrestricted CUSIP number; and 
 (iv) complying with any Applicable
Procedures for delegending; 
 whereupon the Restricted Securities Legend shall be deemed removed from any Global Notes without further action
on the part of Holders. 
 (j) On and after the Free Trade Date, the Company shall also (i) instruct the transfer agent for
the Common Stock to remove the Restricted Stock Legend from any shares of Common Stock issued upon conversion of the Notes that bear the Restricted Stock Legend; (ii) notify the holders of any shares of Common Stock issued upon conversion of
the Notes (to the extent any shares of Common Stock have been issued upon conversion of the Notes) that such Restricted Stock Legend has been removed; (iii) if relevant, notify the transfer agent for the Common Stock to change the CUSIP number
for any shares of Common Stock issued upon conversion of the Notes to the applicable unrestricted CUSIP number; and (iv) comply with any Applicable Procedures that apply to the delegending of any shares of Common Stock issued upon conversion of
a Note. 
 Section 2.07 Replacement Notes. If a mutilated Note is surrendered to the Registrar or if the Holder of a Note
claims that such Note has been lost, destroyed or stolen and the Holder provides evidence of the loss, theft or destruction satisfactory to the Company and the Trustee, the Company shall issue, and the Trustee shall authenticate, a replacement Note
if the requirements of Section 8-405 of the Uniform Commercial Code are met and the Holder satisfies any other reasonable requirements of the Trustee. If required by the Trustee or the Company,

  
 18 

 
such Holder shall furnish an indemnity bond sufficient in the judgment of the Company and the Trustee to protect the Company, the Trustee, the Paying Agent, the Registrar and
any co-registrar from any loss that any of them may suffer if a Note is replaced. The Company and the Trustee may charge the Holder for their expenses in replacing a Note. 
 Upon the issuance of any new Notes under this Section 2.07, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation
thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. 
 Every new Note issued
pursuant to this Section 2.07 in exchange for any mutilated Note, or in lieu of any destroyed, lost or stolen Note, shall constitute an original additional contractual obligation of the Company and any other obligor upon the Notes, whether or
not the mutilated, destroyed, lost or stolen Note shall be at any time enforceable by anyone, and shall be entitled to all benefits of (and shall be subject to all the limitations set forth in) this Indenture equally and proportionately with any and
all other Notes duly issued hereunder. 
 Section 2.08 Outstanding Notes. Notes outstanding at any time include and are
limited to all Notes authenticated by the Trustee except (i) those cancelled by it, (ii) those delivered to it for cancellation and (iii) those deemed not outstanding under this Section 2.08. If the Company or an Affiliate
of the Company holds the Note, a Note does not cease to be outstanding; provided, however, that for purposes of determining whether the Holders of the requisite principal amount of Notes have given or concurred in any request,
demand, authorization, direction, notice, consent, waiver or other action hereunder, Notes owned by the Company or any other obligor upon the Notes or any Affiliate of the Company or such other obligor shall be disregarded and deemed not to be
outstanding. Subject to the foregoing, only Notes outstanding at the time of such determination shall be considered in any such determination (including, without limitation, determinations pursuant to Articles 6 and 9). 

If a Note is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee and the Company receive proof
satisfactory to them that the replaced Note is held by a bona fide purchaser. 
 If the Paying Agent holds, in accordance with
this Indenture, on a Fundamental Change Purchase Date or on the Maturity Date, money sufficient to pay Notes payable on that date, then immediately after such Fundamental Change Purchase Date or Maturity Date, as the case may be, such Notes shall
cease to be outstanding, interest (including Additional Interest and Special Interest), if any, on such Notes shall cease to accrue and such Notes shall cease to be convertible. 

If a Note is converted in accordance with Article 10, then from and after the time of conversion on the Conversion Date, such Note
shall cease to be outstanding and interest (including any Additional Interest and Special Interest), if any, shall cease to accrue on such Note. 
 Section 2.09 Temporary Notes. Until Certificated Notes are ready for delivery, the Company may execute and the Trustee or an authenticating agent appointed by the Trustee shall, upon
written request of the Company, authenticate and deliver temporary Notes (printed or 

  
 19 

 
lithographed) (“Temporary Notes”). Temporary Notes shall be issuable in any authorized denomination, and substantially in the form of Certificated Notes but with such
omissions, insertions and variations as may be appropriate for temporary Notes, all as may be determined by the Company. Every such Temporary Note shall be executed by the Company and authenticated by the Trustee or such authenticating
agent upon the same conditions and in substantially the same manner, and with the same effect, as the Certificated Notes. Without unreasonable delay the Company will prepare, execute and deliver to the Trustee or such
authenticating agent Certificated Notes (other than any Global Note) and thereupon any or all Temporary Notes (other than any Global Note) may be surrendered in exchange therefor, at each office or agency maintained by the Company pursuant to
Section 4.05 and the Trustee or such authenticating agent shall authenticate and deliver in exchange for such Temporary Notes an equal aggregate principal amount of Certificated Notes. Such exchange shall be made by the Company at its own
expense and without any charge therefor. Until so exchanged, the Temporary Notes shall in all respects be entitled to the same benefits and subject to the same limitations under this Indenture as Certificated Notes authenticated and delivered
hereunder. 
 Section 2.10 Cancellation. The Company at any time may deliver Notes to the Trustee for cancellation. The
Registrar, Conversion Agent and the Paying Agent shall forward to the Trustee any Notes surrendered to them for registration of transfer, exchange, conversion, purchase, or payment. The Trustee and no one else
shall cancel all Notes surrendered for registration of transfer, exchange, conversion, purchase, payment or cancellation and shall dispose of such Notes in its customary manner. The Company may not issue new Notes to
replace Notes it has purchased, paid or delivered to the Trustee for cancellation or that any Holder has converted pursuant to Article 10. 
 Section 2.11 Persons Deemed Owners. Prior to due presentment of a Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the
Person in whose name such Note is registered in the Register as the owner of such Note for the purpose of receiving payment of principal, interest (including Additional Interest and Special Interest), if any, or payment of the
Fundamental Change Purchase Price, for the purpose of conversion and for all other purposes whatsoever, whether or not such Note be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee
shall be affected by notice to the contrary. 
 Section 2.12 Transfer of Notes. 

(a) Notwithstanding any other provisions of this Indenture or the Notes, (A) transfers of a Global Note, in whole or in part, shall
be made only in accordance with Sections 2.06 and 2.12(a)(i); (B) transfers of a beneficial interest in a Global Note for a Certificated Note shall comply with Sections 2.06 and 2.12(a)(ii), and (C) transfers of a Certificated Note shall
comply with Sections 2.06 and 2.12(a)(iii) and (iv) below. All such transfers shall comply with the Applicable Procedures to the extent so required. 
 (i) Transfer of Global Note. A Global Note may not be transferred, in whole or in part, to any Person other than the Depositary or a nominee or any successor thereof, and no transfer of a Global
Note to any other Person may be registered; provided that this clause (i) shall not prohibit any transfer of a Note that is issued in exchange for a Global Note but is not itself a

  
 20 

 
Global Note. No transfer of a Note to any Person shall be effective under this Indenture or the Notes unless and until such Note has been registered in the name of such Person. Nothing in this
Section 2.12(a)(i) shall prohibit or render ineffective any transfer of a beneficial interest in a Global Note effected in accordance with the other provisions of this Section 2.12(a). 

(ii) Restrictions on Transfer of a Beneficial Interest in a Global Note for a Certificated Note. 

(A) A beneficial interest in a Global Note may not be exchanged for a Certificated Note unless: 

(1) DTC notifies the Company that it is unwilling or unable to continue as Depositary for such Global Note and a successor Depositary is
not appointed by the Company within 90 days of such notice; or 
 (2) DTC ceases to be registered as a clearing agency under
the Exchange Act and a successor Depositary is not appointed by the Company within 90 days of such cessation, in which case Certificated Notes shall be issued to all owners of beneficial interests in a Global Note in exchange for their beneficial
interests. 
 In connection with the exchange of an entire Global Note for Certificated Notes pursuant to this
Section 2.12(a)(ii), such Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute, and upon Company Order the Trustee shall authenticate and deliver, to each beneficial owner identified by
DTC in exchange for its beneficial interest in such Global Note, an equal aggregate principal amount of Certificated Notes of authorized denominations. 
 (3) An Event of Default has occurred and is continuing, in which case, the owner of a beneficial interest in a Global Note will be entitled to receive a Certificated Note in exchange for its beneficial
interest in such Global Note. 
 (B) Upon receipt by the Registrar of instructions from the Holder of a Global Note directing
the Registrar to (x) issue one or more Certificated Notes in the amounts specified to the owner of a beneficial interest in such Global Note and (y) debit or cause to be debited an equivalent amount of beneficial interest in such Global
Note, subject to the Applicable Procedures: 
 (1) the Registrar shall notify the Company and the Trustee of such instructions
and identify the owner of and the amount of such beneficial interest in such Global Note; 
 (2) the Company shall promptly
execute, and upon Company Order, the Trustee shall authenticate and deliver, to such beneficial owner Certificated Note(s) in an equivalent amount to such beneficial interest in such Global Note; and 

(3) the Registrar shall decrease such Global Note by such amount in accordance with the foregoing. 

  
 21 

 (iii) Transfer and Exchange of Certificated Notes. When Certificated Notes are
presented to the Registrar with a request: (x) to register the transfer of such Certificated Notes; or (y) to exchange such Certificated Notes for an equal principal amount of Certificated Notes of other authorized denominations, the
Registrar shall register the transfer or make the exchange as requested if its reasonable requirements for such transaction are met; provided, however, that the Certificated Notes surrendered for transfer or exchange: 

(1) must be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the
Registrar, duly executed in writing by the Holder thereof or its duly authorized attorney-in-fact; and 
 (2) so long as such
Notes are “restricted securities” (as defined under Rule 144), such Notes are being transferred or exchanged pursuant to an effective registration statement under the Securities Act or pursuant to clause (A), (B) or (C) below,
and are accompanied by the following additional information and documents, as applicable: 
 (A) if such Certificated Notes are
being delivered to the Registrar by a Holder for registration in the name of such Holder, without transfer, a certification from such Holder to that effect; or 
 (B) if such Certificated Notes are being transferred to the Company, a certification from such Holder to that effect; or 
 (C) if such Certificated Notes are being transferred pursuant to an exemption from registration, (i) a certification from such Holder to that effect (in the form set forth in Exhibit B, if
applicable) and (ii) if the Company so requests, an opinion of counsel in form and substance reasonably satisfactory to the Company or any other evidence as to the compliance with the restrictions set forth in the legend thereon that is
reasonably satisfactory to the Company. 
 (iv) Restrictions on Transfer of a Certificated Note for a Beneficial Interest in
a Global Note. A Certificated Note may not be exchanged for a beneficial interest in a Global Note except upon satisfaction of the requirements set forth below. 
 Upon receipt by the Trustee of a Certificated Note, duly endorsed or accompanied by appropriate instruments of transfer, in form satisfactory to the Trustee, together with: 

(A) so long as the Notes are Restricted Notes, certification, in the form set forth in Exhibit B, that such Certificated Note is being
transferred to a QIB in accordance with Rule 144A; and 
 (B) written instructions directing the Trustee to make, or to direct
the Registrar to make, an adjustment on its books and records with respect to such Global Note to reflect an increase in the aggregate principal amount of the Notes represented by the Global Note, such instructions to contain information regarding
the Depositary account to be credited with such increase, then the Trustee shall cancel such Certificated Note and cause, or direct the Registrar to cause, in accordance with the standing instructions and procedures existing between the Depositary
and the Registrar, the aggregate principal amount of Notes represented by the 

  
 22 

 
Global Note to be increased by the aggregate principal amount of the Certificated Note to be exchanged, and shall credit or cause to be credited to the account of the Person specified in such
instructions a beneficial interest in the Global Note equal to the principal amount of the Certificated Note so cancelled. If no Global Notes are then outstanding, the Company shall issue and the Trustee shall authenticate, upon written order of the
Company in the form of an Officer’s Certificate, a new Global Note in the appropriate principal amount. 
 (b) Subject to
the succeeding Section 2.12(c), every Note shall be subject to the restrictions on transfer provided in Section 2.06(f), including the delivery of an opinion of counsel, if so required. Whenever any Restricted Note is presented or
surrendered for registration of transfer or for exchange for a Note registered in a name other than that of the Holder, such Note must be accompanied by a certificate in substantially the form set forth in Exhibit B, dated the date of such surrender
and signed by the Holder of such Note, as to compliance with such restrictions on transfer. The Registrar shall not be required to accept for such registration of transfer or exchange any Note not so accompanied by a properly completed certificate.

 (c) The restrictions imposed by Section 2.06(f) upon the transferability of any Note shall cease and terminate when such
Note has been sold pursuant to an effective registration statement under the Securities Act or transferred in compliance with Rule 144. Any Note as to which such restrictions on transfer shall have expired in accordance with their terms or shall
have terminated may, upon a surrender of such Note for exchange to the Registrar in accordance with the provisions of this Section 2.12 (accompanied, if such restrictions on transfer have terminated by reason of a transfer in compliance with
Rule 144 or any successor provision, by an opinion of counsel having substantial experience in practice under the Securities Act and otherwise reasonably acceptable in form and substance to the Company, addressed to the Company, to the effect that
the transfer of such Note has been made in compliance with Rule 144), be exchanged for a new Note, of like tenor and aggregate principal amount, which shall not bear the legends required by Section 2.01(d). The Company shall inform the Trustee
upon the occurrence of the Free Trade Date and promptly after a registration statement with respect to the Notes or any shares of Common Stock issued upon conversion of the Notes has been declared effective under the Securities Act. The Trustee
shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the aforementioned opinion of counsel or registration statement. 
 (d) The provisions of clauses (i), (ii), (iii) and (iv) below shall apply only to Global Notes: 
 (i) Notwithstanding any other provisions of this Indenture or the Notes, a Global Note shall not be exchanged in whole or in part for a Note registered in the name of any Person other than the Depositary
or one or more nominees thereof, provided that a Global Note may be exchanged for Notes registered in the name of any Person designated by the Depositary if (A) the Depositary has notified the Company that it is unwilling or unable to
continue as Depositary for such Global Note or such Depositary has ceased to be a “clearing agency” registered under the Exchange Act, and a successor Depositary is not appointed by the Company within 90 days or (B) an Event of
Default has occurred and is continuing with respect to the Notes. Any Global Note exchanged pursuant to clause (A) above shall be so exchanged in whole 

  
 23 

 
and not in part, and any Global Note exchanged pursuant to clause (B) above may be exchanged in whole or, from time to time, in part as directed by the Depositary. Any Note issued in
exchange for a Global Note or any portion thereof shall be a Global Note; provided that any such Note so issued that is registered in the name of a Person other than the Depositary or a nominee thereof shall not be a Global Note. 

(ii) Notes issued in exchange for a Global Note or any portion thereof shall be issued in definitive, fully registered form, without
interest coupons, shall have an aggregate principal amount equal to that of such Global Note or portion thereof to be so exchanged, shall be registered in such names and be in such authorized denominations as the Depositary shall designate and shall
bear the applicable legends provided for herein. Any Global Note to be exchanged in whole shall be surrendered by the Depositary to the Trustee, as Registrar. With regard to any Global Note to be exchanged in part, either such Global Note shall be
so surrendered for exchange or, if the Trustee is acting as custodian for the Depositary or its nominee with respect to such Global Note, the principal amount thereof shall be reduced, by an amount equal to the portion thereof to be so exchanged, by
means of an appropriate adjustment made on the records of the Trustee. Upon any such surrender or adjustment, the Trustee shall authenticate and deliver the Note issuable on such exchange to or upon the order of the Depositary or an authorized
representative thereof. 
 (iii) Subject to the provisions of Section 2.12(e), a Holder may grant proxies and otherwise
authorize any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action which such Holder is entitled to take under this Indenture or the Notes. 

(iv) In the event of the occurrence of any of the events specified in clause (i) above, the Company will promptly make available to
the Trustee a reasonable supply of Certificated Notes in definitive, fully registered form, without interest coupons. 
 (e)
Neither any members of, or participants in, the Depositary (collectively, the “Agent Members”) nor any other Persons on whose behalf any Agent Member may act shall have any rights under this Indenture with respect to any Global Note
registered in the name of the Depositary or any nominee thereof, or under any such Global Note, and the Depositary or such nominee, as the case may be, may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the
absolute owner and holder of such Global Note for all purposes whatsoever. The Trustee shall have no responsibility or obligation to any Agent Members or any other Person on whose behalf Agent Members may act with respect to (i) any ownership
interests in the Global Note, (ii) the accuracy of the records of the Depositary or its nominee (iii) any notice required hereunder or (iv) any payments, under or with respect to, the Global Note. Notwithstanding the foregoing,
nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depositary or such nominee, as the case may be, or
impair, as between the Depositary, its Agent Members and any other Person on whose behalf an Agent Member may act, the operation of customary practices of such Persons governing the exercise of the rights of a holder of any Note. The registered
Holder of a Global Note may grant proxies and otherwise authorize any Person, including Agent Members and 

  
 24 

 
persons that may hold interests through Agent Members, to take any action that a Holder is entitled to take under this Indenture or the Notes. 

Section 2.13 CUSIP and ISIN Numbers. 
 (a) The Company, in issuing the Notes, shall use restricted CUSIP and ISIN numbers for such Notes (if then generally in use) until such time as the Restricted Securities Legend is removed pursuant to
Section 2.06(i). At such time as the legend is removed from such Notes pursuant to Section 2.06(i), the Company will use an unrestricted CUSIP number for such Note, but only with respect to the Notes where so removed. The Trustee may use
CUSIP and ISIN numbers in notices as a convenience to Holders; provided, however, that neither the Company nor the Trustee shall have any responsibility for any defect in the CUSIP or ISIN number that appears on any Note, check, advice
of payment or notice, and any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice and that reliance may be placed only on the other identification
numbers printed on the Notes, and any action taken in connection with such a notice shall not be affected by any defect in or omission of such numbers. The Company shall promptly notify the Trustee in the event of any change in the CUSIP or ISIN
numbers. 
 (b) Until such time as the Restricted Stock Legend is no longer required to be borne by any shares of Common Stock
issued upon the conversion of the Notes pursuant to Section 2.06(g) or otherwise, any shares of Common Stock issued upon conversion of the Notes shall bear a restricted CUSIP number. At such time as the Restrictive Stock Legend is no longer
required to be borne by any shares of Common Stock issued upon the conversion of the Notes pursuant to Section 2.06(g) or otherwise, any shares of Common Stock issued upon conversion of the Notes shall bear an unrestricted CUSIP number.

 Section 2.14 Additional Notes; Repurchases. The Company may, without the consent of the Holders and notwithstanding
Section 2.02, reopen this Indenture and increase the principal amount of the Notes by issuing an unlimited amount of additional Notes in the future pursuant to this Indenture with the same terms and with the same CUSIP number as the Notes
initially issued hereunder in an unlimited aggregate principal amount, which will form the same series with the Notes initially issued hereunder, provided that no such additional Notes may be issued unless they will be fungible with the original
Notes for U.S. federal income tax and securities law purposes. Prior to the issuance of any such additional Notes, the Company shall deliver to the Trustee a Company Order, an Officer’s Certificate and an Opinion of Counsel, such Officer’s
Certificate and Opinion of Counsel to cover such matters, in addition to those required by Section 12.05, as the Trustee shall reasonably request. The Company may also from time to time repurchase the Notes in open market purchases or
negotiated transactions without prior notice to Holders. 
 ARTICLE 3. 

REDEMPTION AND REPURCHASES 
 Section 3.01 No Company Right to Redeem. The Company shall have no right to redeem the Notes before the Maturity Date. 

  
 25 

 Section 3.02 Fundamental Change Permits Holders to Require Company to Purchase Notes.

 If a Fundamental Change occurs, each Holder shall have the right, at its option, to require the Company to purchase in cash,
on the Fundamental Change Purchase Date, all of its Notes, or any portion of its Notes in principal amount equal to $1,000 or an integral multiple thereof, on a date (the “Fundamental Change Purchase Date”) specified by the Company
in the Fundamental Change Purchase Notice for such Fundamental Change and that is not less than 20 calendar days or more than 35 calendar days immediately following the Fundamental Change Notice Date, at a price (the “Fundamental Change
Purchase Price”) equal to 100% of the principal amount of the Notes to be purchased, plus accrued and unpaid interest (including Additional Interest and Special Interest), if any, to, but excluding, the Fundamental Change Purchase Date;
provided, however, that if the Fundamental Change Purchase Date occurs after a Record Date for the payment of interest, but on or prior to the corresponding Interest Payment Date, the Company will pay the full amount of accrued and
unpaid interest (including Additional Interest and Special Interest), if any, payable on such interest payment date to the Holder of the Note on such Record Date and reduce the Fundamental Change Purchase Price by such amount. 

Section 3.03 Fundamental Change Conversion Right Notice. 
 (a) On or before the 20th calendar day immediately following the effective date of a Fundamental Change, the Company shall deliver written notice of such Fundamental Change and the resulting purchase
right (the “Fundamental Change Notice,” and the date of such mailing, the “Fundamental Change Notice Date”) to each Holder (and to beneficial owners as required by applicable law), the Trustee and the Paying Agent.
A Fundamental Change Notice for a Fundamental Change shall state: 
 (i) briefly, the events causing such Fundamental Change;

 (ii) the effective date of such Fundamental Change; 
 (iii) the last date on which a Holder may exercise its right to require the Company to purchase such Holder’s Notes under this Article 3; 

(iv) the Fundamental Change Purchase Date; 
 (v) the Fundamental Change Purchase Price; 
 (vi) that the Fundamental Change
Purchase Price for any Notes as to which a Fundamental Change Purchase Notice has been duly tendered and not withdrawn will be paid promptly following the later of the Fundamental Change Purchase Date and the time of surrender of such Notes;

 (vii) that payment may be collected only if the Notes to be repurchased are surrendered to the Paying Agent; 

(viii) the name and address of the Paying Agent and the Conversion Agent; 

  
 26 

 (ix) briefly, the procedures the Holder must follow to exercise its rights under this
Section 3.03; 
 (x) briefly, the conversion rights of the Notes, including an explanation that a condition to conversion
has been satisfied; 
 (xi) the Conversion Rate in effect on the Fundamental Change Notice Date; 

(xii) any adjustments that will be made to the Conversion Rate as a result of the Fundamental Change, including, without limitation, any
Additional Shares by which the Conversion Rate will be increased pursuant to Section 10.07; 
 (xiii) that any Notes with
respect to which a Fundamental Change Purchase Notice has been given may be converted only if such Fundamental Change Purchase Notice is validly withdrawn in accordance with the terms of this Indenture; 

(xiv) the procedures for withdrawing a Fundamental Change Purchase Notice; 

(xv) that, unless the Company defaults in making payment of such Fundamental Change Purchase Price on the Notes surrendered for
repurchase by the Company, interest (including Additional Interest and Special Interest), if any, on Notes for which a Fundamental Change Purchase Notice has been validly given will cease to accrue on and after the Fundamental Change Purchase Date;
and 
 (xvi) the CUSIP and ISIN number(s) of the Notes. 

Section 3.04 Fundamental Change Purchase Notice. 
 (a) To exercise its repurchase rights under Section 3.02(a), a Holder must deliver to the Paying Agent, by the Close of Business on the Business Day immediately preceding the Fundamental Change
Purchase Date, (i)(A) if the Notes that such Holder is tendering for purchase are Global Notes, a duly completed written notice in the form of the “Form of Fundamental Change Purchase Notice” on the reverse side of the Notes, or
(B) if the Notes that such Holder is tendering for purchase are Certificated Notes, the duly completed “Form of Fundamental Change Purchase Notice” on the reverse side of the Notes that such Holder is tendering for purchase (in either
case (A) or case (B), such notice, a “Fundamental Change Purchase Notice”) and (ii) the Notes that such Holder is tendering for purchase on such Fundamental Change Purchase Date. The Fundamental Change Purchase Notice must
state: 
 (A) the portion of the principal amount of the Notes that the Holder will deliver to be purchased, which portion must
be $1,000 or an integral multiple thereof; 
 (B) that such Notes shall be purchased pursuant to the terms and conditions
specified in this Indenture; and 
 (C) if Certificated Notes have been issued, the certificate numbers of the Notes that the
Holder will deliver to be purchased. 

  
 27 

 If the Notes to be purchased are Global Notes, the Holder must deliver the Notes to be
repurchased in accordance with the Applicable Procedures. 
 (b) Unless and until the Paying Agent receives a validly endorsed
and delivered Fundamental Change Purchase Notice, together with any Notes to which such Fundamental Change Purchase Notice pertains, in a form that conforms with the description contained in such Fundamental Change Purchase Notice in all material
aspects, the Holder submitting the Notes shall not be entitled to receive the Fundamental Change Purchase Price for such Notes. 

(c) After delivering a Fundamental Change Purchase Notice to the Paying Agent, a Holder may withdraw such Fundamental Change Purchase
Notice by delivering to the Trustee a written notice of withdrawal at any time prior to the Close of Business on the Business Day immediately preceding the Fundamental Change Purchase Date. Such notice of withdrawal must specify: 

(i) the principal amount of any Notes with respect to which the notice of withdrawal pertains, which must equal $1,000 or an integral
multiple thereof; 
 (ii) if Certificated Notes have been issued, the certificate numbers of the Notes to be withdrawn; and

 (iii) the principal amount, if any, that remains subject to the original Fundamental Change Purchase Notice, which amount
must equal $1,000 or an integral multiple thereof. 
 If the Notes to be withdrawn are Global Notes, a Holder must deliver its
notice of withdrawal in compliance with the Applicable Procedures. 
 Section 3.05 Effect of Fundamental Change Purchase
Notice. 
 (a) If a Holder validly delivers to the Paying Agent a Fundamental Change Purchase Notice (together with all
necessary endorsements) with respect to a Note, such Holder may no longer convert such Note unless and until such Holder validly withdraws such Fundamental Change Purchase Notice in accordance with Section 3.04(c) above. 

(b) Upon the Paying Agent’s receipt of (i) a valid Fundamental Change Purchase Notice (together with all necessary
endorsements) and (ii) the Notes to which such Fundamental Change Purchase Notice pertains, the Holder of the Notes to which such Fundamental Change Purchase Notice pertains shall be entitled, except to the extent such Holder has validly
withdrawn such Fundamental Change Purchase Notice in accordance with Section 3.04(c) above, to receive the Fundamental Change Purchase Price with respect to such Notes promptly following the later of (i) the Fundamental Change Purchase
Date and (ii) if the Notes are Certificated Notes, the date of delivery of such Notes to the Paying Agent, or, if the Notes are Global Notes, the date of book-entry transfer. 

(c) If, on the Fundamental Change Purchase Date, the Company, in accordance with Section 3.06 below, has deposited with the Paying
Agent money sufficient to pay the 

  
 28 

 
Fundamental Change Purchase Price of all of the Notes that Holders have tendered for purchase and have not validly withdrawn in accordance with Section 3.04(c) above: 

(i) such tendered Notes will cease to be outstanding and interest (including Additional Interest and Special Interest), if any, will
cease to accrue (whether or not all of such Notes were delivered to the Paying Agent or book-entry transfer has been made, as applicable); and 
 (ii) all other rights of the Holders with respect to the tendered Notes will terminate (other than the right to receive payment of the Fundamental Change Purchase Price upon delivery or transfer of the
Notes). 
 Section 3.06 Deposit of Fundamental Change Purchase Price. Prior to 10:00 a.m., New York City
time, on the Fundamental Change Purchase Date, as the case may be, the Company shall deposit with the Trustee or with the Paying Agent (or, if the Company or a Subsidiary or an Affiliate of either of them is acting as the
Paying Agent, shall segregate and hold in trust as provided in Section 2.04) an amount of cash (in immediately available funds if deposited on such Business Day), sufficient to pay the aggregate Fundamental Change Purchase Price
of all the Notes or portions thereof which are to be repurchased as of the Fundamental Change Purchase Date. 
 Section 3.07
Notes Purchased in Part. Any Certificated Note that is to be purchased only in part shall be surrendered at the office of the Paying Agent (with, if the Company or the Trustee so requires, due endorsement by, or a written
instrument of transfer in form satisfactory to the Company and the Trustee duly executed by, the Holder thereof or such Holder’s attorney-in-fact duly authorized in writing) and the Company shall execute and the Trustee shall
authenticate and deliver to the Holder of such Note, without service charge, a new Note or Notes, of any authorized denomination as requested by such Holder in aggregate principal amount equal to, and in exchange for, the
portion of the principal amount of the Note so surrendered which is not repurchased, or in the case of a Global Note, the Company shall instruct the Registrar to decrease such Global Note by the principal amount of the repurchased portion of the
Note surrendered. 
 Section 3.08 Covenant to Comply with Securities Laws Upon Purchase of Notes. When repurchasing Notes
under this Article 3, the Company will, to the extent applicable, (i) comply with Rule 13e-4 (or any successor provision) and Rule 14e-1 (or any successor provision) under the Exchange Act, (ii) file the
related Schedule TO (or any successor schedule, form or report) under the Exchange Act, and (iii) otherwise comply with any applicable U.S. federal and state securities laws so as to permit Holders to exercise their rights and
obligations under Section 3.02 in the time and in the manner specified in Section 3.02. 
 Section 3.09 Repayment
to the Company. The Trustee and the Paying Agent shall return to the Company any cash held by them for the payment of the Fundamental Change Purchase Price that remains unclaimed as provided in Paragraph 11 of the form of Note attached as
Exhibit A hereto; provided, however, that to the extent that the aggregate amount of cash deposited by the Company pursuant to Section 3.04 exceeds the aggregate Fundamental Change Purchase Price of the Notes or portions thereof which the Company is
obligated to repurchase as 

  
 29 

 
of the Fundamental Change Purchase Date, then, unless otherwise agreed in writing with the Company, promptly after the Business Day following the Fundamental Change Purchase
Date, the Trustee shall return any such excess to the Company. 
 Section 3.10 Covenant Not to Purchase Notes Upon
Certain Events of Default. 
 (a) Notwithstanding anything to the contrary in this Article 3, the Company shall not
purchase any Notes under this Article 3 if there has occurred and is continuing an Event of Default unless the payment by the Company of the Fundamental Change Purchase Price will cure such Event of Default. 

(b) If a Fundamental Change Purchase Notice is tendered and, on the Fundamental Change Purchase Date, such Fundamental Change Purchase
Notice has not been validly withdrawn in accordance with Section 3.04(c) above, and, pursuant to this Section 3.10, the Company is not permitted to purchase Notes, the Paying Agent will deem withdrawn such Fundamental Change Purchase
Notice. 
 (c) If a Holder tenders a Note for purchase pursuant to this Article 3 and, on the Fundamental Change Purchase
Date, pursuant to this Section 3.10, the Company is not permitted to purchase such Note, the Paying Agent will (i) if such Note is a Certificated Note, return such Note to such Holder, and (ii) if such Note is held in book-entry form,
in compliance with the Applicable Procedures, deem to be cancelled any instructions for book-entry transfer of such Note. 

ARTICLE 4. 

COVENANTS 

Section 4.01 Payment of Notes. 
 (a) The Company shall promptly make all payments on the Notes on the dates, in the manner and as otherwise required under the Notes or this Indenture. If the Company is required to deliver any amounts of
cash and/or shares of Common Stock to the Trustee, the Paying Agent or the Conversion Agent, such amounts of cash and/or shares of Common Stock shall be deposited by the Company with the Trustee, the Paying Agent or the Conversion Agent by 10:00
a.m., New York City time, on the required date. The Company may, at its option, make payments on any Certificated Notes by check mailed to a Holder’s registered address; provided, however, that if a Holder of more than $5,000,000
principal amount of Certificated Notes requests in writing that the Company make payments on its Certificated Notes by wire transfer to an account in the United States, the Company shall, beginning with the interest payment corresponding to the next
Record Date, make all subsequent payments due to such Holder to such account until such Holder notifies the Registrar in writing that the Company should no longer make payments by wire transfer to such account. If the Notes are held in book-entry
form, the Company shall make all payments by wire transfer. 
 (b) The Company shall make any required interest payments
(including of Additional Interest and Special Interest), if any, to the Person in whose name each Note is registered at the Close of Business on the Record Date for such interest payment. The principal, accrued and unpaid interest (including
Additional Interest and Special Interest), if any, or payment of the 

  
 30 

 
Fundamental Change Purchase Price shall be considered paid on the applicable date due if on such date (or, in the case of a Fundamental Change Purchase Price, on the Business Day following the
applicable Fundamental Change Purchase Date) the Trustee or the Paying Agent holds, in accordance with this Indenture, cash sufficient to pay all such amounts then due. 
 Section 4.02 SEC and Other Reports. 
 (a) For so long as the Notes are
outstanding, the Company shall file with the SEC and the Trustee the Company’s annual and quarterly reports, information, documents and other reports which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the
Exchange Act (or copies of such portions of any of the foregoing as the SEC may by rules and regulations prescribe) and, within 15 days of the date on which the Company would be required to file the same with the SEC (after giving effect to any
grace period provided by Rule 12b-25 under the Exchange Act). Documents filed by the Company with the SEC via the EDGAR filing system will be deemed to be filed with the Trustee as of the time such documents are filed via the EDGAR filing system.
The Company shall comply with the other provisions of TIA Section 314(a). Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute
constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely conclusively on
Officer’s Certificates). 
 (b) If, at any time during the six-month period beginning on, and including, the date which is
six months after the last date of original issuance of the Notes offered by the Offering Memorandum and ending on the Free Trade Date, the Company fails to timely file any periodic report that the Company is required to file with the Commission
pursuant to Section 13 or 15(d) of the Exchange Act, as applicable (other than current reports on Form 8-K), and the Company does not cure such failure to file within 14 calendar days, the Company shall pay interest (the “Additional
Interest”) on the Notes, accruing from the due date of the first missed filing that gives rise to such obligation and continuing until the earlier of (i) the Free Trade Date and (ii) the date all such filings have been made.
During the first 90 days on which such Additional Interest is payable, such Additional Interest shall accrue at a rate of 0.25% per annum; thereafter, such Additional Interest shall accrue at a rate of 0.50% per annum. 

(c) In addition, if the Company fails to cause the Notes or any shares of the Common Stock issuable upon conversion of the Notes that are
held by Holders that have not been Affiliates of the Company during the immediately preceding three months to become Freely Tradable on and at all times after the Free Trade Date (or the next succeeding Business Day if the Free Trade Date is not a
Business Day), the Company will pay Additional Interest on the Notes accruing from the Free Trade Date and until the date on which the Notes and any shares of Common Stock issuable upon the conversion of the Notes become Freely Tradable. During the
first 90 days on which such Additional Interest is payable, such Additional Interest will accrue at a rate of 0.25% per annum; thereafter, such Additional Interest will accrue at a rate of 0.50% per annum. 

  
 31 

 (d) Notwithstanding anything else in this Indenture, in no event will (i) the combined
rate of any Additional Interest payable under this Section 4.02 and of any Special Interest payable under Section 6.01(c) exceed 0.50% per annum; or (ii) Additional Interest accrue on any day in which (A)(1) the Company has filed
a shelf registration statement for the resale of the Notes, (2) such shelf registration statement is effective and usable by Holders for the resale of the Notes, and (3) the Holders may register the resale of their Notes under such shelf
registration statement on terms customary for the resale of convertible securities offered in reliance on Rule 144A; or (B) conditions (A)(1) through (A)(3) of this sentence have been satisfied for a period of two years. 

(e) Whenever Additional Interest is accruing on a Record Date, the Company will pay all accrued and unpaid Additional Interest to the
Holders of record on such Record Date on the corresponding Interest Payment Date. If Additional Interest is not accruing on a Record Date, but has accrued since the immediately preceding Record Date, the Company shall pay any accrued and unpaid
Additional Interest on the Interest Payment Date corresponding to the latter Record Date to Holders of record on the latter Record Date. 
 If the Company is required to pay Additional Interest or Special Interest to Holders, the Company shall provide a direction or order in the form of a written notice to the Trustee (and if the Trustee is
not the Paying Agent, to the Paying Agent) of the Company’s obligation to pay such Additional Interest or Special Interest no later than three Business Days prior to the date on which any such Additional Interest or Special Interest is
scheduled to be paid. Such notice shall set forth the amount of Additional Interest or Special Interest to be paid by the Company on such payment date and direct the Trustee (or, if the Trustee is not the Paying Agent, to the Paying Agent) to make
payment to the extent it receives funds from the Company to do so. The Trustee shall not at any time be under any duty or responsibility to any Holder to determine whether the Additional Interest or Special Interest is payable, or with respect to
the nature, extent, or calculation of the amount of the Additional Interest or Special Interest owed, or with respect to the method employed in such calculation of the Additional Interest or Special Interest. 

Section 4.03 Compliance Certificate. Within 120 days after the end of each fiscal year (beginning with the fiscal year ending
January 31, 2014) of the Company, the Company shall deliver to the Trustee an Officer’s Certificate (which Officer’s Certificate shall not be required to include such statements included in Section 12.05) stating
whether, to the knowledge of the signers thereof, the Company is in default in the performance and observance of any of the terms, provisions and conditions of this Indenture (without regard to any period of grace or requirement
of notice provided hereunder) and if the Company shall be in default, specifying all such defaults and the nature and status thereof of which they may have knowledge. 
 Section 4.04 Further Instruments and Acts. Upon request of the Trustee, the Company will execute and deliver such further instruments and do such further acts as may be reasonably necessary
or proper to carry out more effectively the purposes of this Indenture. 
 Section 4.05 Maintenance of Office or Agency.
The Company will maintain, in the continental United States, an office or agency of the Trustee, Registrar, Paying Agent and Conversion Agent where Notes may be presented or surrendered for payment, where Notes may
be surrendered for registration of transfer, exchange, repurchase, or conversion and where 

  
 32 

 
notices and demands to or upon the Company in respect of the Notes and this Indenture may be served. The Corporate Trust Office of the Trustee shall initially be such office or agency for all of
the aforesaid purposes. The Company shall give prompt written notice to the Trustee of the location, and of any change in the location, of any such office or agency (other than a change in the location of the Corporate Trust Office of
the Trustee). If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or
served at the address of the Trustee set forth in Section 12.02. 
 The Company may also from time to time designate one or
more other offices or agencies where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind such designations. 
 Section 4.06 Delivery of Certain Information. At any time when the Company is not subject to Sections 13 or 15(d) of the Exchange Act, upon the request of a Holder, or any beneficial
owner of, or prospective purchaser of, the Notes or a holder of, beneficial owner of, or prospective purchaser of, any shares of Common Stock issued upon the conversion of Notes, the Company will promptly
furnish or cause to be furnished Rule 144A Information to such Holder, or any beneficial owner of, or prospective purchaser of, the Notes or holder of, beneficial owner of, or prospective purchaser of,
shares of Common Stock issued upon the conversion of Notes, as the case may be, to the extent required to permit compliance by such Holder or holder with Rule 144A in connection with the resale of any such Note. Whether a Person is a
beneficial owner shall be determined by the Company to the Company’s reasonable satisfaction. 
 Section 4.07 Par Value
Limitation. The Company will not take any action that, after giving effect to any adjustment pursuant to Section 10.05, would result in the issuance of shares of Common Stock for less than the par value of such shares of
Common Stock. 
 ARTICLE 5. 
 CONSOLIDATION, MERGER AND SALE OF ASSETS 
 Section 5.01 Company May
Consolidate, Merge or Sell Its Assets on Certain Terms. The Company will not consolidate with, merge with or into, or convey, transfer or lease all or substantially all of its property and assets to, any Person unless
the Company is the resulting, surviving or transferee Person unless: 
 (i) the resulting, surviving or transferee Person
(the “Successor Company”) is a corporation organized and validly existing under the laws of the United States of America, any state thereof or the District of Columbia, and the Successor Company expressly assumes, by executing and
delivering a supplemental indenture to the Trustee, all of the Company’s obligations under the Notes and under this Indenture; 
 (ii) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred or shall be continuing; and 

(iii) the Company and the Successor Company shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel,
each stating that: 

  
 33 

 (A) such consolidation, merger, conveyance, transfer or lease and such supplemental
indenture complies with this Section 5.01; and 
 (B) that all conditions precedent to such consolidation, merger,
conveyance, transfer or lease provided for in this Indenture have been satisfied. 
 Section 5.02 Successor Corporation to Be
Substituted. Upon any such consolidation, merger, conveyance, transfer or lease and the assumption by the Successor Company, by supplemental indenture, executed and delivered to the Trustee and satisfactory in
form to the Trustee, of the due and punctual payment of the principal of, accrued and unpaid interest (including Additional Interest and Special Interest), if any, on all of the Notes, the due and punctual delivery
or payment, as the case may be, of any consideration due upon conversion of the Notes and the due and punctual performance of all of the covenants and conditions of this Indenture to be performed by the Company, such Successor
Company shall succeed to and be substituted for the Company, with the same effect as if it had been named herein as the party of the first part. Such Successor Company thereupon may cause to be signed, and may issue in its own
name, any or all of the Notes issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the order of such Successor Company instead of the Company and subject to all the
terms, conditions and limitations in this Indenture prescribed, the Trustee shall authenticate and shall deliver, or cause to be authenticated and delivered, any Notes that such Successor Company thereafter shall cause to
be signed and delivered to the Trustee for that purpose. All the Notes so issued shall in all respects have the same legal rank and benefit under this Indenture as the Notes theretofore or thereafter issued in accordance with the terms of this
Indenture as though all of such Notes had been issued at the date of the execution hereof. Upon any such consolidation, merger, conveyance or transfer (but not upon a lease), the Person named as the “Company” in the first paragraph of this
Indenture or any successor that shall thereafter have become such in the manner prescribed in this Article 5 may be dissolved, wound up and liquidated at any time thereafter and, except in the case of a lease, such Person shall be released from
its liabilities as obligor and maker of the Notes and from its obligations under this Indenture. 
 In case of any such
consolidation, merger, conveyance, transfer or lease, changes in phraseology and form (but not in substance) may be made in the Notes thereafter to be issued as may be appropriate. 

ARTICLE 6. 

DEFAULTS AND REMEDIES 
 Section 6.01 Events of Default. 
 (a) Each of the following events shall be
an “Event of Default”: 
 (i) the Company defaults in the payment of interest (including Additional Interest or
Special Interest, if any) on any Note when the same becomes due and payable and such default continues for a period of 30 days; 

  
 34 

 (ii) the Company defaults in the payment of the principal of any Note when the same becomes
due and payable at the Maturity Date, upon declaration of acceleration, upon any Fundamental Change Purchase Date or otherwise; 

(iii) the failure by the Company to deliver the consideration due upon the conversion of any Notes and such failure continues for a
period of five Business Days; 
 (iv) the failure by the Company to give a Fundamental Change Notice as required pursuant to
Section 3.03 or a Specified Corporate Transaction Notice as required under Section 10.01(a)(iv); 
 (v) the failure by
the Company to comply with its obligations under Article 5 hereof; 
 (vi) the default by the Company in the performance of
or the breach of any other covenant or agreement of the Company in this Indenture with respect to the Notes (other than a covenant or agreement in respect of which a default or breach is specifically addressed in Sections 6.01(a)(i) through
6.01(a)(v) above) and such default or breach continues for a period of 60 consecutive days after written notice of such default is delivered to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in aggregate
principal amount of the Notes then outstanding; 
 (vii) the occurrence of an event of default by the Company as defined under
any mortgage, indenture or instrument under which there may be issued, or by which there may be secured or evidenced, any indebtedness of the Company or any Significant Subsidiary for money borrowed, whether such indebtedness exists as of the Issue
Date or is later created, if that event of default: 
  

	 	•	 	 constitutes the failure to pay when due (whether at express maturity, upon acceleration as a result of an event of default or otherwise) indebtedness
in an aggregate principal amount in excess of $100,000,000, and 

  

	 	•	 	 such event of default continues for a period of 30 days after written notice thereof is delivered to the Company by the Trustee or to the Company and
the Trustee by the Holders of at least 25% of the aggregate principal amount of the Notes then outstanding without such default having been cured or waived, such acceleration having been rescinded or annulled (if applicable) and such indebtedness
not having been paid or discharged; 

 (viii) the Company or any of its Significant Subsidiaries, pursuant to
or within the meaning of any Bankruptcy Law: 
 (A) commences a voluntary case; 

(B) consents to the entry of an order for relief against it in an involuntary case; 

  
 35 

 (C) consents to the appointment of a Custodian of it or for any substantial part of its
property; 
 (D) makes a general assignment for the benefit of its creditors; or 

(E) takes any comparable action under any foreign laws relating to insolvency; or 

(ix) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(A) is for relief against the Company or any of its Significant Subsidiaries in an involuntary case; 

(B) appoints a Custodian of the Company or any of its Significant Subsidiaries or for any substantial part of its or any of its
Significant Subsidiaries’ property; 
 (C) orders the winding up or liquidation of the Company or any of its Significant
Subsidiaries; or 
 (D) grants any similar relief under any foreign laws; 

and, in each such case, the order or decree remains unstayed and in effect for 60 days. 

Each of the foregoing will constitute an Event of Default whatever the cause and regardless of whether voluntary or involuntary or
effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. 
 Notwithstanding anything to the contrary in the Notes or elsewhere in this Indenture, a Default under clause (vi) or (vii) of this Section 6.01(a) is not an Event of Default until the
Trustee or the Holders of at least 25% in aggregate principal amount of the Notes then outstanding notify the Company (and in the case of such notice by Holders, the Trustee) of the Default and the Company does not cure such Default within the time
specified after receipt of such notice. Such notice must specify the Default, demand that it be remedied and state that such notice is a “Notice of Default.” 
 (b) Within the 30 days immediately following the occurrence of an Event of Default or any Default, the Company shall deliver to the Trustee written notice thereof in the form of an Officer’s
Certificate describing such Event of Default or Default and its status and explaining what action the Company is taking or proposes to take with respect thereto. 
 (c) Notwithstanding anything to the contrary in the Notes or elsewhere in this Indenture, excepted as provided in Section 4.02(b) or (c), at the election of the Company, the sole remedy for an Event
of Default specified in Section 6.01(a)(vi) relating to the failure by the Company to comply with Section 4.02(a) (the “Company’s Filing Obligations”), including, without limitation, the obligation to comply with
Section 314(a) of the TIA, shall consist exclusively of the right to receive interest (the “Special Interest”) on the Notes. For the first 90 

  
 36 

 
days after the occurrence of such an Event of Default, the Special Interest will accrue at a rate equal to 0.25% per annum, and (ii) for the 90 days immediately following such 90 day
period, the Special Interest will accrue at a rate equal to 0.50% per annum. The Special Interest will be in addition to any Additional Interest that the Company is required to pay under Section 4.02 and will be payable in the same manner
as Additional Interest; provided, however, that in no event will the combined rate of the Special Interest and any Additional Interest due under Section 4.02 exceed 0.50% per annum. This Special Interest will accrue on the
Notes from and including the date on which an Event of Default relating to a failure to comply with the Company’s Filing Obligations first occurs to but not including the 180th day thereafter (or such earlier date on which the Event of Default
relating to such obligations shall have been cured or waived pursuant to Section 6.04). On such 180th day (or earlier, if such Event of Default is cured or waived pursuant to Section 6.04 prior to such 180th day), such Special Interest
will cease to accrue and, if such Event of Default has not been cured or waived pursuant to Section 6.04 prior to such 180th day, then the Trustee or the Holders of not less than 25% in principal amount of the Notes may declare the principal of
and accrued and unpaid interest on all such Notes to be due and payable immediately. This provision shall not affect the rights of Holders in the event of the occurrence of any other Event of Default. If the Company elects to pay the Special
Interest as the sole remedy for an Event of Default specified in Section 6.01(a)(v) relating to the failure by the Company to comply with the Company’s Filing Obligations, the Company shall notify, in the manner provided for in
Section 12.02, the Holders, the Paying Agent and the Trustee of such election at any time on or before the Close of Business on the fifth Business Day immediately following the date any such Event of Default first occurs (which notice shall
include a statement as to the date from which Special Interest is payable). Unless and until a Trust Officer receives at the Corporate Trust Office such notice, the Trustee may assume without inquiry that no Special Interest is payable. If the
Special Interest has been paid by the Company directly to the Persons entitled to it, the Company shall deliver to the Trustee a certificate setting forth the particulars of such payment. 

Section 6.02 Acceleration. If an Event of Default (other than an Event of Default specified in Sections 6.01(a)(viii) or
6.01(a)(ix) with respect to the Company) occurs and is continuing, the Trustee, by notice to the Company, or the Holders of at least 25% in aggregate principal amount of the Notes then outstanding, by notice to the Company and the Trustee, may
declare the principal amount of Notes outstanding plus accrued and unpaid interest (including Additional Interest and Special Interest), if any, on all the Notes that are not already due and payable to be immediately due and payable. Upon such a
declaration, such accelerated amount shall be due and payable immediately. If an Event of Default specified in Sections 6.01(viii) or 6.01(ix) with respect to the Company (and not solely with respect to one or more of its Significant Subsidiaries)
occurs and is continuing, the principal amount of Notes outstanding plus accrued and unpaid interest (including Additional Interest and Special Interest), if any, on all the Notes shall, automatically and without any action by the Trustee or any
Holder, become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. The Holders of a majority in aggregate principal amount of the Notes at the time outstanding, by notice to the Trustee
and the Company, and without notice to any other Holder, may rescind any declaration of acceleration if the rescission would not conflict with any judgment or decree of a court of competent jurisdiction and if all existing Events of Default have
been cured or waived other than nonpayment of the principal amount or accrued but unpaid interest (including Additional Interest and Special Interest), if any, that has become due solely as 

  
 37 

 
a result of acceleration. No such rescission shall affect any subsequent Default or impair any right consequent thereto. 
 Section 6.03 Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy to collect the payment of principal, accrued and unpaid
interest (including Additional Interest and Special Interest), if any, or payment of the Fundamental Change Purchase Price on the Notes or to enforce the performance of any provision of the Notes or this Indenture. 

The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not produce any of the Notes in the
proceeding. A delay or omission by the Trustee or any Holder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is
exclusive of any other remedy. All available remedies are cumulative. 
 Section 6.04 Waiver of Past Defaults. The
Holders of a majority in aggregate principal amount of the Notes at the time outstanding by written notice to the Trustee and without notice to any other Holder may waive an existing or past default and its consequences except (a) an Event of
Default described in Sections 6.01(a)(i), 6.01(a)(ii) or 6.01(a)(iii) or (b) a default in respect of a provision that under Section 9.02 cannot be amended without the consent of each Holder. When a Default is waived, it is
deemed cured, but no such waiver shall extend to any subsequent or other default or impair any consequent right. 

Section 6.05 Control by Majority. The Holders of a majority in aggregate principal amount of the Notes at the time outstanding may
direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee. However, the Trustee may refuse to follow any direction that conflicts
with law or this Indenture or, subject to Section 7.01, that the Trustee determines is prejudicial to the rights of other Holders or would potentially involve the Trustee in personal liability; provided, however,
that the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such direction. Prior to taking any action hereunder, the Trustee shall be entitled to reasonable indemnification against all losses and
expenses caused by taking or not taking such action. 
 Section 6.06 Limitation on Suits. A Holder may pursue any remedy
with respect to this Indenture or the Notes only if: 
 (a) such Holder shall have previously given to the Trustee written
notice that an Event of Default has occurred and is continuing; 
 (b) the Holders of at least 25% in aggregate principal amount
of the Notes at the time outstanding make a written request to the Trustee to take action because of the Event of Default; 

(c) such Holder or Holders shall have offered to the Trustee security or indemnity reasonably satisfactory to the Trustee against the
costs and other liabilities of compliance with such written request; 

  
 38 

 (d) the Trustee has not complied with such written request within 60 days after receiving
such notice, written request and offer of security or indemnity; and 
 (e) during such 60-day period, the Trustee has not
received from the Holders of at least a majority in aggregate principal amount of the Notes outstanding at such time a direction inconsistent with such written request. 
 A Holder may not use this Indenture to prejudice the rights of any other Holder or to obtain a preference or priority over any other Holder. 

Section 6.07 Rights of Holders to Receive Payment. Notwithstanding any other provision of this Indenture, the right of any
Holder to bring suit for the enforcement of payment of principal, accrued and unpaid interest (including Additional Interest and Special Interest), if any, or payment of the Fundamental Change Purchase Price on or after the
respective due dates, or the right to receive consideration due upon conversion of Notes in accordance with Article 10, shall not be impaired or affected without the consent of such Holder and shall not be subject to the
requirements of Section 6.06. 
 Section 6.08 Collection Suit by Trustee. If an Event of Default specified in
Section 6.01(a)(i) or 6.01(a)(ii) occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company for the whole amount then due and owing (together with interest on any
unpaid interest (including Additional Interest and Special Interest), if any, to the extent lawful) and the amounts provided for in Section 7.07. 
 Section 6.09 Trustee May File Proofs of Claim. The Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee
and the Holders allowed in any judicial proceedings relative to the Company, its creditors or its property and, unless prohibited by law or applicable regulations, may vote on behalf of the Holders in any election of a trustee
in bankruptcy or other Person performing similar functions, and any Custodian in any such judicial proceeding is hereby authorized by each Holder to make payments to the Trustee and, if the Trustee shall consent to the making of such
payments directly to the Holders, to pay to the Trustee any amount due it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and its counsel, and any other amounts due
the Trustee under Section 7.07. 
 Section 6.10 Priorities. If the Trustee collects any money pursuant to this
Article 6, it shall pay out the money in the following order: 
 FIRST: to the Trustee for amounts due under
Section 7.07; 
 SECOND: to Holders for amounts due and unpaid on the Notes for principal, accrued and unpaid interest
(including Additional Interest and Special Interest), if any, payment of the Fundamental Change Purchase Price and the cash deliverable upon conversion of Notes then submitted for conversion, as the case may be, ratably, without preference or
priority of any kind, according to such amounts due and payable on the Notes; and 
 THIRD: the balance, if any, to the Company.

  
 39 

 The Trustee may fix a record date and payment date for any payment to Holders pursuant to
this Section 6.10. At least 15 days before such record date, the Company shall mail to each Holder and the Trustee a notice that states the record date, the payment date and the amount to be paid. 

Section 6.11 Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit
against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion
may assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant.
This Section 6.11 does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by Holders of more than 10% in aggregate principal amount of the Notes at the time outstanding. 

Section 6.12 Waiver of Stay, Extension or Usury Laws. The Company (to the extent it may lawfully do so) shall not at any time
insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter in force, that may affect the covenants or the
performance of this Indenture; and the Company (to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and shall not hinder, delay or impede the execution of any power herein granted
to the Trustee, but shall suffer and permit the execution of every such power as though no such law had been enacted. 

ARTICLE 7. 

TRUSTEE 

Section 7.01 Duties of Trustee. 
 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a
prudent Person would exercise or use under the circumstances in the conduct of such Person’s own affairs. 
 (b) Except
during the continuance of an Event of Default: 
 (i) the Trustee undertakes to perform such duties and only such duties as are
specifically set forth in this Indenture and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 
 (ii) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions
furnished to the Trustee and conforming to the requirements of this Indenture; provided, however, that the Trustee will examine the certificates and opinions to determine whether they conform to the requirements set forth in this
Indenture. 
 (c) The Trustee may not be relieved from liabilities for its own negligent action, its own negligent failure to
act, or its own willful misconduct, except that: 

  
 40 

 (i) this paragraph does not limit the effect of Section 7.01; 

(ii) the Trustee shall not be liable for any error of judgment made in good faith by a Trust Officer unless it is proved that the Trustee
was negligent in ascertaining the pertinent facts; and 
 (iii) the Trustee shall not be liable with respect to any action it
takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05 hereof. 
 (d)
Whether herein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to Sections 7.01(a), (b) and (c). 
 (e) The Trustee shall not be liable for interest on any money received by it or risk or expend any of its own funds. 
 (f) Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 
 (g) No provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties hereunder or in the exercise of
any of its rights or powers. 
 (h) Every provision of this Indenture relating to the conduct or affecting the liability of or
affording protection to the Trustee shall be subject to the provisions of this Article 7 and to the provisions of the TIA, and the provisions of this Article 7 shall apply to the Trustee, Registrar, Paying Agent and Conversion Agent.(i)
The Trustee shall not be deemed to have notice of a Default or an Event of Default unless (i) a Trust Officer of the Trustee has received written notice at its Corporate Trust Office thereof from the Company or any Holder or (ii) a Trust
Officer shall have actual knowledge thereof. 
 Section 7.02 Rights of Trustee. 

(a) The Trustee may conclusively rely upon any document believed by it to be genuine and to have been signed or presented by the proper
person. The Trustee need not investigate any fact or matter stated in the document. The Trustee may, however, in its discretion make such further inquiry or investigation into such facts or matters as it may see fit and, if the Trustee shall
determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally or by agent or attorney at the expense of the Company and shall incur no liability of any kind by
reason of such inquiry or investigation. 
 (b) Before the Trustee acts or refrains from acting (except in connection with an
application for authorization of Notes pursuant to Section 2.02), it may require an Officer’s 

  
 41 

 
Certificate or an Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on the Officer’s Certificate or Opinion of Counsel.

 (c) The Trustee may act through agents, attorneys or custodians and shall not be responsible for the misconduct or negligence
of any agent, attorney or custodian appointed with due care. 
 (d) The Trustee shall not be liable for any action it takes or
omits to take in good faith that it believes to be authorized or within the rights or powers conferred upon it by this Indenture; provided, however, that the Trustee’s conduct does not constitute willful misconduct or negligence.

 (e) The Trustee may consult with counsel of its own selection, and the written advice or opinion of counsel with respect to
legal matters relating to this Indenture and the Notes shall be full and complete authorization and protection from liability in respect to any action taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or
opinion of such counsel. 
 (f) The permissive rights of the Trustee to do things enumerated in this Indenture shall not be
construed as a duty unless so specified herein. 
 (g) The Trustee shall be under no obligation to exercise any of the rights or
powers vested in it by this Indenture at the request or direction of any of the Holders pursuant to this Indenture, unless such Holders shall have offered to the Trustee security or indemnity reasonably satisfactory to the Trustee against the costs,
expenses and liabilities that might be incurred by it in compliance with such request or direction. 
 (h) The rights,
privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent,
custodian and other Person employed to act hereunder, including, without limitation, the Registrar, Paying Agents and Conversion Agent. 
 (i) The Trustee may request that the Company deliver an Officer’s Certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions
pursuant to this Indenture, which Officer’s Certificate may be signed by any Person authorized to sign an Officer’s Certificate, including any Person specified as so authorized in any such certificate previously delivered and not
superseded. 
 Section 7.03 Individual Rights of Trustee. The Trustee in its individual or any other capacity may become
the owner or pledgee of Notes and may otherwise deal with the Company or its affiliates with the same rights it would have if it were not Trustee. However, if the Trustee acquires any conflicting interest it must eliminate the conflict within
90 days, if this Indenture has been qualified under the TIA, apply to the SEC to continue as trustee, or resign. Any Paying Agent, Registrar, Conversion Agent or co-registrar may do the same with like rights.
However, the Trustee must comply with Sections 7.10 and 7.11. 

  
 42 

 Section 7.04 Trustee’s Disclaimer. The Trustee shall not be responsible for and
makes no representation as to the validity, priority or adequacy of this Indenture or the Notes, it shall not be accountable for the Company’s use of the proceeds from the Notes, and it shall not be responsible for any
statement of the Company in this Indenture or in any document issued in connection with the sale of the Notes or in the Notes other than the Trustee’s certificate of authentication. 

Section 7.05 Notice of Defaults. If a Default or Event of Default occurs and is continuing, the Trustee shall mail to each
Holder notice of the Default or Event of Default within 90 days after it is known to a Trust Officer or written notice of it is received by the Trustee; provided, however, that except in the case of a Default described in
Section 6.01(a)(i), 6.01(a)(ii) or 6.01(iii), the Trustee may withhold the notice if and so long as a committee of its Trust Officers in good faith determines that withholding the notice is in the interests of Holders. The second
sentence of this Section 7.05 shall be in lieu of the proviso to TIA Section 315(b) and such proviso is hereby expressly excluded from this Indenture, as permitted by the TIA. 

Section 7.06 Reports by Trustee to Holders. Within 120 days of each January 31, commencing on January 31,
2014, and for so long as any Notes remain outstanding, the Trustee shall mail to each Holder a brief report dated as of January 31 of such year that complies with TIA Section 313(a), if and to the extent required by
such subsection. The Trustee shall also comply with TIA Section 313(b). The Trustee will also transmit by mail all reports as required by TIA 313(c). 
 A copy of each report at the time of its mailing to Holders shall be mailed by the Trustee to the Company and filed with the SEC and each stock exchange (if any) on which the Notes are listed. The Company
agrees to notify promptly the Trustee whenever the Notes become listed on any stock exchange and of any delisting thereof. 

Section 7.07 Compensation and Indemnity. The Company shall pay to the Trustee from time to time such compensation as shall be
agreed upon from time to time in writing for its services. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee upon request for all reasonable
out-of-pocket fees and expenses incurred or made by it, including costs of collection, in addition to the compensation for its services. Such expenses shall include the reasonable compensation, fees and expenses,
disbursements and advances of the Trustee’s agents, counsel, accountants and experts. The Company shall fully indemnify the Trustee against any and all loss, liability, claim, damage or expense (including
reasonable attorneys’ fees and expenses) incurred by it in connection with the acceptance and administration of this trust and the performance of its duties hereunder, including the costs and expenses of defending itself against any
claim (whether asserted by the Company, any Holder or any other Person). The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company of any claim for which it may
seek indemnity of which a Trust Officer has actually received written notice shall not relieve the Company of its obligations hereunder except to the extent such failure shall have materially prejudiced the Company. The Company shall defend the
claim and the Trustee shall cooperate in the defense. If the Trustee is advised by counsel in writing that it may have available to it defenses which are in conflict with the defenses available to the Company, then the Trustee may have separate
counsel and the 

  
 43 

 
Company shall pay the reasonable fees and expenses of such counsel. The Company need not reimburse any expense or indemnify against any loss, liability or expense incurred by the Trustee through
the Trustee’s own willful misconduct or negligence. The Company need not pay for any settlement made by the Trustee without the Company’s consent, such consent not to be unreasonably withheld. All indemnifications and releases from
liability granted hereunder to the Trustee shall extend to its officers, directors, employees, agents, attorneys, custodians, successors and assigns. 
 (a) To secure the Company’s payment obligations under this Section 7.07, the Trustee shall have a lien prior to the Notes on all money or property held or collected by the Trustee other than
money or property held in trust to pay the principal, accrued and unpaid interest (including Additional Interest and Special Interest), if any, or payment of the Fundamental Change Purchase Price on particular Notes. 

(b) The Company’s payment obligations pursuant to this Section 7.07 shall survive the resignation or removal of the Trustee and
the discharge of this Indenture. If the Trustee incurs expenses after the occurrence of a Default specified in Sections 6.01(viii) or 6.01 (ix) with respect to the Company, the expenses are intended to constitute expenses of administration
under the Bankruptcy Law. 
 Section 7.08 Replacement of Trustee. (a) The Trustee may resign at any time by
notifying the Company in writing at least 30 days prior to the proposed resignation. The Holders of a majority in aggregate principal amount of the Notes then outstanding may remove the Trustee by notifying the Trustee in writing. The Company may
remove the Trustee if: 
 (i) the Trustee fails to comply with Section 7.10; 

(ii) the Trustee is adjudged bankrupt or insolvent; 
 (iii) a receiver or other public officer takes charge of the Trustee or its property; or 
 (iv) the Trustee otherwise becomes incapable of acting. 
 (b) If the Trustee
resigns, is removed by the Company or by the Holders of a majority in aggregate principal amount of the Notes then outstanding, or if a vacancy exists in the office of Trustee for any reason (the Trustee in such event being referred to herein as the
retiring Trustee), the Company shall promptly appoint a successor Trustee. 
 (c) A successor Trustee shall deliver a written
acceptance of its appointment to the retiring Trustee and to the Company. Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee
under this Indenture. The successor Trustee shall mail a notice of its succession to Holders. The retiring Trustee shall upon payment of all of its costs and the costs of its agents and counsel promptly transfer all property held by it as Trustee to
the successor Trustee, subject to the lien provided for in Section 7.07. 

  
 44 

 (d) If a successor Trustee does not take office within 60 days after the retiring Trustee
resigns or is removed, the retiring Trustee, the Company or the Holders of at least 10% in aggregate principal amount of the Notes then outstanding may petition at the expense of the Company any court of competent jurisdiction for the appointment of
a successor Trustee. 
 (e) If the Trustee, after written request by any Holder, fails to comply with Section 7.10, such
Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
 (f) Notwithstanding the replacement of the Trustee pursuant to this Section 7.08, the Company’s obligations under Section 7.07 shall continue for the benefit of the retiring Trustee.

 Section 7.09 Successor Trustee by Merger. (a) If the Trustee consolidates with, merges or converts
into, or transfers all or substantially all its corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation or banking association without any
further act shall be the successor Trustee. 
 (b) In case at the time such successor or successors by merger, conversion or
consolidation to the Trustee shall succeed to the trusts created by this Indenture, any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor
trustee, and deliver such Notes so authenticated; and in case at that time any of the Notes shall not have been authenticated, any such successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the
name of the successor to the Trustee. 
 Section 7.10 Eligibility; Disqualification. The Trustee shall at all
times satisfy the requirements of TIA Section 310(a). The Trustee shall have (or, in the case of a corporation included in a bank holding company system, the related bank holding company shall have) a combined capital and surplus
of at least $100,000,000 as set forth in its (or its related bank holding company’s) most recent published annual report of condition. The Trustee shall comply with TIA Section 310(b), subject to the penultimate paragraph
thereof; provided, however, that there shall be excluded from the operation of TIA Section 310(b)(1) any indenture or indentures under which other securities or certificates of interest or participation in other securities of the
Company are outstanding if the requirements for such exclusion set forth in TIA Section 310(b)(1) are met. 
 Section 7.11
Preferential Collection of Claims Against Company. The Trustee shall comply with TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has resigned or been removed shall be
subject to TIA Section 311(a) to the extent indicated therein. 
 Section 7.12 Trustee’s Application for
Instructions from the Company. Any application by the Trustee for written instructions from the Company may, at the option of the Trustee, set forth in writing any action proposed to be taken or omitted by the Trustee under this
Indenture and the date on and/or after which such action shall be taken or such omission shall be effective. The Trustee shall not be liable to the Company for any action taken by, or omission of, the Trustee in accordance with a
proposal included in such application on or after the date specified 

  
 45 

 
in such application (which date shall not be less than three Business Days after the date any officer of the Company actually receives such application, unless any such officer shall have
consented in writing to any earlier date) unless prior to taking any such action (or the effective date in the case of any omission), the Trustee shall have received written instructions in response to such application specifying the action
to be taken or omitted. 
 ARTICLE 8. 
 DISCHARGE OF INDENTURE 
 Section 8.01 Discharge of Liability on
Notes. When (a) the Company delivers to the Registrar all outstanding Notes (other than Notes replaced pursuant to Section 2.07) for cancellation or (b) all outstanding Notes have become due and payable, and the Company
irrevocably deposits with the Trustee or delivers to the Holders, as applicable, cash and/or shares of Common Stock (solely to satisfy outstanding conversions, if applicable) sufficient to pay all amounts due and owing on all
outstanding Notes (other than Notes replaced pursuant to Section 2.07), and if in either case the Company pays all other sums payable hereunder by the Company with respect to the outstanding Notes, then this Indenture
shall, subject to Section 7.07, cease to be of further effect with respect to the Notes or any Holders. The Trustee shall acknowledge satisfaction and discharge of this Indenture with respect to the Notes on demand of the Company
accompanied by an Officer’s Certificate and an Opinion of Counsel and at the cost and expense of the Company. 
 Section
8.02 Repayment to the Company. The Trustee and the Paying Agent shall promptly turn over to the Company upon request any excess money or securities held by them at any time. 

Subject to any applicable abandoned property law, the Trustee and the Paying Agent shall pay to the Company upon request any money held
by them for payments on the Notes that remains unclaimed for two years after the date on which such payments became due, and, thereafter, Holders entitled to the money must look to the Company for payment as general creditors and all liability of
the Trustee or Paying Agent with respect to such money will cease. 
 ARTICLE 9. 

AMENDMENTS 

Section 9.01 Without Consent of Holders. The Company and the Trustee may amend or supplement this Indenture or the Notes without
the consent of any Holder to: 
 (a) cure any ambiguity, omission, defect or inconsistency in this Indenture or in the Notes;

 (b) conform the terms of this Indenture or the Notes to the “Description of Notes” section of the Offering
Memorandum; 
 (c) make provisions with respect to the conversion rights of the Holders in accordance with Section 10.06
hereof; 

  
 46 

 (d) provide for the assumption by a successor corporation of the Company’s obligations
under this Indenture as described in Article 5 hereof; 
 (e) add guarantees with respect to the Notes; 

(f) secure the Notes; 
 (g) add to the Company’s covenants for the benefit of the Holders or surrender any right or power conferred upon the Company; 
 (h) make any change that does not adversely affect the rights of any Holder; 
 (i)
appoint a successor Trustee with respect to the Notes; 
 (j) comply with the rules of any applicable securities depositary,
including DTC; or 
 (k) comply with any requirements of the SEC in connection with the qualification of this Indenture under
the TIA. 
 Section 9.02 With Consent of Holders. With the written consent of the Holders of at least a majority in
aggregate principal amount of the Notes at the time outstanding (including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, the Notes), by Act of such Holders
delivered to the Company and the Trustee, the Company, when authorized by a Board Resolution, may amend or supplement this Indenture or the Notes; provided, however, that, without the consent of each affected Holder, no amendment or
supplement to this Indenture or the Notes may: 
 (a) reduce the percentage in aggregate principal amount of Notes whose Holders
must consent to an amendment of this Indenture or to waive any past Event of Default; 
 (b) reduce the rate of or extend the
stated time for payment of interest (including any Additional Interest or Special Interest) on any Note; 
 (c) reduce the
principal amount or extend the Maturity Date of any Note; 
 (d) make any change that impairs or adversely affects the
conversion rights of any Notes under Article 10 hereof, subject to the provisions set forth in Article 10.06 hereof; 

(e) reduce the Fundamental Change Purchase Price of any Note or amend or modify in any manner adverse to the Holders the Company’s
obligation to make such payments; 
 (f) make any Note payable in a currency other than that stated in the Note; 

(g) change the ranking of the Notes; 
 (h) impair the right of any Holder to receive payment of the principal of, and interest (including Additional Interest or Special Interest), if any, on, such Holder’s Notes on or after the due dates
therefor or to institute suit for the enforcement of any payment on or with respect to such Holder’s Notes; or 

  
 47 

 (i) make any change to the amendment provisions of this Indenture which require each
Holder’s consent or in the waiver provisions of this Indenture. 
 It shall not be necessary for the consent of the Holders
under this Section 9.02 to approve the particular form of any proposed amendment, but it shall be sufficient if such consent approves the substance thereof. 
 Section 9.03 Execution of Supplemental Indentures. Upon the request of the Company, the Trustee shall sign any supplemental indenture authorized pursuant to this Article 9 if the amendment
contained therein does not affect the rights, duties, liabilities or immunities under this Indenture of the Trustee. If the supplemental indenture adversely affects the Trustee’s rights, duties, liabilities or immunities under this Indenture,
then the Trustee may, but need not, sign such supplemental indenture. In executing any such supplemental indenture, the Trustee shall be provided with, and (subject to the provisions of Section 7.01) shall be fully protected in relying upon, an
Officer’s Certificate and an Opinion of Counsel stating that such supplemental indenture is authorized and permitted under this Indenture. 
 Section 9.04 Notices of Supplemental Indentures. After an amendment or supplement to this Indenture or the Notes pursuant to Sections 9.01 or 9.02 becomes effective, the Company shall mail to each
Holder a notice briefly describing such amendment or supplement to this Indenture. The failure to deliver such notice, or any defect in such notice, shall not impair or affect the validity of such amendment or supplement to this Indenture.

 Section 9.05 Effect of Supplemental Indentures. Upon the execution of any supplemental indenture under this
Article 9, (i) this Indenture shall be modified in accordance therewith, (ii) such supplemental indenture shall form a part of this Indenture for all purposes, and (iii) every Holder of Notes theretofore or
thereafter authenticated and delivered hereunder shall be bound thereby. 
 Section 9.06 Conformity with Trust Indenture
Act. Every supplemental indenture executed pursuant to this Article shall comply with the TIA. 
 Section 9.07
Notation on or Exchange of Notes. Notes authenticated and delivered after the execution of any supplemental indenture pursuant to this Article 9 may, and shall, if required by the Trustee, bear a notation in form
approved by the Trustee as to any matter provided for in such supplemental indenture. If the Company shall so determine, new Notes so modified as to conform, in the opinion of the Trustee and the Board of Directors, to any such
supplemental indenture may be prepared and executed by the Company and authenticated and delivered by the Trustee in exchange for outstanding Notes. 
 Section 9.08 Revocation and Effect of Consents, Waivers and Actions. A consent to an amendment or a waiver by a Holder of a Note shall bind the Holder and every subsequent Holder of that Note or
portion of the Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent or waiver is not made on the Note. However, any such Holder or subsequent Holder may revoke the consent or waiver as
to such Holder’s Note or portion of the Note if the Trustee receives the notice of revocation before the date the supplemental indenture setting forth the amendment or waiver becomes effective. After an amendment or

  
 48 

 
waiver becomes effective, it shall bind every Holder. An amendment or waiver becomes effective in accordance with the terms of the supplemental indenture, which shall become effective upon the
execution thereof by the Trustee. 
 The Company may, but shall not be obligated to, fix a record date for the purpose of
determining the Holders entitled to give their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then those Persons who were Holders at such record date (or
their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after such record date. No such
consent shall be valid or effective for more than 120 days after such record date. 
 ARTICLE 10. 

CONVERSIONS 
 Section 10.01 Conversion Privilege and Consideration. 
 (a) Subject to and
upon compliance with the provisions of this Indenture, a Holder shall have the right, at such Holder’s option, to convert the principal amount of its Notes, or any portion of such principal amount that is equal to $1,000 or an integral multiple
thereof, at a conversion rate initially equal to 3.7628 shares of the Common Stock (subject to adjustment as provided in Sections 10.05 and 10.07, the “Conversion Rate”) per $1,000 principal amount of Notes, into an amount of cash
and a number of shares of the Common Stock, if any, determined in accordance with Section 10.03, (x) at any time prior to the Close of Business on the Business Day immediately preceding January 1, 2018, only upon the satisfaction of
one or more of the conditions described in clauses (i) through (iv) below, and (y) on and after January 1, 2018, at any time until the Close of Business on the second Scheduled Trading Day immediately preceding the Maturity Date,
without regard to the conditions described in clauses (i) through (iv) below: 
 (i) During any fiscal quarter (and
only during such fiscal quarter) commencing after April 30, 2013 if, for at least 20 Trading Days (whether or not consecutive) during the 30 consecutive Trading Day period ending on the last Trading Day of the immediately preceding fiscal
quarter, the Last Reported Sale Price of the Common Stock is greater than or equal to 130% of the applicable Conversion Price on such Trading Day. If the Notes become convertible in accordance with this Section 10.01(a)(i), as promptly as
practicable, the Company shall notify the Holders that the condition to conversion described in this Section 10.01(a)(i) has been satisfied and of the Holders’ right to convert their Notes. 

(ii) During the five consecutive Business Day period immediately following any ten consecutive Trading Day period (the
“Measurement Period”) in which, for each Trading Day of such Measurement Period, the Trading Price per $1,000 principal amount of Notes, as determined following a request by a Holder in accordance with the procedures set forth in
this Section 10.01(a)(ii), is less than 98% of the product of (x) the Last Reported Sale Price of the Common Stock on such Trading Day and (y) the Conversion Rate on such Trading Day (for any Trading Day, the “Trading Price
Product”). 

  
 49 

 (A) Unless the Company requests that the Bid Solicitation Agent determine the Trading Price
of the Notes, the Bid Solicitation Agent shall have no obligation to determine the Trading Price of the Notes, and unless a Holder of at least $1,000,000 principal amount of Notes (x) provides the Company with reasonable evidence that the
Trading Price per $1,000 principal amount of Notes for the immediately following Trading Day will be less than 98% of the Trading Price Product for such Trading Day and (y) requests that the Company require the Bid Solicitation Agent to
determine the Trading Price of the Notes on the immediately following Trading Day, the Company shall have no obligation to request that the Bid Solicitation Agent determine the Trading Price of the Notes on such Trading Day. 

(B) Upon receipt from a Holder of such evidence and such a request, the Company shall promptly instruct the Bid Solicitation Agent to
determine (or, if the Company is then acting as Bid Solicitation Agent, the Company shall determine) the Trading Price of the Notes beginning on the next Trading Day and on each successive Trading Day until a Trading Day occurs in which the Trading
Price per $1,000 principal amount of Notes for such Trading Day is greater than or equal to 98% of the Trading Price Product for such Trading Day. 
 (C) As promptly as practicable after the condition to conversion described in this Section 10.01(a)(ii) has been met, the Company shall notify the Holders of the Trading Price and of the
Holders’ right to convert their Notes in accordance with this Section 10.01(a)(ii). On the first Trading Day thereafter on which the Trading Price per $1,000 principal amount of Notes for such Trading Day is greater than or equal to 98% of
the Trading Price Product for such Trading Day, as promptly as practicable, the Company shall notify the Holders of such Trading Price and that the condition to conversion described in this Section 10.01(a)(ii) is no longer satisfied.

 (iii) If the Company elects to: 
 (A) issue to all or substantially all holders of its Common Stock rights, options or warrants that entitle them, for a period of not more than 60 calendar days after the announcement date of such
issuance, to subscribe for or purchase shares of the Common Stock at a price per share of Common Stock less than the average of the Last Reported Sale Prices of the Common Stock for the ten consecutive Trading Day period ending on, and including,
the Trading Day immediately preceding the date of announcement of such issuance; or 
 (B) distribute to all or substantially
all holders of the Common Stock the Company’s assets, debt securities or rights to purchase securities of the Company, which distribution has a per share value, as reasonably determined by the Board of Directors, exceeding 10% of the Last
Reported Sale Price of the Common Stock on the Trading Day immediately preceding the date of announcement for such distribution, 
 then, in
each case, at least 35 Scheduled Trading Days immediately prior to the Ex-Dividend Date for such issuance or distribution, the Company shall mail notice to the Holders describing such issuance or distribution, the Holders’ right to convert
their Notes in accordance with this Section 10.01(a)(iii), the Conversion Rate in effect on the date the Company mails such notice, any adjustments to the Conversion Rate that must be made pursuant to Section 10.05 as a result of such
issuance or distribution, and the effective date for any such adjustments. Once the 

  
 50 

 
Company has given such notice, a Holder may surrender its Notes for conversion at any time until the earlier of (x) the Close of Business on the Business Day immediately preceding the
Ex-Dividend Date for the issuance or distribution or (y) the Company’s announcement that such issuance or distribution will not take place. 
 (iv) If a transaction or event that constitutes a Fundamental Change or a Make-Whole Fundamental Change occurs, in each case, without giving effect to the penultimate paragraph of the definition of
Fundamental Change and regardless of whether the Holders have the right to require the Company to purchase their Notes pursuant to Section 3.02 (a “Specified Corporate Transaction”), the Company shall mail notice (a
“Specified Corporate Transaction Notice”) of such Specified Corporate Transaction to the Holders as promptly as practicable after the Company first learns of the anticipated or actual effective date of such Specified Corporate
Transaction; provided that, for any Specified Corporate Transaction, the Company will use commercially reasonable efforts to deliver the Specified Corporate Transaction Notice for such Specified Corporate Transaction at least 35 Scheduled
Trading Days immediately prior to the effective date for such Specified Corporate Transaction. For any Specified Corporate Transaction, the Specified Corporate Transaction Notice shall describe: 

(A) such Specified Corporate Transaction; 
 (B) the anticipated effective date of such Specified Corporate Transaction; 
 (C)
the Holders’ right to convert their Notes in accordance with this Section 10.01(a)(iv); 
 (D) the Conversion Rate in
effect on the date the Company mails such notice; 
 (E) any adjustments to the Conversion Rate that must be made pursuant to
Section 10.05 as a result of such transaction; 
 (F) whether such Specified Corporate Transaction also constitutes a
Fundamental Change, and, if so, the Holders’ right to require the Company to purchase their Notes pursuant to Article 3; and 
 (G) whether such Specified Corporate Transaction also constitutes a Make-Whole Fundamental Change, and, if so, the Holders’ right under Section 10.07 to receive Additional Shares if they convert
their Notes in connection with such Make-Whole Fundamental Change. 
 Upon the Company’s delivery of a Specified Corporate
Transaction Notice for a Specified Corporate Transaction, a Holder may surrender its Notes for conversion at any time until the Close of Business on the earliest of (w) the 35th Trading Day immediately following the effective date of such
transaction, (x) if such Specified Corporate Transaction constitutes a Fundamental Change, the related Fundamental Change Purchase Date, or (y) if the Company announces that such Specified Corporate Transaction will not occur, the date on
which the 

  
 51 

 
Company makes such announcement, and (z) the second Scheduled Trading Day immediately preceding the Maturity Date. 
 Section 10.02 Conversion Procedure. 
 (a) To convert a Note, a Holder must
(i) in the case of a Global Note, (A) comply with the procedures of the Depositary in effect on the date such Holder surrenders its Note for conversion and (B) if required, pay all funds required under Sections 10.02(e) and 10.02(f)
below, and (ii) in the case of a Certificated Note, (A) complete and manually sign the conversion notice in the form on the reverse of such Certificated Note (a “Notice of Conversion”) or a facsimile of the Notice of
Conversion, (B) deliver the Notice of Conversion, which is irrevocable, and the Certificated Note to the Conversion Agent, (C) if required, furnish appropriate endorsements and transfer documents, (D) if required, pay all transfer or
similar taxes, and (E) if required, pay all funds required under Sections 10.02(e) and 10.02(f) below. 
 (i) On the first
Business Day on which such Holder satisfies all of the requirements set forth in Section 10.02(a) above with respect to a Note (and the conversion of such Note is not otherwise prohibited by Section 3.05 hereof), such Note will be deemed
converted and such Business Day will be the conversion date (the “Conversion Date”) for such Note. 
 (ii) If
the last day on which a Note may be converted is not a Business Day, the Note may be surrendered on the immediately following day that is a Business Day. Upon the conversion of a Note, the Conversion Agent, as promptly as possible, and in no event
later than one Business Day immediately following the Conversion Date for the Note, will provide the Company with notice of the conversion of the Note, and the Company, as promptly as possible, and in no event later than two Business Days after such
Conversion Date, will notify the Trustee, if other than the Conversion Agent, of the conversion of the Note. 
 (b) If a Holder
converts the entire principal amount of a Note, such Person will no longer be a Holder of such Note. 
 (c) If a Holder
surrenders only a portion of a Certificated Note for conversion, promptly after the Conversion Date for such portion, the Company shall execute and the Trustee shall authenticate and deliver to such Holder, a new Certificated Note in an authorized
denomination equal to the aggregate principal amount of the unconverted portion of the surrendered Note. Upon the conversion of an interest in a Global Note, the Trustee shall promptly make a notation on the “Schedule of Increases and
Decreases of Global Note” of such Global Note as to the reduction in the principal amount represented thereby. The Company shall notify the Trustee in writing upon any conversion of a Note effected through any Conversion Agent other than
the Trustee. 
 (d) If any shares of Common Stock are issuable upon the conversion of a Note, the Person in whose name the
certificate or certificates for such shares of Common Stock will be registered will become the holder of record of such shares at the Close of Business on the last VWAP Trading Day of the Observation Period corresponding to the Conversion Date for
such Note. 

  
 52 

 (e) If a Holder surrenders a Note for conversion after the Close of Business on a Record
Date and prior to the Open of Business on the corresponding Interest Payment Date, the Holder must accompany the Note with an amount of cash equal to the amount of interest (including any Additional Interest and Special Interest), if any, that will
be payable on the Note on such corresponding Interest Payment Date; provided, however, that a Holder need not make such a payment (i) if the Company has specified a Fundamental Change Purchase Date that is after the Record Date
and on or prior to the corresponding Interest Payment Date, (ii) to the extent of any overdue interest on the Note, if any overdue interest exists at the time of conversion, or (iii) if the Holder surrenders the Note after the Close of
Business on the last Record Date immediately preceding the Maturity Date. 
 (f) If a Holder surrenders a Note for conversion,
the Company shall pay all stamp taxes and all other duties, if any, which may be imposed by the United States or any political subdivision thereof or taxing authority thereof or therein with respect to the issuance of shares of Common Stock, if any,
upon the conversion. However, if any tax is due because the Holder requests that any shares of Common Stock issued upon conversion be issued in a name other than that of the Holder, the Holder shall pay such tax and the Conversion Agent, until
having received a sum sufficient to pay such tax, may refuse to deliver any certificates representing shares of Common Stock being issued in a name other than that of the converting Holder. Nothing herein shall preclude any tax withholding required
by law or regulations. 
 Section 10.03 Settlement Upon Conversion. 

(a) Except as provided in Section 10.07(d), if a Holder surrenders a Note for conversion, the Company will satisfy its obligation to
convert the Note by delivering, on the third Business Day immediately following the final VWAP Trading Day of the Observation Period corresponding to the Conversion Date for such Note, cash and shares of Common Stock, if any, equal to the sum of the
Daily Settlement Amount for each of the 30 Trading Days during the Observation Period for such Note. 
 (b) Notwithstanding the
provisions of Section 10.03(a), the Company may elect to settle all or a portion of the Daily Share Amounts for each VWAP Trading Day in the Observation Period relating to a Conversion Date in cash (a “Cash Election”).

 (i) To make a Cash Election with respect to all or a portion of the Daily Share Amounts for each Trading Day in the
Observation Period relating to a Conversion Date, on the Business Day immediately following such Conversion Date, the Company must deliver notice (a “Cash Percentage Notice”) to all Holders converting Notes on such Conversion Date.
The Cash Percentage Notice for a Conversion Date must specify the single percentage of the Daily Share Amounts for each VWAP Trading Day in the Observation Period for such Conversion Date that the Company will settle in cash (the “Cash
Percentage”); provided that to make a Cash Election with respect to a Conversion Date occurring on or after the 35th Scheduled Trading Day immediately preceding the Maturity Date, the Company must (A) irrevocably specify a single Cash
Percentage that will apply to every Conversion Date occurring on or after the 35th Scheduled Trading Day immediately preceding the Maturity Date and (B) deliver a Cash Percentage Notice specifying such Cash Percentage to every Holder on or prior to
the 

  
 53 

 
Scheduled Trading Day immediately preceding the 35th Scheduled Trading Day immediately preceding the Maturity Date. 
 (ii) If the Company timely delivers a Cash Percentage Notice for a Conversion Date, (x) the amount of cash that the Company will deliver in lieu of the applicable portion of the shares of Common
Stock comprising the Daily Share Amount for a VWAP Trading Day in the Observation Period relating to such Conversion Date will equal the product of (A) the Cash Percentage specified in the Cash Percentage Notice for such Conversion Date,
(B) the Daily Share Amount for such VWAP Trading Day (calculated as if the Company had not specified a Cash Percentage), and (C) the Daily VWAP for such VWAP Trading Day, and (y) the number of shares of Common Stock that the Company
will deliver as part of the Daily Share Amount for such VWAP Trading Day will equal the product of (A) 100% minus the Cash Percentage for such Conversion Date and (B) the Daily Share Amount for such VWAP Trading Day (calculated as if the
Company had not specified a Cash Percentage). 
 (iii) If, for any Conversion Date, the Company fails to deliver a Cash
Percentage Notice in accordance with Section 10.03(b)(i), the Company must instead settle the Daily Share Amount for each VWAP Trading Day in the Observation Period relating to such Conversion Date by delivering a number of shares of Common
Stock determined in accordance with Section 10.03(a). 
 (c) Notwithstanding the foregoing, the Company will not issue
fractional shares of Common Stock as part of the Daily Share Amount. Instead, if the Daily Share Amount for any VWAP Trading Day includes a fraction of a share of the Common Stock, the Company will, in lieu of delivering such fraction of a share of
Common Stock, pay an amount of cash equal to the product of (i) such fraction of a share and (ii) the Daily VWAP for such VWAP Trading Day of such Observation Period. 

(d) If a Holder surrenders more than one Note for conversion on a single day, the number of shares of Common Stock, if any, that the
Company will deliver, and the amount of cash that the Company will pay in lieu of fractional shares of Common Stock, if any, shall be determined based on the total principal amount of Notes surrendered by such Holder. 

(e) If a Holder converts a Note, the Company will not adjust the Conversion Rate to account for any accrued and unpaid interest on the
Note, and, except to the extent specified in the last sentence of Section 11.01 or in Section 11.02(a), the Company will not make any cash payment to such Holder for any accrued and unpaid interest on the Note. Furthermore, except to the
extent specified in the last sentence of Section 11.01 or in Section 11.02(a), the Company’s delivery to such Holder of the amount of cash and the number of shares of Common Stock, if any, into which such Holder’s Note is
convertible shall be deemed to satisfy and discharge in full the Company’s obligation to pay to such Holder (i) the principal amount of such converted Note and (ii) any accrued and unpaid interest (including Additional Interest and
Special Interest, but not Defaulted Interest), if any, on such converted Note. As a result, except to the extent specified in the last sentence of Section 11.01 or in Section 11.02(a), any accrued and unpaid interest with respect to a
converted Note shall be deemed to be paid in full rather than cancelled, extinguished or forfeited. Upon a conversion of Notes into cash and, if applicable, shares of 

  
 54 

 
Common Stock, accrued and unpaid interest will be deemed to be paid first out of cash paid upon such conversion. 
 (f) Notices. 
 (i) On the second Business Day immediately following the
Conversion Date for any Notes, the Company shall deliver written notice to the Trustee stating (A) the aggregate principal amount of Notes converted on such Conversion Date, (B) whether the Company has made a Cash Election with respect to
such Conversion Date, and (C) if the Company has made a Cash Election for such Conversion Date, the Cash Percentage for such Conversion Date. 
 (ii) On the first Business Day immediately following the last VWAP Trading Day of the Observation Period for each Conversion Date, the Company shall deliver written notice to the Trustee stating
(A) the aggregate principal amount of Notes that were converted on such Conversion Date, (B) the aggregate amount of cash and the aggregate number of Shares that the Company is obligated to deliver to settle all of the Notes converted on
such Conversion Date, and (C) the Daily Share Amounts and the Daily Settlement Amounts for each VWAP Trading Day of the Observation Period for such Conversion Date. 
 Section 10.04 Company to Provide Stock. The Company shall, prior to issuance of any shares of Common Stock under this Article 10, and from time to time as may be
necessary, reserve out of its authorized but unissued shares of Common Stock a sufficient number of shares of Common Stock to permit the conversion of the Notes. 
 (a) Any shares of Common Stock delivered upon conversion of the Notes shall be newly issued shares or treasury shares, shall be duly and validly issued and fully paid and nonassessable, and shall be free
from preemptive rights and shall be free of any lien or adverse claim (except any lien or adverse claim created by the action or inaction of the Holder to whom such shares are delivered). The Company will endeavor promptly to comply with all federal
and state securities laws regulating the offer and delivery of Common Stock, as applicable and if any, upon conversion of Notes; provided, that the Company shall not be obligated to register the offer and sale of the Common Stock under the
Securities Act or any other applicable securities laws. In addition, the Company will cause any such shares of Common Stock to be listed on any stock exchange on which the Common Stock is then listed and will comply with any stock exchange rules
applicable to the Notes and/or the Common Stock (or Reference Property) issuable upon conversion of the Notes. 
 (b) If any
shares of the Common Stock issued upon conversion are required to bear a Restricted Stock Legend, such shares will be issued in physical certificated form, will not be held in book-entry form through the facilities of the Depositary and shall be
treated as “restricted securities” (as defined under Rule 144), and the Company will affix, or will direct its transfer agent to affix the Restricted Stock Legend upon such shares. 

Section 10.05 Adjustments to the Conversion Rate. The Conversion Rate will be adjusted as described in this
Section 10.05, except that the Company will not make any adjustments to the Conversion Rate for any Holder that may participate (as a result of holding the Notes, and at the same time as the holders of the Common Stock
participate) in any of the 

  
 55 

 
transactions described below as if such Holder held, for each $1,000 principal amount of Notes held, a number of shares of the Common Stock equal to the applicable Conversion
Rate, without having to convert its Notes. 
 (a) Dividends, Distributions, Splits and Combinations. If the
Company issues solely shares of the Common Stock as a dividend or distribution on all or substantially all of the shares of the Common Stock, or if the Company effects a share split or a share combination of the Common Stock, the Conversion Rate
will be adjusted based on the following formula: 
  
 

 
 where: 
  

	 	R’ =	the Conversion Rate in effect immediately after the Open of Business on the Ex-Dividend Date of such dividend or distribution or the effective date of such share split
or combination, as the case may be; 

  

	 	R =	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date of such dividend or distribution, or immediately prior to the Open of
Business on the effective date of such share split or combination, as the case may be; 

  

	 	OS’ =	the number of shares of the Common Stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination, as the case may
be; and 

  

	 	OS =	the number of shares of the Common Stock outstanding immediately prior to the Open of Business on such Ex-Dividend Date or effective date, as the case may be.

 Any adjustment made under this Section 10.05(a) shall become effective immediately after the Open of
Business on the Ex-Dividend Date for such dividend or distribution or the effective date for such share split or combination, as the case may be. If any dividend or distribution of the type described in this Section 10.05(a) is declared but not
so paid or made, then the Conversion Rate shall immediately be readjusted, effective as of the date the Company’s Board of Directors determines not to pay such dividend or distribution to the Conversion Rate that would then be in effect had
such dividend or distribution not been declared or announced. 
 For the avoidance of doubt, if the Stock Split occurs (assuming
no other adjustments to the Conversion Rate have occurred), the Notes will have an adjusted Conversion Rate of 15.0512 shares of the Common Stock per $1,000 principal amount of Notes (which is equivalent to an initial Conversion Price of
approximately $66.44 per share of Common Stock). 
 (b) Adjustment for Rights Issue. If the Company issues to all or
substantially all of the holders of the Common Stock any rights, options or warrants (other than pursuant to any rights plan in effect from time to time) entitling such holders for a period of not more than 60 calendar days after the announcement
date of such issuance to subscribe for or purchase shares of the Common Stock, at a price per share less than the average of the Last Reported Sale Prices 

  
 56 

 
of the Common Stock for the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, the Conversion Rate will
be adjusted based on the following formula: 
  
 

 
 where: 
  

	 	R’ =	the Conversion Rate in effect immediately after the Open of Business on the Ex-Dividend Date for such issuance; 

 

	 	R =	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date for such issuance; 

 

	 	O =	the number of shares of the Common Stock outstanding immediately prior to the Open of Business on the Ex-Dividend Date for such issuance; 

 

	 	X =	the total number of shares of the Common Stock issuable pursuant to such rights, options or warrants; 

 

	 	Y =	the number of shares of the Common Stock equal to the aggregate price payable to exercise such rights, options or warrants divided by the average of the Last Reported
Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants. 

Any adjustment made under this Section 10.05(b) will be made successively whenever any such rights, options or warrants are issued
and shall become effective immediately after the Open of Business on the Ex-Dividend Date for such issuance. To the extent that shares of Common Stock are not delivered after the expiration of such rights, options or warrants, the Conversion Rate
shall be readjusted to the Conversion Rate that would then be in effect had the adjustment made upon the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually delivered.
If such rights, options or warrants are not so issued, the Conversion Rate shall immediately be readjusted to equal the Conversion Rate that would then be in effect had the relevant adjustment pursuant to this Section 10.05(b) not occurred.

 For purposes of this Section 10.05(b), in determining whether any issued rights, options or warrants entitle the holders
of the Common Stock to subscribe for or purchase shares of the Common Stock at a price less than the average of the Last Reported Sale Prices of the Common Stock for each Trading Day in the ten consecutive Trading Day period ending on, and
including, the Trading Day immediately preceding the announcement date of such issuance, and in determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration that the Company receives
for such rights, options or warrants and any amount payable on exercise thereof, with the value of such consideration, if other than cash, to be determined by the Board of Directors. 

  
 57 

 (c) Other Distributions. 

(i) If the Company distributes shares of its Capital Stock, evidences of its indebtedness, other assets or property or rights or warrants
to acquire its Capital Stock or other securities, to all or substantially all holders of the Common Stock, excluding: 
  

	 	•	 	 dividends or distributions (including subdivisions) and rights, options or warrants for which an adjustment is made pursuant to Sections 10.05(a) or
10.05(b) above; 

  

	 	•	 	 rights issued to all holders of the Common Stock pursuant to a rights plan, where such rights are not presently exercisable, continue to trade with the
Common Stock and holders will receive such rights together with any Common Stock upon conversion as described below; 

  

	 	•	 	 dividends or distributions paid exclusively in cash for which an adjustment is made pursuant to Section 10.05(d) below; and

  

	 	•	 	 Spin-offs for which an adjustment is made pursuant to Section 10.05(c)(ii) below, then the Conversion Rate will be adjusted based on the following
formula: 

  
 

 
 where: 
  

	 	R’ =	the Conversion Rate in effect immediately after the Open of Business on the Ex-Dividend Date for such distribution; 

 

	 	R =	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date for such distribution; 

 

	 	M =	the average of the Last Reported Sale Prices of the Common Stock for the ten consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the Ex-Dividend Date for such distribution; and 

  

	 	F =	the fair market value, as determined by the Company’s Board of Directors, of the shares of Capital Stock evidences of indebtedness, assets, property, or rights or
warrants distributed with respect to each outstanding share of the Common Stock outstanding immediately prior to the Open of Business on the Ex-Dividend Date for such distribution. 

Notwithstanding the foregoing, if “M” (as defined above) minus “F” (as defined above) is less than $1.00, in lieu of
the foregoing adjustment, each Holder shall receive, for each $1,000 principal amount of Notes held, at the same time and upon the same terms as holders of the Common Stock, the amount and kind of indebtedness, other assets or property of the
Company or rights or warrants to acquire the Company’s Capital Stock or other securities that such Holder would have received as if such Holder had owned a number of shares of the Common Stock equal to the Conversion Rate in effect on the
record date for such distribution. 

  
 58 

 Any adjustment made under this Section 10.05(c)(i) will become effective immediately
after the Open of Business on the Ex-Dividend Date for such distribution. If such distribution is not so paid or made, or if any rights or warrants are not exercised before their expiration date, the Conversion Rate shall be readjusted to be the
Conversion Rate that would then be in effect had such distribution not been declared or to the extent such rights or warrants are not exercised, as applicable. 
 (ii) With respect to an adjustment pursuant to this Section 10.05(c) in which there has been a payment of a dividend or other distribution on the Common Stock of shares of Capital Stock of any class
or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Company and such dividend or distribution is listed for trading or quoted (or will be listed or quoted upon consummation of the spin-off) on a
National Securities Exchange (a “Spin-off”), the Conversion Rate will be increased based on the following formula: 
  

 
 where: 
  

	 	R’ =	the Conversion Rate in effect immediately after the Open of Business on the Ex-Dividend Date for the Spin-off; 

 

	 	R =	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date for the Spin-off; 

 

	 	F =	the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of one share of the Common Stock over the ten
consecutive Trading Day period immediately following, and including, the effective date for the Spin-off (such period, the “Valuation Period”); and 

 

	 	MP =	the average of the Last Reported Sale Prices of the Common Stock over the Valuation Period. 

Notwithstanding the foregoing, (A) if the last VWAP Trading Day of the Observation Period for any conversion occurs on or after the
effective date for the Spin-off, but less than ten Trading Days immediately following, and including, the effective date for the Spin-off, references within this Section 10.05(c)(ii) to ten Trading Days shall be deemed replaced, for purposes of
calculating the affected Daily Settlement Amounts in respect of that conversion, with such lesser number of Trading Days as have elapsed from, and including, the effective date for the Spin-off to, and including, the last VWAP Trading Day of such
Observation Period, and (B) for purposes of determining the Conversion Rate applicable to any conversion for which the Conversion Date occurs during the ten Trading Days commencing on the effective date for any Spin-off, references within the
portion of this Section 10.05(c)(ii) to ten Trading Days shall be deemed replaced with such lesser number of Trading Days as have elapsed from, and including, the effective date for such Spin-off to, but excluding, the relevant Conversion Date.

 Any adjustment made pursuant to this Section 10.05(c)(ii) shall become effective as of the Open of Business on the
Ex-Dividend Date for the Spin-off. If such Spin-off is subsequently 

  
 59 

 
cancelled and does not become effective, the Conversion Rate shall be readjusted to be the Conversion Rate that would have been in effect if such Spin-off had not been declared. 

(d) Adjustment for Cash Distributions. If the Company pays cash dividends or distributions to all or substantially all holders of
the outstanding Common Stock, the Conversion Rate will be adjusted based on the following formula: 
  
 

 
 where: 
  

	 	R’ =	the Conversion Rate in effect immediately after the Open of Business on the Ex-Dividend Date for such distribution; 

 

	 	R =	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date for such distribution; 

 

	 	SP =	the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the Ex-Dividend Date for such distribution; and 

  

	 	C =	the amount in cash per share the Company distributes to holders of the Common Stock in such distribution. 

If “ SP ” (as defined above) minus “ C ” (as defined above) is less
than $1.00, in lieu of the foregoing adjustment, each Holder shall receive, for each $1,000 principal amount of Notes held, at the same time and upon the same terms as holders of the Common Stock, the amount of cash such Holder would have received
if such Holder had owned a number of shares of the Common Stock equal to the Conversion Rate in effect on the record date for such distribution. 
 Any adjustment made under this Section 10.05(d) will become effective immediately after the Open of Business on the Ex-Dividend Date for such distribution. If such distribution is not so paid or
made, the Conversion Rate shall be readjusted to be the Conversion Rate that would then be in effect had such distribution not been declared. 
 (e) Adjustment for Tender Offers or Exchange Offers. If the Company or any of its Subsidiaries makes a payment to holders of the Common Stock in respect of a tender offer or exchange offer by the
Company or any of its Subsidiaries, to the extent that the cash and value of any other consideration included in the payment per share of Common Stock exceeds the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive
Trading Day period commencing on, and including, the Trading Day immediately following the last date on which tenders or exchanges may be made pursuant to such tender offer or exchange offer (the “Expiration Date”), the Conversion
Rate will be increased based on the following formula: 
  
 

 

  
 60 

 where: 
  

	 	R’ =	the Conversion Rate in effect immediately after the Close of Business on the Expiration Date; 

 

	 	R =	the Conversion Rate in effect immediately prior to the Close of Business on the Expiration Date;F = the aggregate fair market value of all cash and any other
consideration (as determined by the Company’s Board of Directors) paid or payable for the shares purchased in such tender or exchange offer as of the expiration time of the tender offer or exchange offer (the “Expiration
Time”); 

  

	 	OS’ =	the number of shares of Common Stock outstanding immediately after the Expiration Time (after giving effect to the purchase of shares of such series pursuant to such
tender offer or exchange offer); 

  

	 	OS =	the number of shares of Common Stock outstanding immediately prior to the Expiration Time (prior to giving effect to the purchase of shares of Common Stock pursuant to
such tender offer or exchange offer); and 

  

	 	SP =	the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period commencing on, and including, the Trading Day immediately
following the Expiration Date. 

 The adjustment to the Conversion Rate under this Section 10.05(e) will be
given effect at the Close of Business on the Expiration Date. If the Expiration Date is less than ten Trading Days prior to, and including, the last VWAP Trading Day of the Observation Period in respect of any conversion, references within this
Section 10.05(e) to ten Trading Days shall be deemed replaced, for purposes of calculating the affected Daily Settlement Amounts in respect of that conversion, with such lesser number of Trading Days as have elapsed from, and including, the
Trading Day next succeeding the Expiration Date to, and including, the last VWAP Trading Day of such Observation Period. For purposes of determining the Conversion Rate applicable to any conversion during the ten Trading Day period commencing on the
Trading Day next succeeding the Expiration Date, references within this Section 10.05(e) to ten Trading Days shall be deemed replaced with such lesser number of Trading Days as have elapsed from, and including, the Trading Day next succeeding
the Expiration Date to, but excluding, the relevant Conversion Date. 
 (f) Holder Participation in Adjustment Events.
Notwithstanding the foregoing, if pursuant to this Section 10.05, an adjustment to the Conversion Rate becomes effective on any Ex-Dividend Date or effective date and a Holder that has converted its Notes would (i) receive shares of Common
Stock based on an adjusted Conversion Rate and (ii) be a record holder of the shares of Common Stock on the record date for the dividend, distribution or event giving rise to the adjustment pursuant to this Section 10.05, then, in lieu or
receiving shares of Common Stock at such an adjusted Conversion Rate, such Holder will participate in the related dividend, distribution or other event giving rise to such adjustment and shall receive a number of shares of Common Stock, if any, upon
conversion based on an unadjusted Conversion Rate. 
 (g) Adjustments Not Yet Effective. 

  
 61 

 If a Holder converts a Note and, on any VWAP Trading Day during the Observation Period corresponding to the
Conversion Date for such Note: 
 (A) shares of Common Stock are deliverable as part of the Daily Settlement Amount for such
VWAP Trading Day; 
 (B) any event that requires an adjustment to the Conversion Rate pursuant to Sections 10.05(a), (b), (c),
(d) or (e) has occurred, but will not result in an adjustment to the Conversion Rate for such VWAP Trading Day for such Holder; and 
 (C) the shares of Common Stock (or the cash value thereof) that the Holder shall receive as part of the Daily Settlement Amount for such VWAP Trading Day will not be entitled to participate in the
distribution or transaction requiring the adjustment (because such shares were not held by such Holder on the record date corresponding to such distribution or transaction or otherwise), 
 then the Company will adjust the number of shares of Common Stock (or the cash value thereof) deliverable to such Holder as part of the Daily Settlement Amount for such VWAP Trading Day in a manner that
appropriately reflects the relevant distribution or transaction requiring adjustment. 
 In addition, if a Holder converts a
Note and, on any VWAP Trading Day during the Observation Period corresponding to the Conversion Date for such Note, any event that requires an adjustment to the Conversion Rate pursuant to Sections 10.05(a), (b), (c), (d) or (e) has
occurred, but will not result in an adjustment to the Conversion Rate for such VWAP Trading Day for such Holder, then the Company will adjust the amount of cash deliverable to such Holder as part of the Daily Settlement Amount for such VWAP Trading
Day in a manner that appropriately reflects the relevant distribution or transaction requiring adjustment. 
 (h) Other
Adjustments. Whenever any provision of this Indenture requires the calculation of Last Reported Sale Prices, Daily VWAPs or any functions thereof over a span of multiple days, the Board of Directors will make appropriate adjustments to such
prices, functions of such prices, the Conversion Rate, or the amount of cash and the number of shares of the Common Stock, if any (subject to the Company’s right under Section 10.03(b) to pay cash in lieu of all or a portion of any shares
of Common Stock deliverable as part of a Daily Share Amount), due upon conversion to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion Rate in which the Ex-Dividend Date
of the event occurs, at any time prior to or during the period over which such average is to be calculated. 
 (i) Rights
Plans. If the Company adopts a stockholder rights plan and, on the Conversion Date for a Note, (i) such plan is in effect and (ii) the rights provided for in such plan have not yet separated from the Common Stock, each share of Common
Stock issued upon the conversion of Notes on such Conversion Date (x) shall be entitled to receive the number of rights, if any, associated with one share of Common Stock under such stockholder rights plan, and (y) shall, if issued in
certificated form, bear such legends, if any, as may be required under such stockholder rights plan; provided, however, that if prior to the Conversion Date for a Note, 

  
 62 

 
the rights separate from the Common Stock in accordance with the provisions of the applicable stockholder rights plan, a converting Holder shall not be entitled to receive such rights upon
conversion, and on the date of such separation, the Conversion Rate will be adjusted in accordance with Section 10.05(c); provided, further, that such adjustment shall be subject to readjustment upon the expiration, termination of
redemption of such separated rights. 
 (j) Deferral of Adjustments. The Company need not adjust the Conversion Rate
unless such adjustment would require an increase or decrease in the Conversion Rate by at least 1%; provided that, if an adjustment to the Conversion Rate is not made because the adjustment does not change the Conversion Rate by at least 1%
(after giving effect to any other adjustment not previously made but carried forward pursuant to this sentence), then all of the adjustments that have not been made and that are not made will be carried forward and taken into account in the first
future adjustment that would result in an adjustment of at least 1% to the Conversion Rate; provided, further, that notwithstanding the foregoing, (i) all such carried forward adjustments not previously made that would apply to a
Note shall be made on the first VWAP Trading Day of the Observation Period corresponding to the Conversion Date for such Note and, on each subsequent VWAP Trading Day of such Observation Period, the Company shall be required to make any adjustments
to the Conversion Rate that applies to such Note without regard to whether such adjustments could otherwise be carried forward pursuant to this Section 10.05(j). 
 (k) Simultaneous and Successive Adjustments. If this Article 10 requires adjustments to the Conversion Rate under more than one of Sections 10.05(a), (b), (c) or (d), and the Ex-Dividend
Dates (or, in the case of a Spin-off, the effective date of such a Spin-off) for the distributions giving rise to such adjustments shall occur on the same date, then such adjustments shall be made, without duplication, by applying, first, the
provisions of Section 10.05(a); second, the provisions of Section 10.05(c); third, the provisions of Section 10.05(d); and, fourth, the provisions of Section 10.05(b). 

After an adjustment to the Conversion Rate under this Article 10, any subsequent event requiring an adjustment under this
Article 10 shall cause an adjustment to the Conversion Rate as so adjusted, without duplication. 
 (l) Voluntary
Increases. From time to time, the Company may (but is not required to) increase the Conversion Rate by any amount for a period of at least 20 Business Days if (i) the Board of Directors determines that such increase is in the best interest
of the Company, (ii) such increase is irrevocable during such period and (iii) if any shares of the Company’s Capital Stock are listed on New York Stock Exchange, such increase does not violate any applicable New York Stock Exchange
rules. In addition, the Company may (but is not required to) increase the Conversion Rate to avoid or diminish the taxation of any subdivisions of the Common Stock, dividends on the Common Stock, rights distributions to purchase stock or other
securities to holders of the Common Stock, or distributions to holders of the Common Stock of securities convertible into or exchangeable for shares of the Common Stock. 
 (m) No Other Adjustments. Except as specifically described in this Section 10.05, the Conversion Rate will not be subject to adjustment as a result of any issuance of shares of Common Stock,
securities convertible into or exchangeable for shares of Common Stock or 

  
 63 

 
rights, options or warrants to purchase shares of Common Stock or securities convertible into or exchangeable for shares of Common Stock. In addition, if the application of the formulas in
Sections 10.05(a) through 10.05(e) would result in a decrease in the Conversion Rate, no adjustment to the Conversion Rate will be made (other than as a result of a reverse share split or share combination); provided that, for the avoidance
of doubt, if the Company adjusts the Conversion Rate pursuant to Section 10.05(a), 10.05(b), 10.05(c), or 10.05(d) and the event that gave rise to the adjustment is not paid or made, delivered or issued or fails to become effective, as
applicable, the Company may readjust the Conversion Rate as expressly contemplated in the applicable section. Without limiting the foregoing, the Conversion Rate will not be adjusted upon the following events: 

(i) upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or
interest payable on securities of the Company and the investment of additional optional amounts in shares of Common Stock under any plan; 
 (ii) upon the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present or future employee, director or consultant benefit plan or program of or assumed
by the Company or any of its Subsidiaries; 
 (iii) ordinary course of business Capital Stock repurchases including structured
or derivative transactions, 
 (iv) pursuant to a Capital Stock repurchase program approved by the Board of Directors (but, for
the avoidance of doubt, excluding transactions described in Section 10.05(e)); 
 (v) for a change in the par value of the
Common Stock; 
 (vi) any accrued and unpaid interest (including any Additional Interest and Special Interest), if any; or

 (vii) upon the issuance of any shares of Common Stock pursuant to any option, warrant, right, or exercisable, exchangeable or
convertible security outstanding as of the Issue Date. 
 (n) Notice of Adjustments. Whenever an event occurs that will
require an adjustment to the Conversion Rate pursuant to this Section 10.05, the Company shall, at least 35 Scheduled Trading Days prior to the anticipated effective date of such adjustment, mail to the Holders a notice of such event describing
the event requiring adjustment to the Conversion Rate pursuant to this Section 10.05, the effective date of the adjustment and the adjusted Conversion Rate; provided, however, that if on such date, the Company does not have
knowledge of such event or the adjusted Conversion Rate cannot be calculated, the Company shall deliver such notice as promptly as practicable upon obtaining knowledge of such event or information sufficient to make such calculation, as the case may
be, and in no event later than the effective date of such adjustment; provided, further, however, that no such notice will be required with respect to the Stock Split. On or before the day on which the Company is required to
deliver notice to the Holders pursuant to this Section 10.05(n), the Company shall file such notice, together with an Officer’s Certificate briefly describing the event triggering the adjustment to the Conversion

  
 64 

 
Rate pursuant to this Section 10.05 and the Company’s manner of computing the adjustment, with the Conversion Agent and the Trustee. To the Trustee and the Conversion Agent, receipt of
such notice and of such Officer’s Certificate shall be conclusive evidence that the adjustment is correct and in effect on the effective date stated in such notice. Neither the Trustee nor the Conversion Agent shall be under any duty or
responsibility with respect to any such notice of adjustment except to exhibit the same to any Holder desiring inspection thereof. 
 Section 10.06 Effect of Reclassification, Consolidation, Merger or Sale. 

(a) Upon the occurrence of: 
 (i) any recapitalization, reclassification or change of the Common Stock (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
subdivision or combination for which an adjustment is provided pursuant to Section 10.05); 
 (ii) any sale or conveyance
to another person of all or substantially all of the property and assets of the Company; 
 (iii) any sale, lease or other
transfer to another Person of substantially all of the consolidated assets of the Company and its Subsidiaries; 
 (iv) a
consolidation, merger, or combination involving the Company; or 
 (v) any statutory share exchange, 

and, in each case, as a result of which the Common Stock will be converted into, or exchanged for, stock, other securities, other property or assets
(including cash or any combination including cash) (any such event, a “Merger Event,” such stock, securities, other property or assets, “Reference Property,” and the kind and amount of such stock, securities, other
property or assets that a holder of one share of the Common Stock immediately prior to the effective date of such Merger Event would have been entitled to receive upon the occurrence of such transaction, a “Unit of Reference
Property,” provided that if a Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of election by holders
of the Common Stock), then each Unit of Reference Property will be deemed to be the Weighted Average Consideration), then: 

(A) on or prior to the effective date of such Merger Event, the Company or the successor or purchasing Person, as the case may be, shall
execute with the Trustee a supplemental indenture (which shall comply with the TIA as in force at the date of execution of such supplemental indenture if such supplemental indenture is then required to so comply) providing for the conversion and
settlement of the Notes as set forth in this Indenture and for adjustments to the Conversion Rate that shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article 10. If, in the case of any Merger Event,
the Reference Property includes shares of stock or other securities and assets of a corporation other than the successor or purchasing corporation, as the case may be, then such supplemental indenture shall also be executed by such other corporation
and shall contain such additional provisions to protect the interests of the Holders as the Board of Directors shall 

  
 65 

 
reasonably consider necessary by reason of the foregoing, including to the extent required by the Board of Directors and practicable the provisions providing for the repurchase rights set forth
in Article 3 herein; 
 (B) subject to the provisions of Sections 10.01 and 10.07, at and after the effective date of such
Merger Event, the right of Holders to convert each $1,000 principal amount of Notes into cash and shares of Common Stock, if any (subject to the Company’s right to pay cash in lieu of all or any portion of the shares of Common Stock), shall be
changed into a right to convert each $1,000 principal amount of Notes into cash and Units of Reference Property, if any (subject to the Company’s right to pay cash in lieu of all or any portion of the Units of Reference Property) so that on or
after the effective date of such Merger Event, 
 (1) references in Section 10.01 to “the Last Reported Sale Price of
the Common Stock” shall be deemed to be references to “the Last Reported Sale Price of a Unit of Reference Property”; 
 (2) the Daily VWAP for a VWAP Trading Day (and any functions thereof) will be calculated based on the value of a Unit of Reference Property on such VWAP Trading Day; 

(3) instead of delivering shares of Common Stock to converting Holders as part of the Daily Share Amount for a VWAP Trading Day, the
Company shall deliver a number of Units of Reference Property equal to the number of shares of Common Stock (subject to the Company’s right to pay cash in lieu of all or a portion of the shares of Common Stock that the Company would otherwise
have been obligated to deliver to such converting Holder as part of the Daily Share Amount for such VWAP Trading Day); and 

(4) instead of delivering an amount of cash in lieu of fractional shares of Common Stock based on the Daily VWAP of the Common Stock,
the Company will deliver an amount of cash in lieu of fractional Units of Reference Property, with the amount of cash calculated in accordance with Section 10.03 (except using the Daily VWAP computed in accordance with clause (2) above).

 (C) For the purposes of this Section 10.06, if a Merger Event causes the Common Stock to be converted into, or
exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of election by holders of the Common Stock), the “Weighted Average Consideration” for such Merger Event means the
weighted average, per share of Common Stock, of the types and amounts of consideration received by the holders of the Common Stock that affirmatively make an election receive in such Merger Event. 

(b) Notices. 
 (i) As soon as practicable after it determines the Weighted Average Consideration, the Company shall notify the Holders of the Weighted Average Consideration. 

(ii) As soon as practicable upon learning the anticipated or actual effective of a Merger Event, the Company shall deliver written notice
to the Holders stating: 

  
 66 

 (1) a brief description of such Merger Event; 

(2) the Conversion Rate in effect on the date the Company delivers such notice; 

(3) the anticipated effective date for the Merger Event; 
 (4) that the Notes will be convertible into Reference Property in lieu of shares of Common Stock on and after the effective date for the Merger Event; and 

(5) the composition of a Unit of Reference Property for such Merger Event. 
 provided, however, that the Company will use commercially reasonable efforts to deliver such written notice at least 35 Scheduled Trading Days immediately prior to the effective date for
such Merger Event. 
 (c) If the Company executes a supplemental indenture pursuant to this Section 10.06, as promptly as
practicable, the Company shall file with the Trustee an Officer’s Certificate briefly describing such Merger Event, the composition of a Unit of Reference Property for such Merger Event, any adjustment to be made with respect thereto and that
all conditions precedent to such Merger Event under this Indenture have been complied with. Any failure to deliver such Officer’s Certificate shall not affect the legality or validity of such supplemental indenture. 

(d) The provisions of this Section 10.06 shall apply successively to successive Merger Events. 

Section 10.07 Adjustment to Conversion Rate Upon Certain Transactions. 

(a) If a Make-Whole Fundamental Change occurs and a Holder converts a Note “in connection” with such Make-Whole Fundamental
Change, the Company will, in the circumstances described in this Section 10.07, increase the Conversion Rate for such Note by the number of additional shares Common Stock (the “Additional Shares”) described in this
Section 10.07. For the purposes of this Section 10.07, any conversion during the period beginning on, and including, the effective date of a Make-Whole Fundamental Change (the “Make-Whole Fundamental Change Effective
Date”) and ending on, and including, the Close of Business on the earliest of (i) the 35th Scheduled Trading Day immediately following the Make-Whole Fundamental Change Effective Date, (ii) if the Make-Whole Fundamental Change is
also a Fundamental Change, the Fundamental Change Purchase Date corresponding to such Fundamental Change, and (iii) the second Scheduled Trading Day immediately preceding the Maturity Date, will be deemed to be “in connection with”
such Make-Whole Fundamental Change, regardless of any other condition to conversion. 
 (b) The numbers of Additional Shares by
which the Conversion Rate will be increased if a Holder converts a Note in connection with a Make-Whole Fundamental Change will be determined by reference to the table below, based on the Make-Whole Fundamental Change Effective Date for such
Make-Whole Fundamental Change and the Stock Price for such Make-Whole Fundamental Change. 

  
 67 

 (c) The following table sets forth hypothetical Make-Whole Fundamental Change Effective
Dates, Stock Prices and the number of Additional Shares by which the Conversion Rate will be increased for a Holder that converts a Note in connection with a Make-Whole Fundamental Change having such Make-Whole Fundamental Change Effective Date and
Stock Price. The Stock Prices set forth in the first row of the tables (i.e., the column headers) will be adjusted on each date on which the Conversion Rate is adjusted pursuant to Section 10.05. The adjusted Stock Prices will equal the Stock
Prices in effect immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the Conversion Rate in effect immediately prior to the adjustment giving rise to the share price adjustment, and the denominator of which is
the Conversion Rate in effect immediately after the adjustment. The numbers of Additional Shares set forth in the table below will be adjusted in the same manner and at the same time as the Conversion Rate. 

 

																																																	
	 	 	Stock Price	 
	 Make-Whole

Fundamental
 Change

Effective Date
	 	$180.79	 	 	$190.00	 	 	$200.00	 	 	$225.00	 	 	$250.00	 	 	$265.76	 	 	$275.00	 	 	$300.00	 	 	$350.00	 	 	$400.00	 	 	$450.00	 	 	$500.00	 
	 March 18, 2013
	 	 	1.7684	  	 	 	1.5854	  	 	 	1.4120	  	 	 	1.0677	  	 	 	0.8176	  	 	 	0.6947	  	 	 	0.6326	  	 	 	0.4939	  	 	 	0.3073	  	 	 	0.1952	  	 	 	0.1256	  	 	 	0.0812	  
	 April 1, 2014
	 	 	1.7684	  	 	 	1.6057	  	 	 	1.4219	  	 	 	1.0584	  	 	 	0.7965	  	 	 	0.6689	  	 	 	0.6048	  	 	 	0.4628	  	 	 	0.2761	  	 	 	0.1675	  	 	 	0.1026	  	 	 	0.0628	  
	 April 1, 2015
	 	 	1.7684	  	 	 	1.5965	  	 	 	1.4021	  	 	 	1.0197	  	 	 	0.7473	  	 	 	0.6163	  	 	 	0.5512	  	 	 	0.4088	  	 	 	0.2277	  	 	 	0.1282	  	 	 	0.0723	  	 	 	0.0402	  
	 April 1, 2016
	 	 	1.7684	  	 	 	1.5579	  	 	 	1.3507	  	 	 	0.9461	  	 	 	0.6630	  	 	 	0.5299	  	 	 	0.4647	  	 	 	0.3258	  	 	 	0.1601	  	 	 	0.0781	  	 	 	0.0373	  	 	 	0.0167	  
	 April 1, 2017
	 	 	1.7684	  	 	 	1.4817	  	 	 	1.2554	  	 	 	0.8164	  	 	 	0.5189	  	 	 	0.3857	  	 	 	0.3229	  	 	 	0.1971	  	 	 	0.0696	  	 	 	0.0224	  	 	 	0.0054	  	 	 	0.0008	  
	 April 1, 2018
	 	 	1.7684	  	 	 	1.5003	  	 	 	1.2372	  	 	 	0.6816	  	 	 	0.2372	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  

 If the exact Stock Price and Make-Whole Fundamental Change Effective Date for a Make-Whole Fundamental Change are not set
forth in the table above, then: 
 (A) if the Stock Price is between two prices listed in the table or the Make-Whole
Fundamental Change Effective Date is between two dates listed in the table, then the number of Additional Shares by which the Conversion Rate will be increased for a Holder that converts its Notes in connection with such Make-Whole Fundamental
Change will be determined by a straight-line interpolation between the numbers of Additional Shares set forth for the higher and lower listed prices in the table and the two Make-Whole Fundamental Change Effective Dates in the table, based on a
365-day year; 
 (B) if the Stock Price is greater than $500.00, subject to adjustment in the same manner and at the same time
as the Stock Prices listed in the table, the Conversion Rate will not be adjusted; and 
 (C) if the Stock Price is less than
$180.79, subject to adjustment in the same manner and at the same time as the Stock Prices listed in the table, the Conversion Rate will not be adjusted. 
 Notwithstanding the foregoing, in no event will the Conversion Rate exceed 5.5312, subject to adjustment in the same manner and at the same time as the Conversion Rate under Section 10.05 

(d) If a Holder converts a Note in connection with a Make-Whole Fundamental Change, the Company will settle such conversion of such Note
in accordance with Section 10.03; provided, however, that notwithstanding anything to the contrary in Section 10.03, if a Holder converts a Note in connection with a Make-Whole Fundamental Change described in clause (2)

  
 68 

 
of the definition Fundamental Change in which the holders of the Common Stock receive only cash in consideration for their shares of Common Stock, the Company will settle such conversion by
delivering to such Holder, on the third Business Day immediately following the Conversion Date for such Note, an amount of cash, for each $1,000 principal amount of such Note converted, equal to the product of (i) the Conversion Rate on the
Conversion Date for such Note (including any Additional Shares added to such Conversion Rate pursuant to this Section 10.07) and (ii) the Stock Price. 
 Section 10.08 Miscellaneous. 
 (a) Company Determination Final. Any
determination and/or calculation that the Company or the Board of Directors must make pursuant to this Article 10 is conclusive, absent manifest error. 
 (b) Trustee’s Disclaimer. The Trustee has no duty to determine when an adjustment under this Article 10 should be made, how it should be made or what it should be. The Trustee shall not
be accountable for and makes no representation as to the validity or value of any securities or assets issued upon conversion of Notes. The Trustee shall not be responsible for the Company’s failure to comply with this Article 10. Each
Conversion Agent shall have the same protection under this Section 10.08 as the Trustee. 
 ARTICLE 11. 

PAYMENT OF INTEREST 
 Section 11.01 Payment of Interest. The Company shall pay interest on the Notes at a rate of 0.25% per annum, payable semi-annually in arrears on April 1 and October 1 of each
year (each, an “Interest Payment Date”) or, if any such day is not a Business Day, the immediately following Business Day, commencing October 1, 2013. Interest on a Note shall be paid to the
Holder of such Note at the Close of Business on March 15 or September 15 (each, a “Record Date”), as the case may be, immediately preceding the related Interest Payment Date, and shall be
computed on the basis of a 360-day year comprised of twelve 30-day months. In the event of the maturity, conversion, or repurchase of a Note by the Company at the option of the Holder, interest shall cease to accrue on such
Note. If the Conversion Date for a Note occurs after a Record Date but on or before the corresponding Interest Payment Date, the interest payable on such Interest Payment Date will be paid to the Holder of such Note on such Record Date
notwithstanding the conversion of such Note. 
 Section 11.02 Defaulted Interest. Any installment of interest that is
payable, but is not punctually paid or duly provided for on any Interest Payment Date (“Defaulted Interest”), shall forthwith cease to be payable to the Holders in whose names the Notes were registered on the Record
Date applicable to such installment of interest. Defaulted Interest (including any interest on such Defaulted Interest) may be paid by the Company, at its election, as provided in Sections 11.02(a) or 11.02(b). 

(a) The Company may elect to make payment of any Defaulted Interest (including any interest on such Defaulted Interest) to the Holders in
whose names the Notes are registered at the Close of Business on a special record date for the payment of such Defaulted Interest (a 

  
 69 

 
“Special Record Date”), which shall be fixed in the following manner. The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid and
the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to
the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Holders entitled to such Defaulted Interest as provided in this Section 11.02(a). Thereupon the Trustee
shall fix a Special Record Date for the payment of such Defaulted Interest, which shall be not more than 15 calendar days and not less than ten calendar days prior to the date of the proposed payment and not less than ten calendar days after the
receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such Special Record Date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted
Interest and the Special Record Date therefor to be sent by first-class mail, postage prepaid, to each Holder at such Holder’s address as it appears in the registration books of the Registrar, not less than ten calendar days prior to such
Special Record Date. Notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid to the Holders in whose names the Notes are registered at the
Close of Business on such Special Record Date and shall no longer be payable pursuant to Section 11.02(b). 
 (b)
Alternatively, the Company may make payment of any Defaulted Interest (including any interest on such Defaulted Interest) in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Notes may be listed,
and upon such notice as may be required by such exchange if, after notice given by the Company to the Trustee of the proposed payment pursuant to this Section 11.02(b), such manner of payment shall be deemed practicable by the Trustee.

 Section 11.03 Interest Rights Preserved. Subject to the foregoing provisions of this Article 11 and, to
the extent applicable, Sections 2.06 and 2.07, each Note delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Note shall carry the rights to interest accrued and unpaid, and
to accrue, which were carried by such other Note. 
 ARTICLE 12. 

MISCELLANEOUS 
 Section 12.01 Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies, or conflicts with another provision that is required to be included in this Indenture
by the TIA, the required provision shall control. 
 Section 12.02 Notices. Any request, demand,
authorization, notice, waiver, consent or communication shall be in writing and delivered in Person or mailed by first-class mail, postage prepaid, addressed as follows or transmitted by facsimile transmission or other similar means of
unsecured electronic methods to the following: 
 if to the Company: 

  
 70 

 salesforce.com, inc. 

The Landmark @ One Market, Suite 300 
 San Francisco, California 94105 
 Facsimile: (415) 901-8437 

Attn: General Counsel 
 if to the Trustee, Registrar, Paying Agent or Conversion Agent: 
 U.S. Bank
National Association 
 633 West 5th Street, 24th Floor 
 Los Angeles, California 90071 
 Facsimile: (213) 615-6197 

Attn: Paula M. Oswald, Corporate Trust Services 
 (salesforce.com 0.25% Convertible Senior Notes due 2018) 
 The Company or the
Trustee, by notice given to the other in the manner provided above, may designate additional or different addresses for subsequent notices or communications. 
 Any notice or communication given to a Holder shall be mailed to the Holder, by first-class mail, postage prepaid, at the Holder’s address as it appears on the registration books of the Registrar and
shall be deemed given on the date of such mailing. 
 Failure to mail a notice or communication to a Holder or any defect in it
shall not affect its sufficiency with respect to other Holders. If a notice or communication is mailed in the manner provided above, it is duly given, whether or not received by the addressee. 

If the Company mails a notice or communication to the Holders, it shall, at the same time, mail a copy to the Trustee and each of the
Registrar, Paying Agent and Conversion Agent.If the Company is required under this Indenture to give a notice to the Holders, in lieu of delivering such notice to the Holders, the Company may deliver such notice to the Trustee and cause the Trustee
to have delivered such notice to the Holders on or prior to the date on which the Company would otherwise have been required to deliver such notice to the Holders. In such a case, the Company shall also cause the Trustee to mail a copy of the notice
to each of the Registrar, Paying Agent and Conversion Agent at the same time it mails the notice to the Holders. 
 Section
12.03 Communication by Holders with Other Holders. Holders may communicate pursuant to TIA Section 312(b) with other Holders with respect to their rights under this Indenture or the Notes. The Company, the Trustee, the
Registrar, the Paying Agent, the Conversion Agent and anyone else shall have the protection of TIA Section 312(c). 
 Section 12.04 Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall
furnish to the Trustee: 

  
 71 

 (a) an Officer’s Certificate stating that, in the judgment of the signers, all
conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 
 (b)
an Opinion of Counsel stating that, in the judgment of such counsel, all such conditions precedent relating to the proposed action (to the extent of legal conclusions) have been complied with. 

Section 12.05 Statements Required in Certificate or Opinion. Each Officer’s Certificate or Opinion of Counsel with respect to
compliance with a covenant or condition (except for such Officer’s Certificate required to be delivered pursuant to Section 4.03) provided for in this Indenture shall include: 

(a) a statement that each Person making such Officer’s Certificate or Opinion of Counsel has read such covenant or condition;

 (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or judgments
contained in such Officer’s Certificate or Opinion of Counsel are based; 
 (c) a statement that, in the judgment of each
such Person, he has made such examination or investigation as is necessary to enable such Person to express an informed judgment as to whether or not such covenant or condition has been complied with; and 

(d) a statement that, in the judgment of such Person, such covenant or condition has been complied with. 

Section 12.06 Separability Clause. In case any provision in this Indenture or in the Notes shall be invalid, illegal or
unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 12.07 Rules by Trustee. The Trustee may make reasonable rules for action by or a meeting of Holders. 
 Section 12.08 Governing Law. THE INDENTURE AND EACH NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK BUT WITHOUT GIVING EFFECT TO
ANY APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. 
 Section 12.09 No Recourse Against Others. A director, officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Notes or
this Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Note, each Holder shall waive and release all such liability. The waiver and release shall be part of the consideration for
the issue of the Notes. 

  
 72 

 Section 12.10 Calculations. The Company will be responsible for making all
calculations called for under the Notes. These calculations include, but are not limited to, determinations of the Last Reported Sale Prices of the Common Stock, Daily VWAPs, Daily Conversion Values, Daily Settlement Amounts, accrued interest
payable on the Notes and the Conversion Rate in effect on any Conversion Date. 
 The Company will make these calculations in
good faith and, absent manifest error, the calculations will be final and binding on Holders. The Company will provide to each of the Trustee and the Conversion Agent a schedule of its calculations, and each of the Trustee and Conversion Agent is
entitled to rely upon the accuracy of such calculations without independent verification. The Trustee will forward the Company’s calculations to any Holder upon the request of such Holder. 

All calculations shall be made to the nearest cent or to the nearest 1/10,000th of a share, as the case may be. 

Section 12.11 Successors. All agreements of the Company, the Trustee, the Registrar, the Paying Agent and the
Conversion Agent in this Indenture and the Notes shall bind their respective successors. 
 Section 12.12 Multiple
Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. One signed copy is enough to prove this Indenture. 

Section 12.13 Table of Contents; Headings. The table of contents and headings of the Articles and Sections of this Indenture have
been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof. 
 Section 12.14 Force Majeure. The Trustee, Registrar, Paying Agent, and Conversion Agent shall not incur any liability for not performing any act or fulfilling any duty,
obligation or responsibility hereunder by reason of any occurrence beyond the control of such person (including but not limited to any act or provision of any present or future law or regulation or governmental authority, any act of God or
war, civil unrest, local or national disturbance or disaster, any act of terrorism, or the unavailability of the Federal Reserve Bank wire or facsimile or other wire or communication facility). 

Section 12.15 Submission to Jurisdiction. The Company (i) agrees that any suit, action or proceeding against it
arising out of or relating to this Indenture or the Notes, as the case may be, may be instituted in any U.S. federal court with applicable subject matter jurisdiction sitting in The City of New York; (ii) waives, to the
fullest extent permitted by applicable law, any objection which it may now or hereafter have to the laying of venue of any such suit, action or proceeding, and any claim that any suit, action or proceeding in such a court has been brought in
an inconvenient forum; and (iii) submits to the non-exclusive jurisdiction of such courts in any suit, action or proceeding. 
 Section 12.16 Legal Holidays. In any case where any Interest Payment Date, Fundamental Change Purchase Date, Conversion Date or Maturity Date is not a Business Day,

  
 73 

 
then any action to be taken on such date need not be taken on such date, but may be taken on the immediately following Business Day with the same force and effect as if taken on such
date, and no interest shall accrue for the period from and after such date. 
 Section 12.17 No Security Interest
Created. Except as provided in Section 7.07, nothing in this Indenture or in the Notes, expressed or implied, shall be construed to constitute a security interest under the Uniform Commercial Code or similar
legislation, as now or hereafter enacted and in effect, in any jurisdiction. 
 Section 12.18 Benefits of Indenture.
Nothing in this Indenture or in the Notes, expressed or implied, shall give to any Person, other than the parties hereto, any Paying Agent, any Conversion Agent, any authenticating agent, any
Registrar and their successors hereunder or the Holders, any benefit or any legal or equitable right, remedy or claim under this Indenture. 

  
 74 

 IN WITNESS WHEREOF, salesforce.com, inc. has caused this Indenture to be duly executed as a
deed the day and year first before written. 
  

			
	salesforce.com, inc.
		
	By:	 	 /s/ Burke F. Norton

	Name: Burke F. Norton
	Title: Executive Vice President and Chief Legal Officer

  

salesforce.com, inc. 0.25% Convertible Senior Notes – Indenture Signature Page 

 IN WITNESS WHEREOF, the undersigned, being duly authorized, has executed this Indenture as
of the date first above written. 
  

			
	U.S. BANK NATIONAL ASSOCIATION, as Trustee, Paying Agent, Registrar and Conversion Agent
		
	By:	 	 /s/ Paula Oswald

	Name:	 	Paula Oswald
	Title:	 	Vice President

  

salesforce.com, inc. 0.25% Convertible Senior Notes – Indenture Signature Page 

 EXHIBIT A 

FORM OF NOTE 
 [FORM OF FACE OF NOTE] 
 [Include the following legend for Global Notes
only (the “Global Securities Legend”):] 
 [THIS IS A GLOBAL NOTE WITHIN
THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS CONVERTIBLE NOTE
FOR ALL PURPOSES. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE
ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY
(AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.TRANSFERS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS TO NOMINEES OF THE DEPOSITORY TRUST COMPANY, OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S
NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN ARTICLE TWO OF THE INDENTURE REFERRED TO ON THE REVERSE HEREOF.] 

[Include the following legend on all Notes that are Restricted Notes (the “Restricted Securities
Legend”):] 
 [THE SALE OF THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, PRIOR TO THE RESALE RESTRICTION TERMINATION DATE (AS DEFINED BELOW), THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE (AND ANY BENEFICIAL INTEREST HEREIN
OR THEREIN) MAY NOT BE OFFERED, RESOLD OR OTHERWISE TRANSFERRED, EXCEPT: 
  

	 	(A)	TO THE COMPANY OR ANY SUBSIDIARY THEREOF; 

  

	 	(B)	PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; 

  
 A-1

	 	(C)	TO A PERSON THAT YOU REASONABLY BELIEVE TO BE A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT; OR 

 

	 	(D)	UNDER ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (INCLUDING, IF AVAILABLE, THE EXEMPTION PROVIDED BY RULE 144 UNDER THE
SECURITIES ACT). 

 THE “RESALE RESTRICTION TERMINATION DATE” MEANS THE DATE: (A) THAT IS AT LEAST
ONE YEAR AFTER THE LAST DATE OF ORIGINAL ISSUANCE OF THE NOTES; AND (B) ON WHICH THE COMPANY HAS INSTRUCTED THE TRUSTEE THAT THIS LEGEND WILL NO LONGER APPLY IN ACCORDANCE WITH THE PROCEDURES DESCRIBED IN THE INDENTURE. 

PRIOR TO ANY TRANSFER PURSUANT TO THE FOREGOING CLAUSE (D), THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH
CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS THEY MAY REASONABLY REQUIRE AND MAY RELY UPON TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT. 
 NO AFFILIATE OF THE COMPANY MAY PURCHASE OR OTHERWISE ACQUIRE NOTES.] 

  
 A-2

 No.: [            ] 

CUSIP: 79466L AC8 
 ISIN: US79466LAC81

 Principal Amount $ [            ] 

as revised by the Schedule of Increases 
 and Decreases in the Global Note attached hereto 
 salesforce.com, inc.

 0.25% Convertible Senior Notes due 2018 
 salesforce.com, inc., a Delaware corporation, promises to pay to [            ] [include “Cede & Co.” for Global
Note] or registered assigns, the principal amount of $ [            ] on April 1, 2018 (the “Maturity Date”). 

Interest Payment Dates: April 1 and October 1. 
 Record Dates: March 15 and September 15. 
 Additional provisions of this
Note are set forth on the other side of this Note. 

  
 A-3

 
			
	salesforce.com, inc.
		
	By:	 	  

	Name:
	 Title:

Dated:

  

salesforce.com, inc. 0.25% Convertible Senior Notes – Note Signature Page 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

U.S. BANK NATIONAL ASSOCIATION, as Trustee, certifies that this is one of the Notes referred to in the within-mentioned Indenture.

  

			
	By:	 	  

	Name:
	Title: Authorized Signatory
	Dated:

  

salesforce.com, inc. 0.25% Convertible Senior Notes – Note Signature Page 

 [FORM OF REVERSE OF NOTE] 

SALESFORCE.COM, INC. 
 0.25% Convertible Senior Notes due 2018 
 This Note is one of a duly authorized
issue of Notes of the Company, designated as its 0.25% Convertible Senior Notes due 2018 (the “Notes”), all issued or to be issued under and pursuant to an Indenture dated as of March 18, 2013 (the
“Indenture”), between the Company and U.S. Bank National Association (the “Trustee”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations
of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders. Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Indenture. 

 

	1.	Interest. 

 This Note shall bear
cash interest at the rate of 0.25% per annum. Interest on this Note shall accrue from the Issue Date or from the most recent date to which interest has been paid or provided for. Interest shall be payable semiannually in arrears on April 1
and October 1 of each year, beginning on October 1, 2013, to the Holder of record of this Note as of the Close of Business on the March 15 or September 15 immediately preceding each Interest Payment Date. Each payment of cash
interest on this Note shall include interest accrued for the period commencing on and including the immediately preceding Interest Payment Date (or, if none, the Issue Date) through the day before the applicable Interest Payment Date. Any payment
required to be made on any day that is not a Business Day shall be made on the next succeeding Business Day and no interest or other amount will be paid as a result of any such postponement. Interest shall be calculated using a 360-day year composed
of twelve 30-day months. Interest shall cease to accrue on this Note upon its Maturity Date, conversion or repurchase by the Company at the option of the Holder upon the occurrence of a Fundamental Change. 

Subject to certain exceptions, interest on Notes converted after a Record Date, but on or prior to the corresponding Interest Payment
Date, will be paid to the Holder of the Notes on the Record Date, but upon conversion, the Holder must pay the Company the interest which has accrued and will be paid by the Company on such Interest Payment Date. No such payment need be made
(1) if the Company has specified a Fundamental Change Purchase Date that is after a Record Date and on or prior to the next Interest Payment Date; (2) to the extent of overdue interest, if any overdue interest exists on the Conversion Date
with respect to such Notes; or (3) if such Notes are surrendered for conversion after the Close of Business on the Record Date immediately preceding the Maturity Date. 

 

	2.	Method of Payment. 

 The Company
shall promptly make all payments in respect of the Notes on the dates and in the manner provided herein and in the Indenture. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, accrued and
unpaid interest (including Additional Interest and Special Interest), if any, or payment of the Fundamental Change Purchase Price in money of the United States that at the time of payment is 

  
 A-6

 
legal tender for payment of public and private debts. The Company will make all payments in respect of a Global Note registered in the name of the Depositary or its nominee to the Depositary or
its nominee, as the case may be, by wire transfer of immediately available funds to the account specified by such Holder. If an Interest Payment Date is a date other than a Business Day, payment may be made at that place on the next succeeding day
that is a Business Day and no interest shall accrue for the intervening period. 
  

	3.	Paying Agent, Conversion Agent and Registrar. 

 Initially, U.S. Bank National Association, will act as the Trustee, Paying Agent, Conversion Agent and Registrar. The Company may appoint and change any Paying Agent, Conversion Agent or Registrar without
notice, other than notice to the Trustee; provided, however, that the Company will maintain at least one Paying Agent in the United States of America, which shall initially be an office or agency of the Trustee. The Company or any of
its Subsidiaries or any of their affiliates may act as Paying Agent, Conversion Agent or Registrar. 
  

	4.	Indenture. 

 The terms of the
Notes include those stated in the Indenture and those made part of the Indenture by reference to the TIA. Capitalized terms used herein and not defined herein have the meanings ascribed thereto in the Indenture. The Notes are subject to all such
terms, and Holders are referred to the Indenture and the TIA for a statement of those terms. 
  

	5.	Purchase By the Company at the Option of the Holder upon a Fundamental Change. 

 (a) At the option of the Holder, and subject to the terms and conditions of the Indenture, upon the occurrence of a Fundamental Change, each Holder will have the right, at its option, to require the
Company to purchase for cash all of its Notes, or any portion of its Notes in principal amount equal to $1,000 or an integral multiple of thereof, at a Fundamental Change Purchase Price equal to 100% of the principal amount of Notes to be purchased
plus accrued and unpaid interest (including Additional Interest and Special Interest), if any, to but excluding, the Fundamental Change Purchase Date. To exercise its purchase right, a Holder must deliver, on or before the Close of Business on the
Business Day immediately preceding the Fundamental Change Purchase Date, written notice to the Trustee of such Holder’s exercise of its purchase right, together with the Notes with respect to which the right is being exercised. Subject to such
Holder’s satisfaction of certain requirements in the Indenture, the Company is required to purchase the Notes on a date specified by the Company that is no fewer than 20 calendar days and no more than 35 calendar days after the date on which
the Company delivers notice of the Fundamental Change, which date shall be no more than 20 calendar days after the effective date of the Fundamental Change. 
 (b) Holders have the right to withdraw a Fundamental Change Purchase Notice delivered pursuant to Paragraph 5(a) above by delivering to the Paying Agent, in accordance with the provisions of the
Indenture, a written notice of withdrawal at any time prior to the Close of Business on the Business Day immediately preceding the Fundamental Change Purchase Date. If cash sufficient to pay the Fundamental Change Purchase Price of all Notes or
portions thereof to be repurchased as of the Fundamental Change Purchase Date is deposited with the 

  
 A-7

 
Paying Agent on the Fundamental Change Purchase Date, interest (including Additional Interest and Special Interest), if any, will cease to accrue on such Notes (or portions thereof) immediately
after such Fundamental Change Purchase Date, and the Holder thereof shall have no other rights as such other than the right to receive the Fundamental Change Purchase Price upon surrender of such Note. 

 

	6.	Conversion. 

 (a) Subject to and
upon compliance with the provisions of the Indenture (including, without limitation, the conditions to conversion of this Note set forth in Section 10.01 of the Indenture), a Holder hereof has the right, at such Holder’s option, to convert
the principal amount hereof or any portion of such principal amount that is $1,000 or an integral multiple thereof, subject to Sections 10.01 and 10.03 of the Indenture, into cash and shares of Common Stock, if any (subject to the Company’s
right to deliver cash in lieu of all or a portion of such shares of Common Stock), at the Conversion Rate in effect on the Conversion Date. The Conversion Rate shall initially equal 3.7628 shares of Common Stock per $1,000 and is subject to
adjustment as described in the Indenture. For the avoidance of doubt, if the Stock Split occurs (assuming no other adjustments to the Conversion Rate have occurred), the Notes will have an adjusted Conversion Rate of 15.0512 shares of the Common
Stock per $1,000 principal amount of Notes (which is equivalent to an initial Conversion Price of approximately $66.44 per share of Common Stock). 
 (b) To surrender a Note for conversion, a Holder must (1) complete and manually sign the irrevocable conversion notice below or as provided by the Conversion Agent (or complete and manually sign a
facsimile of such notice) and deliver such notice to the Conversion Agent; (2) surrender the Note to the Conversion Agent (if the Note is a Certificated Note); (3) if required, furnish appropriate endorsements and transfer documents;
(4) if required pay all transfer or similar taxes; and (5) if required, pay funds under Sections 10.02(e) and 10.02(f) of the Indenture. If a Holder holds a beneficial interest in a Global Note, such Holder must also comply with any
procedure of DTC applicable to the conversion of a beneficial interest in such Global Note. 
  

	7.	Denominations; Transfer; Exchange. 

 The Notes are in fully registered form, without coupons, in denominations of $1,000 of principal amount and integral multiples of $1,000. A Holder may transfer or exchange Notes in accordance with the
Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. The Registrar need not transfer or exchange
any Notes in respect of which a Fundamental Change Purchase Notice has been given and not withdrawn (except, in the case of a Note to be repurchased in part, the portion of the Note not to be repurchased). 

 

	8.	Amendment, Supplement and Waiver. 

Subject to certain exceptions, the Indenture or the Notes may be amended or supplemented with the written consent of the Holders of at
least a majority in aggregate principal 

  
 A-8

 
amount of the Notes at the time outstanding by the Company and the Trustee. The Company and the Trustee may also amend or supplement the Indenture or the Notes without the consent of any Holder
to: (A) cure any ambiguity, omission, defect or inconsistency in the Indenture or in the Notes; (B) conform the terms of the Indenture or the Notes to the “Description of Notes” section of the Offering Memorandum;
(C) make provisions with respect to the conversion rights of the Holders in accordance with Section 10.06 of the Indenture; (D) provide for the assumption by a successor corporation of the Company’s obligations under the
Indenture as described in Article 5 of the Indenture; (E) add guarantees with respect to the Notes; (F) secure the Notes; (G) add to the Company’s covenants for the benefit of the Holders or surrender any right or power
conferred upon the Company; (H) make any change that does not adversely affect the rights of any Holder; (I) appoint a successor Trustee with respect to the Notes; (J) comply with the rules of any applicable securities depositary,
including DTC; or (K) comply with any requirements of the SEC in connection with the qualification of the Indenture under the TIA. 
  

	9.	Defaults and Remedies. 

 Each of
the following is an Event of Default under the Indenture: (A) the Company defaults in the payment of interest (including Additional Interest and Special Interest), if any, on any Note when the same becomes due and payable and such default
continues for a period of 30 days; (B) the Company defaults in the payment of principal of any Note when the same becomes due and payable at the Maturity Date, upon declaration of acceleration, upon any Fundamental Change Purchase Date or
otherwise; (C) the failure by the Company to deliver the consideration due upon the conversion of any Notes and such failure continues for a period of five Business Days; (D) the failure by the Company to deliver a Fundamental Change
Notice as required by Section 3.03 of the Indenture or to deliver a Specified Corporate Transaction Notice as required by Section 10.01(a)(iv) of the Indenture; (E) the failure by the Company to comply with its obligations under
Article 5 of the Indenture; (F) the default in the performance of or the breach of any other covenant or agreement of the Company in the Indenture with respect to the Notes (other than a covenant or agreement in respect of which a default
or breach is specifically addressed in Sections 6.01(a)(i) through 6.01(a)(v) of the Indenture) and such default or breach continues for a period of 60 consecutive days after written notice of such default is delivered to the Company by the Trustee
or to the Company and the Trustee by the Holders of 25% or more in aggregate principal amount of the Notes then outstanding; (G) the occurrence of an event of default as defined under any mortgage, indenture or instrument under which there may
be issued, or by which there may be secured or evidenced, any indebtedness of the Company or any Significant Subsidiary for money borrowed, whether such indebtedness exists as of the Issue Date or is later created, if that event of default:
(i) constitutes the failure to pay when due (whether at express maturity, upon acceleration as a result of an event of default or otherwise) indebtedness in an aggregate principal amount in excess of $100,000,000, and (ii) such event of
default continues for a period of 30 days after written notice thereof is delivered to the Company by the Trustee or to the Company and the Trustee by the Holders of 25% or more of the aggregate principal amount of the Notes then outstanding without
such Default having been cured or waived, such acceleration having been rescinded or annulled (if applicable) and such indebtedness not having been paid or discharged; (H) the Company or any of its Significant Subsidiaries pursuant to or within
the meaning of any Bankruptcy Law: (i) commences a voluntary case; (ii) consents to the entry of an order for relief against it in an involuntary case; (iii) consents to the appointment of a Custodian of it or for any substantial part
of its property; 

  
 A-9

 
(iv) makes a general assignment for the benefit of its creditors; or (v) takes any comparable action under any foreign laws relating to insolvency; or (I) a court of competent
jurisdiction enters an order or decree under any Bankruptcy Law that: (i) is for relief against the Company or any of its Significant Subsidiaries in an involuntary case; (ii) appoints a Custodian of the Company or any of its Significant
Subsidiaries or for any substantial part of its or any of its Significant Subsidiaries’ property; (iii) orders the winding up or liquidation of the Company or any of its Significant Subsidiaries; or (iv) grants any similar relief
under any foreign laws; and, in each such case, the order or decree remains unstayed and in effect for 60 days. 
 The Indenture
provides that if an Event of Default (other than an Event of Default specified in Sections 6.01(a)(viii) or 6.01(a)(ix) of the Indenture with respect to the Company) occurs and is continuing, the Trustee by notice to the Company or the Holders of at
least 25% in aggregate principal amount of the Notes then outstanding by notice to the Company and the Trustee, may declare the principal amount plus accrued and unpaid interest (including Additional Interest and Special Interest), if any, on the
Notes to be due and payable immediately. If an Event of Default specified in Sections 6.01(a)(viii) or 6.01(a)(ix) of the Indenture with respect to the Company (and not solely with respect to one or more of its Significant Subsidiaries), occurs and
is continuing, the principal amount plus accrued and unpaid interest, if any, on the Notes shall, automatically and without any action by the Trustee or any Holder, become and be immediately due and payable without any declaration or other act on
the part of the Trustee or any Holders. The Holders of a majority in aggregate principal amount of the Notes at the time outstanding, by notice to the Trustee and the Company, and without notice to any other Holder, may rescind any declaration of
acceleration if the rescission would not conflict with any judgment or decree and if all existing Events of Default have been cured or waived other than nonpayment of the principal amount or accrued but unpaid interest (including Additional Interest
and Special Interest), if any, that have become due solely as a result of acceleration. No such rescission shall affect any subsequent Default or impair any right consequent thereto. 

 

	10.	Persons Deemed Owners. 

 The
registered Holder of this Note may be treated as the owner of this Note for all purposes. 
  

	11.	Unclaimed Money or Notes. 

 The
Trustee and the Paying Agent shall return to the Company upon written request any money or securities held by them for the payment of any amount with respect to the Notes that remains unclaimed for two years, subject to applicable unclaimed property
law. After return to the Company, Holders entitled to the money or securities must look to the Company for payment as general creditors, unless an applicable abandoned property law designates another Person. 

 

	12.	Trustee Dealings with the Company. 

 Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the owner or pledgee of Notes and may otherwise deal with and
collect obligations owed to it by the Company or its affiliates and may otherwise 

  
 A-10

 
deal with the Company or its affiliates with the same rights it would have if it were not the Trustee. 
  

	13.	Calculations in Respect of Notes. 

The Company will be responsible for making all calculations called for under the Notes. These calculations include, but are not limited
to, determinations of the Last Reported Sale Prices of Common Stock, Daily VWAPs, Daily Conversion Values, Daily Settlement Amounts, any accrued interest payable on the Notes and the Conversion Rate in effect on any Conversion Date. 

The Company will make these calculations in good faith and, absent manifest error, the calculations will be final and binding on Holders
of the Notes. The Company will provide to each of the Trustee and Conversion Agent schedule of its calculations, and each of the Trustee and Conversion Agent is entitled to rely upon the accuracy of such calculations without independent
verification. The Trustee will forward the Company’s calculations to any Holder of the Notes upon the request of such Holder. 
  

	14.	No Recourse Against Others. 

 A
director, officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations or their
creation. By accepting a Note, each Holder waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Notes. 
  

	15.	Authentication. 

 This Note shall
not be valid until an authorized signatory of the Trustee manually signs the Trustee’s certificate of authentication on the other side of this Note. 
  

	16.	Abbreviations. 

 Customary
abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with right of survivorship and not as tenants in common), CUST (=custodian), and
U/G/M/A (=Uniform Gift to Minors Act). 
  

	17.	GOVERNING LAW. 

 THE INDENTURE
AND THE NOTES SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK BUT WITHOUT GIVING EFFECT TO ANY APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION
WOULD BE REQUIRED THEREBY. 

  
 A-11

	18.	CUSIP Numbers. 

 Pursuant to a
recommendation promulgated by the Committee on Uniform Note Identification Procedures, the Company has caused CUSIP numbers to be printed on the Notes and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No
representation is made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 

 

	19.	Additional Interest; Special Interest. 

 Holders shall be entitled to payments of Additional Interest or Special Interest to the extent set forth in the Indenture. 
 If the Company is required to pay Additional Interest or Special Interest to Holders, the Company shall provide a direction or order in the form of a written notice to the Trustee (and if the Trustee is
not the Paying Agent, to the Paying Agent) of the Company’s obligation to pay such Additional Interest or Special Interest no later than three Business Days prior to the date on which any such Additional Interest or Special Interest is
scheduled to be paid. Such notice shall set forth the amount of Additional Interest or Special Interest to be paid by the Company on such payment date and direct the Trustee (or, if the Trustee is not the Paying Agent, to the Paying Agent) to make
payment to the extent it receives funds from the Company to do so. The Trustee shall not at any time be under any duty or responsibility to any Holder to determine whether the Additional Interest or Special Interest is payable, or with respect to
the nature, extent, or calculation of the amount of the Additional Interest or Special Interest owed, or with respect to the method employed in such calculation of the Additional Interest or Special Interest. 

The Company will furnish to any Holder, upon written request and without charge, a copy of the Indenture which has in it the text of this
Note in larger type. Requests may be made to: 
 salesforce.com, inc. 
 The Landmark @ One Market, Suite 300 
 San Francisco, California 94105 

Attn: General Counsel 

  
 A-12

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this Note 

 
  
  

 
 (Insert assignee’s soc. sec. or tax ID no.)

  
  

 
  
 (Print or type assignee’s name, address and zip code) 
 and irrevocably appoint
                agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 

  
 A-13

 CONVERSION NOTICE 
 To convert this Note into shares of the Common Stock of the Company, check the box   ̈ 
 To convert only part of this Note, state the principal amount to be converted (which must be $1,000 or an integral multiple of $1,000): 
 If you want the stock certificate made out in another Person’s name fill in the form below: 
  

 
  

 
 (Insert the other Person’s soc. sec. or tax
ID no.) 
  
  

 
  
 (Print or type other Person’s name, address and zip code) 
  

									
	 Date:
	 	  
	  		  	Your Signature:	 	  

 (Sign exactly as your name appears on the other side of this Note) 

Signature Guaranteed 
  

			
	  

	Participant in a Recognized Signature Guarantee Medallion Program
		
	By:	 	  

		 	      Authorized Signatory

  
 A-14

 FUNDAMENTAL CHANGE REPURCHASE NOTICE 

U.S. Bank National Association 
 633 West 5th
Street, 24th Floor 

Los Angeles, California 90071 
 Facsimile:
(213) 615-6197 
 Attn: Paula M. Oswald, Corporate Trust Services 
 (salesforce.com 0.25% Convertible Senior Notes due 2018) 
 The undersigned
registered owner of this Note hereby acknowledges receipt of a notice from salesforce.com, inc. (the “Company”) as to the occurrence of a Fundamental Change with respect to the Company and specifying the Fundamental Change Purchase
Date and requests and instructs the Company to pay to the registered holder hereof in accordance with the applicable provisions of the Indenture referred to in this Note (1) the entire principal amount of this Note, or the portion thereof (that
is equal to $1,000 principal amount or an integral multiple thereof) below designated, and (2) if such Fundamental Change Purchase Date does not fall during the period after a Record Date and on or prior to the corresponding Interest Payment
Date, accrued and unpaid interest, if any, thereon to, but excluding, such Fundamental Change Purchase Date. 
 Certificate
Number: 
  

					
	Dated:	 	  
	 	
			
		 		 	  

		 		 	Signature(s)
			
		 		 	  

		 		 	Social Security or Other Taxpayer Identification Number
			
		 		 	 Principal amount to be repaid (if less than all):
 $            ,000

			
		 		 	NOTICE: The above signature(s) of the Holder(s) hereof must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or
any change whatever.

  
 A-15

 [Include for Global Note] 
 SCHEDULE OF INCREASES AND DECREASES OF GLOBAL NOTE 
 Initial Principal
Amount of Global Note: 
  

									
	 Date
	  	Amount of Increase
in
Principal
Amount of Global
Note	  	Amount of
Decrease in
Principal Amount
of Global Note	  	Principal Amount
of Global Note
After Increase or
Decrease	  	Notation by
Registrar or 
Note
Custodian
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 A-16

 EXHIBIT B 

FORM OF TRANSFER CERTIFICATE 
 0.25% Convertible Senior Notes due 2018 
 Transfer Certificate 

In connection with any transfer of any of the Notes within the period prior to the expiration of the holding period applicable to sales
thereof under Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”) (or any successor provision), the undersigned registered owner of this Note hereby certifies with respect to
$            principal amount of the above-captioned Notes presented or surrendered on the date hereof (the “Surrendered Notes”) for registration of transfer, or for
exchange or conversion where the securities issuable upon such exchange or conversion are to be registered in a name other than that of the undersigned registered owner (each such transaction being a “transfer”), that such transfer
complies with the restrictive legend set forth on the face of the Surrendered Notes for the reason checked below: 
  ̈  A transfer of the Surrendered Notes is made to the Company or any of its Subsidiaries; or 
  ̈  The transfer of the Surrendered Notes complies with Rule 144A under the Securities Act; or 

 ̈  The transfer of the Surrendered Notes is pursuant to an effective
registration statement under the Securities Act; or 
  ̈  The transfer
of the Surrendered Notes is pursuant to another available exemption from the registration requirement of the Securities Act. 

Unless the box below is checked, the undersigned confirms that, to the undersigned’s knowledge, such Notes are not being transferred
to an “affiliate” of the Company as defined in Rule 144 under the Securities Act (an “Affiliate”). 
  ̈  The transferee is an Affiliate of the Company. 
  

			
	 Date:
	 	  

			
	 By:
	 	  

  
 B-1

 (If the registered owner is a corporation, partnership or fiduciary, the title of the Person
signing on behalf of such registered owner must be stated.) 
  

			
	 Signature Guaranteed

	
	  

	 Participant in a Recognized Signature

	
	 Guarantee Medallion Program

		
	 By:
	 	  

	                 Authorized
Signatory

  
 B-2

 EXHIBIT C 

RESTRICTED STOCK LEGEND 

THE SALE OF THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND
ACCORDINGLY, PRIOR TO THE RESALE RESTRICTION TERMINATION DATE (AS DEFINED BELOW), THIS SECURITY (AND ANY BENEFICIAL INTEREST HEREIN) MAY NOT BE OFFERED, RESOLD, OR OTHERWISE TRANSFERRED, EXCEPT: 

 

	(A)	TO THE COMPANY OR ANY SUBSIDIARY THEREOF; 

  

	(B)	PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; OR 

 

	(C)	UNDER ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (INCLUDING, IF AVAILABLE, THE EXEMPTION PROVIDED BY RULE 144 UNDER THE
SECURITIES ACT). 

 THE “RESALE RESTRICTION TERMINATION DATE” MEANS THE DATE: (A) THAT IS AT LEAST ONE YEAR AFTER
THE LAST DATE OF ORIGINAL ISSUANCE OF THE COMPANY’S 0.25% CONVERTIBLE SENIOR NOTES DUE 2018; AND (B) ON WHICH THE COMPANY HAS INSTRUCTED THE TRANSFER AGENT THAT THIS LEGEND WILL NO LONGER APPLY, IN ACCORDANCE WITH THE PROCEDURES DESCRIBED
IN THE INDENTURE FOR THE NOTES. 
 PRIOR TO ANY TRANSFER PURSUANT TO THE FOREGOING CLAUSE (C), THE COMPANY AND THE COMPANY’S TRANSFER AGENT
RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS THEY MAY REASONABLY REQUIRE AND MAY RELY UPON TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT
SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 

  
 C-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]